|
Fenofibrate - Anti-hyperlipaemic (Dec 1999)
|
Zaleplon Sedative/hypnotic- (Jan 2002)
|
|
Bicalutamide - Antiandrogens - Hormones(1984)
|
Cefetamet - Cephalosporins @- (Nov 2002)
|
|
Itopiride hydrochloride- Antiemetic Prokinetic Agent -(July 2002)
|
Tolterodine - Anticholinergics- (FDC- List )- (Sep 2001)
|
|
Divalproex sodium @ - Anticocovulsants (June 2004)
|
Lercanidipine- @ Calcium Channel Blocker- (FDC- List )- (2002)
|
|
Cetrorelix- Ovulation Stimulant - Sex Hormone
|
Interferon - Interferon ALFA - n3
|
|
Montelukast + Bambuterol
|
Pipercillin + Tazobactam - Extended Spectrum
|
|
Filgrastin (recombinant ) granulocyte Factor G-CSF - (Sep 1993)
|
Camylofin Dihcl + Nimesulide
|
|
Interferon alpha 2b @ (July 1982)
|
Ramipril+Hydrochlorthiazide
|
|
Escitalopram - @ Select serotonin reuptake inhibitors- (FDC- List ) (Aug 2004)
|
Reboxetine- @Selective noradrenaline reuptake inhibitor
|
|
Phenothiazines @ -refer Chlorpromazine
|
ACE Inhibitors- refer Captopril @ - Anti-hypertensives
|
|
Contraceptives - Oral- Refer Progesterone
|
Verapramil( *** ) @ - Calcium Channel Blocker
|
|
Fludrocortisone @
|
Glucorticoids - Refer Dexamethasone
|
|
Rivaroxaban - Xarelto- @- Selective Factor Xa Inhibitor-(July 2011)
|
Tricyclic antidepressants- Refer Amitriptyline
|
|
Beta Adrenergic Blockers- Refer Atenolol
|
Losartan Potassium +Atenolol
|
|
Etoricoxib - Selective Cox 2- Inhibitors- (FDC- List ) -(Mar 2008)
|
Efavirenz- @ -Antiviral- (FDC- List ) (May 1993)
|
|
Amisulpride - Antipsychotic agents- (Aug 2006)
|
Trasnsexamic acid + Ethamsylate ( IRRATIONAL COMBINATION )
|
|
Pergolide - @ - Anticonvulsant
|
Antioxidants
|
|
Pimecrolimus - Immunomodulators- Topical - (July 2004)
|
Aluminium hydroxide/Mag salts @ ( *** ) - Antacids- (FDC List) - (June 1967)
|
|
Phenoxybenzamine Hcl - @ Agents for Pheochromocytoma
|
Metyrosine - @ Agents for Pheochromocytoma
|
|
Nitroprusside Sodium-Agents for Hypertensive Emergencies
|
Diazoxide Parentrl@ ( * ) - Agents for Hypertn Emergen
|
|
Thiazide Diuretics- Refer Chlorthiazide
|
Hydantoins- Refer Phenytoin Sodium
|
|
Sulfonylurea- Refer Chlorpropamide
|
Epoprostenol Sodium ( * ) @ - Peripheral Vasodilators
|
|
Antiplatelet agents- Refer Dipyridamole
|
Nasal decongestants - Refer Phenylpropanolamine
|
|
Loop diuretic- Refer Furosemide
|
Sulindac- NSAIDs agent @
|
|
Benzodizepines - Refer Diazepam
|
Vasodilators- Refer Hydralazine
|
|
SSRI- Selective Serotonin reuptake Inhibit- Refer Fluoxetine
|
Nondepolarizing Neuromuscular Blockes- Ref Mivacurium Chlori
|
|
Potassium sparing diuretics- Refer Spironolactone
|
Somaterm - @ growth hormone
|
|
Aminoglycosides- Refer Amikacin
|
Skeletal Muscle Relaxant- Refer Orphenadrine
|
|
Anticholinergic agents- Refer Biperiden
|
Xanthine derivatives (Theophylline )- Refer Aminophylline
|
|
Ivermecitin @ - Anthelminitics- (FDC- List )- (2014)
|
Methylmethacrylate
|
|
Calcipotriol + Betamethasone -(FDC-List)
|
Tazarotene- Retinoids- Dermatological-(FDC-List )- (Sept 2003)
|
|
Calcium channel Blockers- Refer Verapramil
|
DISORDERS AND /OR ADVERSE REACTIONS - 2.CARDIO-VASCULAR SYSTEM - SUMMARY
|
|
DISORDERS AND /OR ADVERSE REACTIONS- 1. ALIMENTARTY SYSTEM - SUMMARY
|
DISORDERS AND / OR ADVERSE REACTIONS - 6. GENITO-URINARY SYSTEM- SUMMARY
|
|
DISORDERS AND /OR ADVERSE REACTIONS - 7. Infections & Infestations - SUMMARY
|
Bismuth salts @
|
|
Bismuth subsalicylates @ ( * ) (BSS) - Antidiarrheals
|
Magaldrate @ - Antacids- (FDC- List )-(Nov 1992)
|
|
Lansoprazole@( * )-Proton pump inhibitors -(Dec 1994)
|
Oxythazine- (FDC - List )
|
|
Cimetidine @ ( *** ) - Histamine H2 antagonists
|
Ranitidine@( *** )-Histamine H2 antagonists- (June 1981)
|
|
Nizatidine @ ( ** ) - Histamine H2 antagonists
|
Sucralfate @ ( ** )-(FDC- List )- (April 2002)
|
|
Famotidine @ ( * ) - Histamine H2 antagonists - (Oct 1986)
|
Omeprazole @ ( * ) - Proton pump inhibitors- (FDC - List )- (April 1991)
|
|
Misoprostol - @ -Prostaglandins- (July 1988)
|
Pantoprazole - @ Proton pump inhibitors - (FDC - List )- (Dec 1998)
|
|
Esomeprazole - @ Proton pump inhibitors- (FDC- List ) (2001)
|
Rabeprazole - @Proton pump inhibitors-(FDC- List)- (Aug 1991)
|
|
Gast.-Intsl. sed.,ant.-acid-sed.comb.& oth.ulcer heal.drgs
|
Dicyclomine - @ Antispasmodics - (FDC- List )
|
|
Clidinium bromide - @ Quartenary antichonergics- (FDC-List)
|
Mepenzolate bromide- @ Quaternary anticholinergics
|
|
Propantheline @ - Quartenary antichonergics
|
Isopropamide - @ Quaternary anticholinergics
|
|
Drotaverine hcl - Antispasmodics- (FDC- List ) (Sep 2008)
|
Hyosine-@Anticholinergic/Antispasmodic- (FDC- List )- (Aug 2005)
|
|
Mebeverine hcl -Antispasmodics- (FDC- List )- (July 2006)
|
Metoclopramide @ ( *** ) - GI stimulants- (FDC- List )- (1985)
|
|
Dexpanthenol- GI stimulants
|
Domperidone - Antiemetics (NDA 1985)
|
|
Doxylamine succinate @ - Antiemetics
|
Histamine H2 Antagonists- Refer Cimetidine
|
|
Bulaquine - Antimalarial
|
Hydrotalcite - Antiulcerant- (FDC- List )
|
|
Modafinil -@ -CNS Stimulant- Analeptics- (Dec 2003)
|
Domperidone + Omeprazole -
|
|
Domperidone+Paracetamol
|
Oxyphenonium bromide - Ulcer healing drugs
|
|
Finasteride - @- Andorgen hormone inhibitor - (June 1992)
|
Somatostatin- (April 1995)- Anti-haemorrhage
|
|
Mosapride @ GI stimulant- (FDC- List)- (Mar 2001)
|
Mosapride + Methylpolysiloxane -
|
|
Pinervarium bromide - @ - Antispasmodics
|
Activated dimethicone.-(FDC List)
|
|
Laxitives,purgatives& lubricants
|
Paraffin - @ - Laxatives- (FDC- List ) (Jan 2009)
|
|
Laxatives@
|
Sodium pico sulphate - @- Laxatives- (FDC- List )- (Feb 1997)
|
|
Bisacodyl @ - Laxatives-(2010)
|
Polyethlene Glycol Electrolyte Soln (PEG-ES) - Bowel evacuant -(FDC- List ) - (2007)
|
|
Dioctyl Sod. sulphosuccinate.- @ -Laxatives
|
Lactulose -Bowel evacuants- (FDC- List )- (March 2006)
|
|
Sennosides/Senna - @ Laxatives
|
Docusate calcium@ - Fecal softeners
|
|
Isopgul husk - Laxatives
|
Gum karaya - Laxatives
|
|
Glucomannan(fibre gel polysacch)-(Sep 1993)
|
Psyllium hydrophylic mucilloid- @ - Laxatives
|
|
Drugs acting on the colon and rectum
|
Betamethasone - @ Topical corticosteroids - (FDC -List)- (July 1984)
|
|
Betamethasone + Miconazole
|
Betamethasone + Gentamycin + Miconazole
|
|
Betamethasone + salicylic acid
|
Betamethasone + Neomycin
|
|
Ziprasidone - Antipsychotic Agents - Benzisoxazole derivative- (Sep 2004)
|
Dutasteride- Androgen Hormone Inhibitor- Sex Hormones - (Feb 2004)
|
|
Epirubicin Hcl - Chemotherapeutic drugs
|
Caffeine ( *** ) - @ Analeptics -(FDC-List) (Mar 1976)
|
|
Clindamycin @ - Lincosamides-(FDC-List) (Nov 1996)
|
5-amino salicylic acid - @ -Antidiarrhoeals
|
|
Sulphasalazine @ Anti-inflammatory drug
|
Cinchocaine hcl @ - Rectal anesthetics
|
|
Loperamide Plain - @Antidiarrheals-(FDC- List)- (Oct 2001)
|
Furazolidone Plain /Combinations @
|
|
Dried Yeast
|
Diphenoxylate + Atropine @ - Antidiarrheals
|
|
Olsalazine Sodium @ -Antidiarrhoeals
|
Mesalamine (5-amino salicylic acid)- @ Antidiarrheals-(Apr 2002)
|
|
Colistin sulphate ( * ) - Antidiarrheal- ( FDC- List )
|
Pancreatic& hepato-billary prepartions
|
|
Tricholine citrate - @ -
|
Essential phospholipids
|
|
Protease
|
Trithioparmethoxy phenyl propane - @ -
|
|
Ursodeoxycholic acid -Ursodiol @ ( Dec 2004 ) - Gall stone soluble agent *
|
Monoctanoin - @- Gallstone solubilizing agents
|
|
Bile salts sequestrants @ ( *** )
|
Silymarin - Hepatobiliary agent- (June 1995)
|
|
Octreotide - @ - Growth hormone release- inhibiting agent
|
Enzymes,digestives
|
|
Diastase
|
Pyridine 3-carboxy ad. N-hydrx.met.nic.- (FDC- List )
|
|
Sodium citrate @ - ( *** ) Systemic Alkalinizers
|
Pancreatin @
|
|
Fungal diastase
|
Amylase- (FDC -List)
|
|
Pepsin
|
Bromelains
|
|
CARDIOVASCULAR SYSTEMS
|
Cardiac disorders
|
|
Diltiazem @ ( *** ) - Calcium channel blocker (1982)
|
Lisonopril @ ( ** ) -ACE(angiotensin convert enzym) inhib- (1987)
|
|
Lisonopril + Hydrochlorthiazide
|
Isosorbide 5-mononitrate @ ( * ) - Anti-anginal drugs- (FDC- List )- (1991)
|
|
Amyl nitrate- @ Anti-anginal drugs
|
Donepezil-Neurodegenerative disease drugs (Mar -2001)
|
|
Nicergoline - Peripheral vasoconstricors
|
Melantoin- (1998)
|
|
Mephentermine sulphate ( * * ) - Vasopressors used in shock
|
Nicorandil - Potassium channel activator- @- (Jan 1997)
|
|
Isosorbide dinitrate - @ Anti-anginal drugs
|
Digoxin@( ***) - Cardiac glycosides
|
|
Mexiletine @ ( *** ) - Antiarrhythmic agents
|
Etophyline + Theophyline
|
|
Quinidine sulphate@( *** ) -Antiarrhythmic agents
|
Moricizine hcl @ ( * ) - Antiarrhythmic agents
|
|
Ibutilide fumarate- Antiarrhythmic agents
|
Lidocaine hcl( * )- @ - Antiarrhythmic agents- ( FDC- List )
|
|
Tocainide hcl @ ( * ) - Antiarrhythmic agents
|
Encainide hcl - @ Antiarrhythmic agents
|
|
Flecainide acetate @ ( *** ) - Antiarrhythmic agents
|
Bretylium tosylate ( * ) - Antiarrhythmic agents
|
|
Adenosine ( * )-Antiarrhythmic agents
|
Dobutamine Hcl ( * ) - Vasopressors used in shock (Oct 1993)
|
|
Ramipril -@ACE(angiotensin converting enzyme) inhibitors- (FDC- List )- (Aug1991)
|
Quinapril- @ACE(angiotensin converting enzyme) inhibitors- (FDC- List )- (Nov 1991)
|
|
Moexipril - @ ACE(angiotensin converting enzyme) inhibitors
|
Fosinopril - @ ACE(angiotensin converting enzyme) inhibitors- (1991)
|
|
Benazepril - @- ACE(angiotensin converting enzyme) inhibitors- (FDC-List)(Apr 1996)
|
Candesartan Cilexetil - Angiotensin II Receptor Antagonists- (FDC-List) (2000)
|
|
Dipyridamole @ ( * ) - Aggregation Inhibitr - Antiplt Agt
|
Abciximab - Glycoprotein IIb Inhibitor - Antiplatalet agent
|
|
Dipyridamole+Aspirin
|
Phenytoin Sodium - @- ( *** ) - Anticonvulsant- (June 2007)
|
|
Amlodipine @ ( * ) - Calcium channel Blocker- (FDC -List )- (July 1992)
|
Amlodipine + Atenolol
|
|
Amlodipine + Enalapril maleate
|
Amlodipine + Lisinopril
|
|
Benidipine hcl - anti-anginal
|
Lacidipine - Anti-hypertensive-(May 1997)
|
|
Amlodipine + Losartan
|
Amlodipine + Benazepril
|
|
Disopyramide@( *** ) -Antiarrhythmic agents
|
Dopamine ( ** )@-Vasopressors used in shock- ( FDC- List ) (Apr 2002)
|
|
Isoproterenol hcl ( * ) @ -Vasopressors used in shock
|
Epinephrine @ ( ***) - Vasopressors used in shock
|
|
Norepinephrine (Levarterenol )-Vasopressors used in shock
|
Metaraminol ( ** ) - Vasopressors used in shock
|
|
Methoxamine hcl ( * ) - Vasopressors used in shock
|
Phenylephrine hcl ( ** ) - @ - Vasopressors used in shock- (FDC- List )- (Jan 2008)
|
|
Phenylephrine hcl + Topicamide
|
Propranolol @ ( *** ) - Beta- Adrenergic blocker- (FDC- List )- (Feb 1980)
|
|
Pindolol @ - Beta- Adrenergic blocker
|
Procainamide @ ( ** ) - Antiarrhythmic agents
|
|
Amiodarone hcl @ ( *** ) - Antiarrhythmic agents- (Dec 1985)
|
Amrinone lactate -Vasodilator
|
|
Milrinone lactate- Inotropic Agents-(Dec 1987)
|
Sotatol hcl @ - Beta-Adrenergic blocker
|
|
Furosemide + Spironolactone - Diuretics Combination
|
Propafenone @ ( *** ) - Antiarrhythmic agents
|
|
Aspirin -(Acetyl Salicylic Acid) @ ( * ) Analgesic- (FDC -List)- (Feb 2003)
|
Difunisal@( * ) Anti-inflammatory agent
|
|
Anginal drugs coronary vasodilators
|
Nifedipine @ ( *** ) - Calcium channel Blocker- (FDC- List )- (Mar 2008)
|
|
Nisoldipine @ ( * ) - Calcium channel Blocker
|
Nicardipine @ ( * ) - Calcium channel Blocker- (Oct 1993)
|
|
Bepridil Hcl @ ( * ) - Calcium channel Blocker
|
Isradipine @ ( * ) - Calcium channel Blocker
|
|
Glyceryl trinitrate ( * )-@Antianginal agent
|
Nitroglycerine - @- Antianginal agent- (FDC- List )- (April 2002)
|
|
Erythrityl tetranitrate @ ( * ) Antianginal agent
|
Telmisartan - Angiotensin II Antagonists- (FDC- List )- (May 2008)
|
|
Pentaerythritol tetranitrate @ Antianginal drugs
|
Atenolol @ ( *** ) --Beta- Adrenergic blocker- (FDC- List )- (2006)
|
|
Metoprolol @ ( *** ) - Beta- Adrenergic blocker- (FDC- List )- (Oct 1982)
|
Esmolol @ ( ** ) - Beta- Adrenergic blocker
|
|
Penbutolol @ ( * ) - Beta- Adrenergic blocker
|
Carteolol @ ( * ) - Beta- Adrenergic blocker
|
|
Nadolol @ ( * ) - Beta- Adrenergic blocker
|
Atenolol + Nifedipine- (FDC -List)
|
|
Bisoprolol fumarate @ - Beta-Adrenergic blocker- (FDC-List) (Feb 1992)
|
Lidoflazine - Anti-anginals
|
|
Oxyfedrine hcl - @ - Antianginal
|
Dilazep dihcl - Antianginal
|
|
Trimetazidine - @ - Antianginal
|
Acebutolol @ ( ** ) - Beta-Adrenergic blocker
|
|
Irbesartan - Angiotensin II Receptor Antagonists- (FDC- List )- (June 2000)
|
Peripheral vasodilators
|
|
Nylidrin hydrochloride - @ Peripheral vasodilators
|
Nicotinic acid derivatives - @ Perpheral vasodilators
|
|
Cyclandelate - @ Peripheral vasodilators
|
Papaverine hcl - @ Peripheral vasodilator
|
|
Ethaverine hcl - @ Peripheral vasodilator
|
Pentoxifylline - @ Haemorheologic agent
|
|
Cinnarazine - @ Antihistamine-(FDC-List) (Feb 1992)
|
Cinnarazine + Domperidone
|
|
Isoxsuprine - @ Peripheral vasodilators
|
Nimodipine @ ( * ) - Calcium Channel Blocker- (Dec 1988)
|
|
Eicosapentaenoic acid @ - Metabolic disorders- (FDC- List) (Sep 1989)
|
Methyldopa @ ( *** )- Antiadrenergic agents- centraly actg- (FDC- List )
|
|
Guanfacine hcl -@Antiadrenergic agents- centrally acting
|
Guanabenz - @ Antiadrenergic agents- centrally acting
|
|
Alteplase Recombinant- @ - Tissue Plasmsmogn Actv- Throm Agts
|
Promazine - @ Antipsychotic agent -Phenotiazine derivative
|
|
Captopril @ ( *** ) - ACE(angiotens convertg enzym) inhibitors- (FDC-List)
|
Captopril + Hydrochlorothiazide
|
|
Clopamide - @ Diuretics
|
Celiprolol - Antihypertensive
|
|
Enalapril maleate - @ ACE (angiotensin convert enzyme)inhibitors- (FDC- List ) (Aug 1989)
|
Losartan Potassium - @Angiotensin II antagonists- (FDC- List )-(April 1995)
|
|
Phentolamine - @ Agent for Pheochromocytoma
|
Perindopril @ - ACE (Angiotensin - Converting Enyme Inhbt)- (FDC- List ) - (Sep 1991)
|
|
Fenoldopam Mesylate - @ Agents for Hypertensive Emergencies
|
Labetalol hcl@( * )-Alpha/Beta adrenergic blocker
|
|
Carvedilol ( ** ) @ - Alpha/Beta adrenergic blocker
|
Enalapril mal + Hydrocholrthiazide
|
|
Reserpine + dihydrallazine@Antihypertensive
|
Reserpine( ** )@ -Aantiadrenergic agents-periph acting- (FDC- List )- (June 1972)
|
|
Reserpine + dihydrallazine+Hydrochlotothiazide @
|
Clonidine hcl. - @ Antiadrenergic agents- centrally acting- (FDC-List)
|
|
Clonidine + chlorthalidone - Antihypertensive
|
Nitrendipine - @-Calcium Channel blocker- (FDC- List )- (May 1991)
|
|
Felodipine @ ( ** ) - Calcium Channel Blocker -(May 1991)
|
Atenolol + Amiloride + hydrochlorothiazide
|
|
Metoprolol tartarate + Hydrocholrthiazide
|
Atenolol + Chlorthalidone
|
|
Propanolol + Dihydrallazine sulphate
|
Propranolol + Dihydrallazine sulphate + Hydrachlorothiazide
|
|
Propranolol + Hydrochlorothiazide
|
Propranolol + Hydralazine
|
|
Indapamide - @ Thiazides and related diuretics- (FDC -List )
|
Guanethidine sulp@( *** ) - Antiadrenergic agen -Perip act
|
|
Levobunolol - @Beta-adrenergic blocking agent- (May 1996)
|
Guanadrel sulfate @ ( * ) -Antiadrenergic agen- Perip act
|
|
Spironolacton + Hydroflumethizide
|
Prazosin @ ( * ) - Antiadrenergic agent- Periph actg- (June 1990)
|
|
Minoxidil - @ -Peripheral Vasodilators- (FDC- List )- (Apr 1988)
|
Treprostinil sodium - @ Peripheral Vasodilators
|
|
Acenocoumarol - Anticoagulant
|
Triflupromazine - @ Antiemetic/antivertigo agents
|
|
Terazosin - @ -Alpha 1 Adrenergic blocker- (Jan 1995)
|
Doxazosin mesylate-@Antiadrenergic agents-Periph acting (Mar 1999)
|
|
Hydralazine hcl@( ** )-Peripheral Vasodilators
|
Furosemide + Amiloride- Diuretics Combination
|
|
Amiloride+ Hydrchlorthiazide ( * )
|
Vaso-constrictors and migraine treatments
|
|
Ergot alkaloids @ - Agents for Migraine
|
Sumatriptan @ ( * ) - Agents for Migraine- (FDC -List )- (Dec 1992)
|
|
Methysergide maleate- @ Agents for Migraine
|
Flunarizine - @ Agents for Migraine- (Nov 1990)
|
|
Fondaparinux Sodium - Selective Factor Xa Inhibitor- (Jan 2008)
|
Warfarin @ - ( *** ) Coumarin and Indandione derivative
|
|
Tinzaparin sodium - @ LMW Heparin -Antocoagulant
|
Protamine sulphate - @ Heparin antagonist
|
|
Phenindione - Antithrombotic
|
Clopidogrel - @ Antithrombotic-(FDC-List) (Sep 2008)
|
|
Streptokinase - @ Thrombolytic enzymes
|
Erythropoietin - Recombinant Human- (FDC- List ) (Jan 1993)
|
|
Ticlopidine - @ ( * ) Aggregation Inhibitors- Antiplatelet Agent- (Feb 1993)
|
Nicoumalone - Anticoagulant
|
|
Calcium Dobesilate monohydrate -Hemostatic
|
Haemostatics
|
|
Methyl Hespridin - Hemostatic
|
Citrus bioflavanoid compound - Haemostatics
|
|
Rutin + Adrenochrome monosemicarbazone
|
Adrenachrome monosemicarbazone
|
|
Aminocaproic acid @ - Hemostatics- systemic
|
Tranexamic acid - @- Hemostatic -systemic- (FDC- List )- (2002)
|
|
Vitamin K @ (Phytonadione )- (FDC- List )
|
Carboprost @ - Prostagladin - Abortifacients
|
|
Haemocoagulase -Hemostatics
|
Ethamsylate - Haemostatics(May 1988)
|
|
Ergometrine Maleate + Adrenochromesemicarbazone + Rutin
|
Diosmin - Haemostatic(Nov 2013)
|
|
Aprotinin - ( * ) Hemostatics ,systemic
|
Cilostazol- Aggregation Inhibitors- @- Antiplatalet Agent -(1999))
|
|
Mesoridazine - @ Antipsychotic Agent- Phenothiazine derivat
|
CENTRAL NERVOUS SYSTEMS
|
|
Aspirin + Caffeine
|
Aspirin + Paracetamol + Codiene
|
|
DISORDERS AND/OR ADVERSE REACTIONS- 3. CENTRAL NERVOUS SYSTEM - SUMMARY
|
Paracetamol + Chlormezanone/Chlorzoxazone
|
|
Paracetamol + Chlorpheniramine maleate
|
Dextropropoxyphene @ ( ** )- Narcotic agonist analgesics
|
|
Dextropropoxyohene Hcl + Paracetamol
|
Dextropropoxyphene Hcl + Acetaminophen
|
|
Dextropropoxyphene Hcl + Acetominophen + Cyclomine
|
Dicyclomine Hcl + Paracetamol
|
|
Metamizol - Analgin - Analgesics
|
Camylofin - Antispasmodic
|
|
Ethoheptazine Citrate - Analgesics
|
Pentazocine Hcl @
|
|
Pentazocine Hcl + Paracetamol
|
Dezocine-@Narcotic agonist analgesics
|
|
Butorphanol tartrate - @ Narcotic agonist analgesics
|
Nalbuphine hcl - @ Narcotic agonist analgesics- (Feb 2007)
|
|
Orphenadrine - @ Skeletal Muscle relaxant- Centrally actg- (FDC- List )
|
Carbamazepene @ ( *** ) - Anticonvulsant
|
|
Buprenorphine - @ Narcotic agonist analgesics- (FDC-List)- (Dec 2008)
|
Ethylmorphine - Antitussive
|
|
Vitamin B-1- @-
|
Mefanamic acid + combinations @
|
|
Mefanamic + Drotaverine
|
Nefopam - Analgesics
|
|
Ketorolac Tromethamine ( ** ) @ - NSAIDs- (FDC- List )- (Nov 1989)
|
Tramadol + Paracetamol
|
|
Tramadol Hcl ( * ) - @- Central analgesics- (FDC- List )- (1993)
|
Acetophenzaine - @ Antipsychotic agent - Phenothizine deriv
|
|
Perphenazine - @ Antipsychotic agent - Phenothizine derivat
|
Trifluoperazine Hcl - @ Antipsychotic agent- Phenothiz derivative
|
|
Chlorprothixene - @ Antipsychotic agent - Thioxanthen deriv
|
Thiothixene - @ Antipsychotic agent - Thioxanthene derivat
|
|
Methotrimeprazine - @ Central anagesics
|
Hypnotics
|
|
Phenobarbitone @ ( * ) - Barbiturates - Long acting
|
Mephobarbital @ - Barbiturates long acting
|
|
Amobarbital @ - Barbiturates - intermediate acting
|
Aprobarbital @ - Barbiturates intermediate acting
|
|
Butabarbital @ - Barbiturates intermediate acting
|
Secobarbital @ - Barbiturates - short acting
|
|
Pentobarbital sodium @ Barbiturates short acting
|
Nitrazepam - @ Benzodiazepines
|
|
Flurazepam - @ Benzodiazepines ( Hypnotic)
|
Diazepam ( *** ) - @ Benzodiazepines- ( FDC- List )
|
|
Halazepam- @ Benzodiapines
|
Temazepam (* ) - @ Benzodiapines ( Hypnotics )
|
|
Estazolam - @ Benzidiazepines ( Hypnotic )
|
Triazolam - @ Benzodiazipines ( Hypnotics )
|
|
Quazepam -@Benzodiazipines ( Hypnotic )
|
Clobazam -Onfi -@- Benzodiaopines (Nov 1997)
|
|
Chloral Hydrate derivatives - @ Sedative/Hynotics
|
Zolpidem Tartrate - @- Imidazopyridines- Sed/Hyp- (May 1999)
|
|
Paraldehyde - @ Imidazopyridines- Sed/Hyp
|
Acetyl Carbromal - @ Ureides- Sedative/Hypnotic
|
|
Isocarboxazid - @ Monoamine Oxide Inhibitors
|
Paliperidone -@- Antipsychotic agent - Benzisoxazole- (Sep 2008)
|
|
Mianserin @ - Tetracyclic antidepressant
|
Desipiramine@ - Tricyclic antidepressants
|
|
Mefanamic acid - @ NSAID Agents- (FDC- List )- (July 2002)
|
Glutethimide@Piperidine derv-Sed/Hyp
|
|
Ethchlorvynol @ - 2Tert Acetylnc Alco-Sed/hy
|
Ethinamate- @ Carbamate - Sed/Hyp
|
|
Propiomazine - @ - Sedative/Hypnotic
|
Triclofos sodium - Sedative/ Hypnotic
|
|
Morphine sulphate - @ Narcotic agonist analgesics
|
Zopiclone - Sedative /Hypnotic- (Aug 1996)
|
|
Hydromorphone -@Narcotic agonist analgesics
|
Levorphanol tattrate - @Narcotic agonist analgesics
|
|
Methadone hcl - @ Narcotic agonist analgesics- (FDC- List )
|
Meperidine hcl @ ( * ) - Narcotic agonist analgesics
|
|
Oxymorphone - @ Narcotic agonist analgesics
|
Sufentanil citrate - @ Narcotic agonist analgesics
|
|
Alfentanyl - @ Narcotic agonist analgesi
|
Levomethadyl acetate-@Narcotic agonist analg
|
|
Zuclopenthixol Acetate @ -Sedative- (July 1999)
|
Sedatives and tranquillisers
|
|
Alprazolam - @ Benzodiazepines- (June 1988)
|
Alprazolam + Seratraline -(Aug 2006)
|
|
Chlordiazepoxide - @ Benzodiazepines- (FDC-List) (July 1973)
|
Clorazepate dipotassium - Benzodiapines @
|
|
Lorazepam-@Benzodiazepines
|
Oxazepam - @ Benzodiazepines
|
|
Buspirone - @ Antianxiety agent (Oct 1990)
|
Meprobamate - @ Antianxiety agent
|
|
Risperidone (* ) @ - Benzisoxazole- Antianxiety agent- (Dec 1987)
|
Haloperidol ( *** ) @ Butyrophenone- Antipsychotic agent- (Feb 1990)
|
|
Molidone hcl - @ Dihydroindolone-Antipsychotic agent
|
Penfluridol- Antipschotic agents
|
|
Trifluoperidol - @ Antipsychotic agents
|
Sulbutamine - Water soluble vitamins
|
|
Chlorpromazine ( ** ) - @ Phenothiazines- - Antiemetics-(FDC-List) (May 1979)
|
Prochlorperazine - @ Phenothiazines - Antiemetics
|
|
Fluphenazine - @ Phenothiazines - Antiemetics
|
Thioproperazine - @ Phenothiazones - Antiemetics
|
|
Pimozide - @ Diphenylbutylpiperidine- Antipsychotc
|
Loxapine - @Dibenzoxapine-Antisychotic (Sep 1990)
|
|
Flupentixol - @ Antidepressant
|
Amitriptyline ( *** ) @ - Tricyclic
|
|
Amitriptyline + Chlordiazepoxide
|
Doxepin ( * ) - @ Tricyclic
|
|
Nortriptyline - @ Tricyclic
|
Dothiepin -@ Tricyclic
|
|
Imipramine - @ Tricyclic
|
Imipramine + Diazepam -
|
|
Trimipramine - @ Tricyclic
|
Clomipramine - @ Tricyclic (Feb 1992)
|
|
Fluoxetine ( ** ) @- selective serotonin reuptake inhibitors- (Mar 1990)
|
Sertraline hcl ( * ) @ - select serotonin reuptake inhibtrs- (Dec 1991)
|
|
Paroxetine hcl ( **) @ -sele serotonin reuptake inhibitors- (Dec 1992)
|
Fluvoxamine maleate (***) @ -select serotonin reuptake inhib (Mar 1995)
|
|
Phenelzine ( *** ) @ - Monoamine Oxidase inhibitors
|
Tranylcypromine ( *** ) @ - Monoamine Oxidase Inhibitors
|
|
MAOI- Monoamine Oxidase Inhibitors @ - Refer Phenelzine
|
Olanzapine- Antipsyhotic agent- thienbenzodiazepine deri- (FDC- List )- (Jan 2000)
|
|
Moclobemide- @ Antidepressant-(July 2000)
|
Citalopram- @ Select serotonin uptake inhibitors (Oct 2001)
|
|
Lithium Carbonate ( *** ) @-Antimaniac agent -Antipsychot- (June 2004)
|
Methylphenidate hcl - @ Psychotherapeutic agent- (Dec 2004)
|
|
Tacrine hcl( * )@ -THA-tetrahydroaminoacidine ) Psychothr
|
Pemoline - @ Psychotherapeutic agent
|
|
Trazodone - @ Triazolopyridine- Antidepressants
|
Bupropion hcl - @ Aminoketone - Antidepressant (2001)
|
|
Venlafaxine @ Phenethylamine- Antidepressant- (Dec 1993)
|
Nefazodone hcl ( * ) @ - Phenylpiperaz- Antidepressant
|
|
St.John's Wort - Hypericin - Antidepressant
|
Amoxapine - @ Tricyclic
|
|
Mirtazapine - ( *** ) - @ - Tetracyclic antidepressant- (Feb 2001)
|
Tianeptine - Anti-depressant
|
|
Clozapine - @ Tricyclic - dibenzoxapine (Mar 1995)
|
Nitroxazepine hcl
|
|
Promethazine - @ Phenothiazines - Antihistamine
|
Buclizine hcl @ Anti-allergic -(June 2006)
|
|
Dimenhydrinate - @ Anticholinergic- Antiemetics
|
Meclizine - @ Anticholinergics- Antiemetics
|
|
Cyclizine - @ Anticholinergics- Antiemetics
|
Meclizine + Nicotinic acid -
|
|
Betahistine - @ Antivertigo drugs
|
Ondansetron -@ - 5-HT3 Receptor Antagonists- Antiemetic/Antivertigo Agents- (May 1985)
|
|
Trimethobenzamide hcl - @ - Anticholinergics- Antiemetics
|
Diphenidol - @ Antiemetic/Antivertigo agen
|
|
Benzquinamide hcl - @ Antiemetic/Antivertigo agents
|
Dronabinol ( *** ) -@ Antiemetic/Antivertigo agent
|
|
Granisetron hcl - @ - 5-HT3 Receptor Antagonists - Antiemetic/Antivertigo agents- (Dec 1993)
|
Phosphated carbohydrate soln- Antiemetic/Antivertigo
|
|
Hydantoin,Phenytoin - Refer Phenytoin Sodium @
|
Barbiturates (*** ) @
|
|
Valproic acid /Sodium valproate( *** )@- (FDC- List )- (Jan 1988)
|
Primidone ( ** ) - @ Anticonvulsant
|
|
Ethosuximide @ - Succinamides - Anticonvul - Ref Succinim
|
Paramethadione- @ - Oxizolinediones- Anticonvulsant
|
|
Clonazepam - @ Benzodiapines- Anticonvulsant- (FDC-List) (Jan 1995)
|
Gabapentin ( * ) - @ Anticonvulsant- (FDC- List) -(July 1995)
|
|
Lamotrigine ( * ) - @ Anticonvulsant- (FDC- List )- (Dec 1994)
|
Felbamate ( * ) - @ Anticonvulsant
|
|
Phenacemide- @ Anticonvulsant
|
Rigidity and tremor controllers
|
|
Levodopa - ( *** ) @Antiparkinson agents-(FDC-List)- (Dec 1983)
|
Biperiden ( ** ) - @ Antiparkinson agents
|
|
Amantadine - @ Antiparkinson agents
|
Tetrabenazine - Neuromuscular disorders- (March 1999)
|
|
Levodopa + Carbidopa- Antiparkinson agents-(2008)
|
Baclofen - @ Centrally acting Skeletal muscle relaxant- (Sep 1995)
|
|
Trihexyphenidyl hcl @ Anticholinergics- Antiparkinson agt
|
Procyclidine - @ Antiparkinson agents
|
|
Selegiline hcl - @ -Antiparkinson agent- (Aug-1991)
|
Piribedril- @ Cerebral activators- Dopamine antogonists- (Sep 1993)
|
|
C.N.S. stimulants
|
Amphetamines (* ) @
|
|
Rivastigmine hydrogen tartarate-@-Exelon Patch (Oct 2014 )
|
Cerebral activators
|
|
Piracetam- Neurodegenerative disorder
|
Co-Dergocrine -Ergot alkaloid
|
|
Ergoloid Mesylate-Ergot alkaoid @ ( ** )- Psychotherap agt
|
Pyrithnol
|
|
Ginko Biloba extract(Sep 1992)
|
DISORDERS AND /OR ADVERSE REACTIONS - 4. MUSCULO-SKELETAL SYSTEM - SUMMARY
|
|
Non-steroidal anti-inflammatory drugs
|
Indomethacin @ ( *** ) - Plain
|
|
Oxyphenbutazone -Plain
|
Oxyphenbutazone - Combinations
|
|
NSAIDs - Refer Ibuprofen-Propionic acid deriv. and others
|
Ibuprofen Plain- @ ( *** ) Propion deriv - (FDC- List )- (1974)
|
|
Ibuprofen + Other combinations
|
Ibuprofen + Paracetamol
|
|
Flurbiprofen - Propion deriv @ ( Nov 2009)
|
Ketoprofen Plain - @ (May 1991 DCGI) -Propion deriv
|
|
Naproxen @ ( ** ) - Propionic Acid derivatives- (Apr 1988)
|
Oxprenolol
|
|
Travoprost- Prostagladin Agonist- Agents For Glaucoma - (FDC- List )- (Jan 2008)
|
Peginterferon alfa -2a (rbe ) - Immunomodulators- Immunologic Agents
|
|
Sorbinil
|
Nitazoxamide - Anti-diarrhoeals- (FDC- List )- (March 2004)
|
|
SYSYEM DISORDER AND /OR ADVERSE REACTIONS
|
Piroxicam @ - Other derivatives - NSAIDs Agents- (FDC- List )- Mar 1996 (DCGI)
|
|
Serratiopepsidase - Other derivatives
|
Diclofenac Sodium -Other derivatives@- ( FDC- List )( Jul 2007)
|
|
Salicylates,Aspirin @ ( *** ) - Other derivatives- (FDC- List )- (2008)
|
Chymotrypsin - Other derivatives- (FDC List) (Sep 1971)
|
|
Auranofin - @ Other derivatives
|
Tenoxicam - Other derivatives @- (April 1993)
|
|
Diclofenac potassium@- (Apr 2008)
|
Penicillamine ( *** ) @ - other derivatives
|
|
Diclofenac+Paracetamol
|
Diclofenac + Paracetamol + Chlormezanone/Chlorzoxazone
|
|
Tizanidine hcl - Centrally Acting- Skeletal Muscle Relaxants- (Dec 1993)
|
Meloxicam -other derivatives
|
|
Diclofenac Pot+Paracetamol
|
Sodium salicylate - Other derivatives @
|
|
Hydroxychloroquine sulfate @ Antirheumatic Agents(Jan 2008)
|
Gold compound@
|
|
Nabumetone @ NSAIDs- Anti-inflammatory Agents- (May 1999)
|
Celecoxib @ Selective Cox- 2 Inhibitors-(FDC- List) (Feb 2000)
|
|
Rofecoxib @ - Selective Cox 2 Inhibitoers
|
Chondrotin sulphate sodium
|
|
Leflunomide - Antirheumatic Agents-(2001)
|
Diclofenac sodium+Gentamicin
|
|
Piroxicam Beta- Cyclodextrin
|
Musle relaxants
|
|
Carisoprodal - @ Skeletal muscle relaxant
|
Carisprodol + Ibuprofen
|
|
Meclofenamate - @ NSAID Agents
|
Nitrozolamide + Ofloxacin
|
|
Oxybutynin Hcl - @- Antispasmodic agents- (Sept 1998)
|
Posaconazole @ - Triazole Antifungals
|
|
Isoprenaline Hcl - Cardiac agents
|
Tetrahydrozoladine - @ Nasal Decongestants
|
|
Lincomycin -@Linosamides- (FDC- List )-(1989)
|
Beclomethasone - @ Inhaled Steroids- (FDC -List)- (Apr 1974)
|
|
Altretamine - ( Hexamethylamine ) Antineoplastics
|
Cladribine ( 2-chlorodeoxyadenosine , CdA ) - @ - Antineoplastic
|
|
Uracil Mustard - Nitrogen mustard - @ - Alkylating agents
|
Lacosamide - Anticonvulsant-(June 2010)
|
|
Rosuvastatin + Fenofibrate
|
Indapamide +Amlodipine
|
|
Pentosan Polysulphate Sodium - @- Interstitial cystitis agent
|
Lidocaine + Prilocaine
|
|
Zaltoprofen
|
Taurine + Racemethionine
|
|
Valethamate Bromide
|
Chlormezanone- @ Skeletal muscle relxant
|
|
Chlorzoxazone - @ Skeletal muscle relaxant
|
Chlorphenesin maleate - @ Skeletal muscle relaxant
|
|
Methocarbamol - @ Skeletal muscle relaxant
|
Succinyl choline chloride(***) -Muscle relax-Adjun to anes
|
|
Hexafluorenium bromide - Muscle relaxant -Adjun to anest
|
Cyclobenzaprine - @ Skeletal muscle relaxant- (Jan 2008)
|
|
Metaxalone - @ Skeletal muscle relaxant
|
Dantrolene Sodium - ( * ) @ Skeletal muscle relaxant
|
|
Atracurium besylate (***) - Neuromus blckrs- Adjun to anes
|
Rubefacients
|
|
Methyl nicotinate
|
Methyl salicylate- (FDC- List )-(2007)
|
|
Menthol/Camphor
|
Benzydamine - Aural Anti-inflammaoy preparations
|
|
Diclofenac diethylamine
|
Mephenesin
|
|
Neuromuscular drugs
|
Pyridostigmine bromide - @.- Antimyasthenics
|
|
Pancuronium bromide(***) -Nondeplr Neuromusl blckrs- Cura
|
HORMONES
|
|
HORMONES AND RELATED SYNTHETIC COMPOUNDS
|
Testosterone & salts & deriv.-(FDC- List)-(Jan 1994)
|
|
Medroxyprogestrone ( * ) @ - Progestins
|
Megestrol acetate -Carcino -Chemotherapeutic drugs- (Dec 2012)
|
|
Dydrogesterone - Sex Hormones
|
Norethisterone ( Norethisterone ) - Contraceptives -(FDC List)- (Nov 1962)
|
|
Hydroxyprogesterone- Sex Hormones
|
Danazol@ Sex Hormones
|
|
Norgestrel - Oral contraceptive- ( FDC- List )- (Aug 1968)
|
Levonorgestrel -@Oral Contraceptive-(FDC-List)- (Jan 1981)
|
|
Oestriol succinate-Oestrgen deficiency
|
Ethinyl oestradiol (Estrogens ( ** ) @ - (FDC- List )
|
|
Estradiol- @-Estrogen- Sex hormones - ( FDC- List )- (Mar 2007)
|
Clomiphene citrate @ Ovulation stimulant - Sex Hormones
|
|
Estrogens - conjugated ( *** ) @- ( FDC- List ) (Nov 2006)
|
Pyridoxine (*)- Vitamins- (FDC- List )
|
|
Allyloesternol- Progestogens
|
Mesterolone- (FDC- List )-(May 1967)
|
|
Progesterone ( *** ) @ - Bleeding disorders
|
Mifepristone- Abortifacients - Uterine- Active Agents- (FDC- List )- (Feb 2002)
|
|
Follitropin alpha
|
Triptorelin acetate- Gonadotropin-Releasing Hormone Analog- Hormones- (July 1993)
|
|
Oral contraceptives- Refer Progesterone
|
Centchroman - Oral contraceptive
|
|
Desogestrel @- Contraceptives- ( FDC- List )
|
Almotriptan - @ Agents for Migraine
|
|
Intra-uterine contraceptive divise -(IUCD)
|
Corticosteroids and related compounds- Refer Dexamethasone
|
|
Dexamethasone-@( *** )Glucocorticoids- ( FDC- List ) (Nov 1971)
|
Prednisolone ( *** )- @ Glucocorticoids- (FDC- List )- (July 2003)
|
|
Nandrolone- @ Anabolic steroids
|
Triamcinolone @ ( *** ) - Glucocorticosteroid
|
|
Hydrocortisone acetate( *** ) -@Glucocorticosteroid- (FDC- List )- (June 1973)
|
Fluocinolone @ - Topical corticosteroids
|
|
Fluticasone propionate @ - Topical corticosteroids- (FDC- List ) -(Mar 1996)
|
Flurometholone ( *** ) - @ Corticosteroid- (FDC- List )
|
|
Flunisolide @ - Intranasal Steroids
|
Tibolone - synthetic steroid- (Oct 1996)
|
|
Trophic hormones and related drugs
|
Menotrophin- @- Trophic Hormones- Gonadrotrophins
|
|
Human chorionic gonadotrophin -@- Hormones
|
Urofollitropin(Menotrophin) @
|
|
Bromocriptine ( * ) - @ Anti-Parkinson (Oct 2009)
|
Somatropin
|
|
Corticotropin ( ACTH ) @
|
Alprostadil (prostaglandin E-1) @ Agents for pat Duct Arter
|
|
Vasopressin - @posterior pituitary hormone
|
Benzocaine @ - Local anesthetic
|
|
Follicle Stimulating Hormone
|
Hyper and hypoglycaemics
|
|
Insulins @ ( *** )- (FDC- List )- (Sep 1987)
|
Chlorpropamide @ ( *** ) - Sulfonylureas
|
|
Acetohexamide @ - Sulfonylureas
|
Acarbose ( * ) -@- Alpha glucosidase inhibitor - (FDC List) (1981)
|
|
Metformin ( *** ) - @ Biguanide -Hypoglycemic agent- (FDC- List )- (Sept 1980)
|
Glibenclamide @ (Glyburide) - Sulfonylureas- Hypoglycemic- (FDC- List )- (Nov 1995)
|
|
Gliclazide@( ** )-Hypoglycemic agent-(FDC- List )- (Nov 1988)
|
Glipizide@-Sulfonylureas-Hypoglycemic agent- (FDC- List )- (Mar 1998)
|
|
Glimepiride-@-( ** )-Sulfonylureas-Hypoglycemic- (FDC- List )- (Nov 1995)
|
Rosiglitazone -@ Thiazolidienediones- Antidiabetic Agents- (FDC- List )- (Dec 2006)
|
|
Repaglinide - @- Meglitinides- Antidiabetic Agents- (March 2000)
|
Pioglitazone @ Thiazolidinediones- Antidiabetic Agents- ( FDC- List )- (1986)
|
|
Rosiglitazone + Metformin-
|
Glipizide+Metformin@
|
|
Nateglinide- Antidiabetic gents- (FDC- List )- (Mar 1986)
|
Glucagon/Guar gum -@-
|
|
Tolbutamide @ - Sulfonylureas
|
Desmopressin acetate( * ) @ Posterior Pituitiary Hormones- (May 2008)
|
|
Tolazamide @ - Sulfonylureas
|
Thyroid and antithyroid drugs - Refer Thyroglobulin
|
|
Thyroxine Sodium @- Hormones
|
Thyroid extract @
|
|
Propylthiouracil @ Antithyroid Agents
|
Carbimazole @ Anti-thyroid substance
|
|
Thyroglobulin ( ** ) @
|
Levothyroxine sodium @ - Thyroid Drugs
|
|
Iodine - @
|
Alfacalcidol
|
|
Other hormones
|
GENITO-URINARY SYSTEM
|
|
Diuretics and antidiuretics
|
Amiloride ( ** ) @ - Potassium sparing diuretics -(FDC List)
|
|
Triamterene ( * ) -@- Potassium sparing diuretics- (FDC- List )- (Oct 1975)
|
Acetazolamide ( * ) @ - Carbonic anhydrase
|
|
Dichlorphenamide ( * ) @ - Carbonic anhydrase
|
Methazolamide ( * ) @ - Carbonic anhydrase
|
|
Furosemide ( *** ) - @ Loop diuretics - (FDC- List )
|
Bumetanide - @ Loop diuretics- (FDC- List)
|
|
Ethacrynic acid - @ Loop diuretics
|
Torasemide ( *** ) - @ - Loop diuretics- (FDC- List )- (Aug 1993)
|
|
Spironolactone ( ** ) @ - Potassium sparing diuretics- (FDC- List)- (May 2010)
|
Hydrochlorthiazide ( *** ) @Thiazide & related diuretics
|
|
Chlorothiazide ( *** ) @ Thiazide and related diuretics
|
Methyclorthiazide -@ Thiazide and related diuretics
|
|
Hydroflumethiazide@ -Thiazide and related diuretics- (FDC- List )
|
Metolazone - @ -Thiazide and related diuretics- (FDC- List )- (Apr 2003)
|
|
Bendroflumethiazide @ -Thiazide and related diuretics
|
Polythiazide @ Thiazide and related diuretics
|
|
Benzthiazide @ - Thiazide and related diuretics
|
Quinethazone@-Thiazide and related diuretics
|
|
Hydrochlorthiazide+Ramipril
|
Flavoxate @ - Antispasmodic agents
|
|
Chlorthalidone @ Thiazide and related diuretics
|
Xipamide @
|
|
Urinary anti-infectives and antispamodics
|
Phenazopyridine @ - Urinary Antiseptics
|
|
Nalidixic acid ( ** ) @ Quinolones
|
Nitrofurantoin ( * ) @ Nitrofurans- (Sep 2008)
|
|
Sulphamethizole
|
Methenamine mandelate @ Methenamines
|
|
Local & syst.drugs for vaginal & urethal conditions
|
Bethanechol - @- Urinary Cholinergics
|
|
Neostigmine Methylsulfate - @ -Urinary Cholinergics
|
Polycarbophil - Bulk-Producing Laxatives
|
|
Drugs acting on the uterus
|
Ergometrine @ - (FDC- List )
|
|
Methyl ergometrine maleate
|
Ormeloxifene
|
|
Oxytocin @ - Oxytocics - Uterine -Active Agents
|
Ritodrine( *** )- @- Oxytocic drug
|
|
Ethacridine
|
Dinoprostone-@- Uterine -Active Agents- Sex Hormones (Feb 1990)
|
|
Spermicidal contraceptives
|
Nonylphenoxypolethoxyethanol
|
|
Nonoxynol- Contraseptive
|
Sildenafil Citrate- @ - Phosphodiesterase Type 5 Inhibitors- Impotence Agents -(Jan 2001)
|
|
INFECTIONS AND INFESTATIONS
|
Ampicillin - @ Aminopenicillins- (FDC- List )- (May 1994)
|
|
Amoxycillin @ - Aminopenicillins- ( FDC- List )- (June 1996))
|
Cloxacillin @ - Penicillase resistent- (FDC - List )
|
|
Carbencillin @ - Extended Spectrum
|
Phenoxymethyl penicillin ( Penicillin V ) @
|
|
Benzathine Penicillin @
|
Becampicillin - @ Aminopenicillins
|
|
Penicillin V Potassium/Penicillin G Pot ( ***) @ - Natural
|
Piperacillin @ - Extended Spectrum- (FDC- List )- (Aug 1989)
|
|
Ampicillin+ Cloxacillin- (FDC -List)
|
Ampicillin+ Cloxacillin+ Lactobacillus- (FDC -List)
|
|
Clavulanic acid + Amoxycillin-(FDC-List) (Aug 1990)
|
Procaine Penicillin + Penicillin G
|
|
Methicillin Sodium- @ Penicillinase resist Penicillin
|
Naficillin Sodium- Penicillinase resist Penicilin
|
|
Oxacillin Sodium - @ Penicillinase resist Penicillin
|
Dicloxacillin Sodium-@Penicillinase resist Penicillin
|
|
Ticarcillin Sodium- @ - Extended Spectrum Penicillin- (FDC -List )- (Oct 1996)
|
Mezlocillin Sodium- Extended Spectrum Penicillin
|
|
Teicoplanin - Antibiotics- (1997)
|
Ampicillin + lactobacillus sporagenes
|
|
Amoxycillin + Carbosisteine- (FDC -List)
|
Cephalexin - Cephalosporins - @ First Generation- (FDC-List)(Dec 1994)
|
|
Cephalosporins and related antibiotics ( * ) @
|
Cefazolin Na. - Cephalosporins @ - First generation
|
|
Cefadroxil - Cephalosporins @ - First generation- (FDC-List) (Feb 1989)
|
Cefpodoxime Proxetil - @ Cephalosporins- Second generation- (FDC-List) (July 2007)
|
|
Loracarbef- Cephalosporins- @ Second generatin
|
Cefprozil - Cephalosporins- @ Second generation- (FDC-List) (Dec 1991)
|
|
Ceftibuten- Cephalosporins- @ Third generation (Dec 1995)
|
Cephalothin Sodium- Cephalosporins @ - First generation
|
|
Cefmetazole Sodium- Cephalosporins- @ Second generation
|
Cefamandole Nafate - Cephalosporins @ - Second generation
|
|
Cefoxitin Sodium - Cephalosporins @ - Second generation
|
Cefepime hcl - Cephalosporins @ - Third generation- (FDC-List)(Oct 2002)
|
|
Cefotaxime - Cephalosporins- @ Third generation- (FDC-List) (Dec 2003)
|
Cefdinir- Cephalosporin @ - Third Generation( Oct 2001)
|
|
Ceftriaxone Na - Cephalosporins- @ Third generation- (FDC -List) (April 1988)
|
Ceftizoxime - Cephalosporins - @ Third generation( May 1990)
|
|
Cefuroxime Na - Cephalosporins @ - Second generation- (FDC-List) (June 1998)
|
Cefonicid Na - Cephalosporins - @ Second generation
|
|
Cefotetan Disodium - Cephalosporins @ - Second generat
|
Cephradine - Cephalosporins @ - First generation
|
|
Cefaclor - Cephalosporins @ - Second generation(Apr 1991)
|
Cefoperazone sodium - Cephalosporins- @ Third generation- (FDC-List)
|
|
Cefixime trihydrate - Cephalosporins- @ Third generation- (FDC-List) (Mar 1993)
|
Cephalexin + Carbocisteine
|
|
Ceftazidime - Cephalosporins- @ Third generation- (FDC-List) (June 1988)
|
Roxatidine @ - Histamine H2 antagonists-(May 1991)
|
|
Cephalexin + Probenecid
|
Aztreonam- @ - Monobactams-(Nov 2002)
|
|
Cefaperazone + Sulbactum - (FDC-List)
|
Tetracycline ( *** ) @ Tetracyclines
|
|
Doxycycline@Tetracyclines- (FDC- List ) (Nov 2007)
|
Minocycline - @ - Tetracyclines- (May 1988)
|
|
Linezolid @ - Oxazolidinones- Anti-Infectives- (FDC- List )- (Jan 1994)
|
Democlocycline@
|
|
Methacycline hcl - @ Tetracyclines
|
Oxytetracycline @ Tetracyclines- (FDC- List )- (July 1993)
|
|
Chloramphenicol (***) -@- (Antibiotic)
|
Erythromycin ( *** ) @ - Macrolide- (FDC- List ) (Mar 1974)
|
|
Roxithromycin - @-Macrolide- (March 1992)
|
Roxithromycin + Ambroxol - (IRRATIONAL COMB.)
|
|
Azithromycin ( * ) - @ Macrolide (Nov 1996)/2007)
|
Dirithromycin ( * ) - @Macrolides
|
|
Troleandomycin ( ** )- @ Macrolides
|
Azithromycin +Fluconazole +Secnidazole
|
|
Erythromycin + Bromhexine
|
Spectinomycin - @ - Anti-infectives
|
|
Polymyxin B ( * ) - Anti-infectives
|
Novobiocin- @
|
|
Gentamicin - @ Aminoglycosides
|
Spiramycin @ Anti-infectives- (FDC- List )- (March 1994)
|
|
Amikacin ( *** ) - @ Aminoglycosides
|
Sisomycin
|
|
Kanamycin - @ Aminoglycosides
|
Neomycin Sulphate- @ -Aminoglycosides, Oral- (FDC- List )- (Nov 1977)
|
|
Netlimicin - @ Aminoglycosides
|
Tobramycin - @ -Aminoglycoside- (FDC- List )- (Sep 2002)
|
|
Vancomycin ( * )-@- (1994)
|
Clarithromycin ( *** ) - @ Macrolide antibiotic (Oct 1991)
|
|
Framycetin - (Soframycin) - (FDC- List )(Apr 1987)
|
Sulphanamides and other antibacterials
|
|
Sulphadiazine + Trimethoprim
|
Sulphadiazine ( *** ) @-(FDC- List )
|
|
Sulphamethaoxazole + Trimethoprim ( ** ) @
|
Sulfamoxole + Trimethoprim
|
|
Phthalylsulphthazole
|
Sulfamoxole
|
|
Sulphacetamide @ -
|
Trimethoprim ( * ) - @- (FDC- List )- (July 1970)
|
|
Norfloxacin ( * ) @ - Fluoroquinolones
|
Fluoroquinolones - @ Refer Ciprofloxacin
|
|
Norfloxacin + Tinidazole
|
Ciprofloxacin ( *** ) - @ Fluoroquinolones- (FDC-List) (1997)
|
|
Ciprofloxacin + Tinidazole -
|
Pefloxacin - @ Fluoroquinolones- (May 1991)
|
|
Ofloxacin - @ Fluoroquinolone- (FDC- List )- (Feb 1990)
|
Ofloxacin + Tinidazole -
|
|
Moxifloxacin - Fluoroquinolones- (FDC- List )- (June 2001)
|
Lomefloxacin ( * )@-Fluoroquinolones-(Feb 1992)
|
|
Sparfloxacin - @ Fluoroqinolones- (Nov 1996)
|
Enoxacin ( * ) - @ Fluoroquinolones
|
|
Levofloxacin-@Fluroquinolones- (FDC- List )- (July 1999)
|
Gatifloxacin ( ** )- @ Fluriquinolones- (FDC-List )- (1987)
|
|
Antitubercular drugs
|
Rifampicin - Plain ( *** ) @- (FDC- List )-(June 1983)
|
|
Rifabutin ( * ) @ - Antitubercular drug- (Dec 1992)
|
Rifampicin + Isoniazid ( ** )@
|
|
Rifampicin + Isoniazid +Pyrazinamide ( ** ) @
|
Ethambutol - Plain @ - Antitubercular Agents
|
|
Ethambutol + Isoniazid
|
Isoniazid - Plain( *** ) @
|
|
Isoniazid + Thiacetazone
|
Sodium PAS- @ - (aminosalicylate sodium)
|
|
Pyrazinamide @ Anti-tubercular Drug
|
Streptomycin ( ** ) - @ Aminoglycoside
|
|
Capreomycin- @ -Antitubercular drug
|
Ethionamide @ - Antubercular drugs
|
|
Cycloserine @ - Antitubercular drugs
|
Prothionamide - Antitubercular drugs
|
|
Clofazimine - @ Leprostatics
|
Dapsone - DDS( *** )@Leprostatics
|
|
Amphotericin ( *** ) -@ Polyene antibiotics - Antifungal- (2008)
|
Natamycin - @ - Polyene antibiotics - Antifungal
|
|
Nystasin - @ - Polyene antibiotics - Antifungal
|
Flucytosine (5-FC-; 5-Fluorocytosine)- @ Antifungal
|
|
Terbinafine hcl ( ** ) - @- Topical anti-infective- (Dec 1986)
|
Griseofulvin( * )-@Antifungal
|
|
Clotrimazole -@ Imidazoles-Antifungal - ( FDC -List) (July 2007)
|
Ketoconazole ( *** ) - @ Imidazoles- Antifungal- (FDC- List )- (Feb 2009)
|
|
Fluconazole ( *** ) - @ Triazoles - Antifungal- ( FDC- List ) -(Jan 1993)
|
Terconazole - @ Imidazoles - Antifungal
|
|
Itraconazole ( *** )- @ Triazole- Antifungal -(Sep 1992)
|
Econazole - @ Imidazole - Antifungal
|
|
Miconazole - @ Imidazole - Antifungal
|
Tinidazole - Plain-(FDC- List )- (Sep 1984)
|
|
Tinidazole + Diloxanide Furoate
|
Metronidazole - Plain @ ( *** )- (FDC- List )- (Oct 1977)
|
|
Metronidazole + Diloxinide Furoate
|
Iodoquinol - Diiodohyoxyquin @ - Amebecides
|
|
Paromomycin- @- Aminoglycoside Oral- Amebicides- (Aug 2006)
|
Ornidazole - Nitroimidazole- (FDC- List )- (Jan 1997)
|
|
L-ornithine- L- asparate- Liver disorders
|
Metronidazole + Furazolidone
|
|
Secnidazole- Anti-bacterial- (May 1993)
|
Chloroquine - @ 4-Aminoquinoline derivatives- (FDC- List ) - (Oct 2007)
|
|
Amodiaquine - @ 4-Aminoquinoline derivatives
|
Mefloquine ( * ) - @ - 4- Aminoquinolne derivatives- (March 1997)
|
|
Sulphadoxine + Pyrimethamine @
|
Pyrimethamine - @-Folic acid antagonist- Antimalarial- (FDC- List )- (May 1978)
|
|
Primaquine Phosphate @ - 8- Aminoquinoline compound
|
Mepacrine hcl or Atabrine or Quinacrine -@- Antimalarials
|
|
Quinacrine@Antimalarial
|
Artemether- @- Antimalarial (Aug 1996)
|
|
Proguanil hcl - @ - Anti-malarials
|
Quinine sulphate @ - Anti-malarials- (FDC- List ) - (Aug 2006)
|
|
Artesunate - Antimalarial- (FDC-List)- (Aug 1996)
|
Mebendazole - @ Anthelmintics
|
|
Mebendazole + Pyrantel -
|
Albendazole - Anthelmintics -
|
|
Thiabendazole - @ Anthelmintics
|
Pyrantel - @ Anthelmintics- (FDC- List )- (April 2001)
|
|
Praziquantel - @- Anthelmintics- (FDC- List )(March 2010)
|
Oxamniquine - @ Anthelmintics
|
|
Diethylcarbamazine -@- Anthelmintics
|
Diethylcarbamazine + Chlorpheniramine mal
|
|
Niclosamide - @ Anthelmintics
|
Pentavalent antimony
|
|
Levamisole- @ - Antineoplastics- (FDC- List )- (Sep 1984)
|
Antivirals
|
|
Zidovudine ( *** ) - @ - Antiviral agent- (FDC- List )- (1985)
|
Ribavirin - @ - Antiviral agent- (Nov 1990)
|
|
Famciclovir ( * ) - @ Antiviral agent (June 1994)
|
Stavudine - @- Antiviral agent - ( FDC- List )- (June 1994)
|
|
Valacyclovir -@Antiviral agent- (Jan 1995 )
|
Ritonavir ( *** ) -@-Antiviral agent- (FDC- List )- (1March 1996)
|
|
Indinavir ( *** ) - @ Antiviral agent- (March 1996)
|
Lamivudine (3TC)-( * )@Antiviral agent- ( FDC- List )- (Nov 1995)
|
|
Saquinavir mesylate- @ -Antiviral agent- (Dec 1995)
|
Foscarnet ( * ) - @ Antiviral agent
|
|
Didanosine ( * ) - @ Antiviral agent(Oct 1991)
|
Ganciclovir ( *** ) - @ Antiviral agent-(1989)
|
|
Zalcitabine (Dideoxycytidine -DDC) ( *** ) @ Antiviral agt
|
Rimantadine Hcl ( * ) - @ - Antiviral agent
|
|
Lamivudine+Zidovudine
|
Vaccines and anti-toxins
|
|
Immune Gamma Globulin -@-
|
BCG Vaccine @
|
|
Factor IX coagulation plasma protein -@
|
Factor VIII concentrate
|
|
Tonics;appetite stimulants
|
Calcium + Vitamins
|
|
Iron + Vitamins- (FDC List)
|
Cyproheptadine @ - Piperazines- Antihistamines
|
|
Liver fractions- (FDC- List )
|
Protein/ hydrolysate
|
|
Protein + Vitamins + Minerals
|
Iron preparations
|
|
Ferrous fumarate ( *** ) @
|
Ferrous citrate @
|
|
Ferrous sulphate ( *** ) @ - (FDC - List )
|
Ferric succinate @
|
|
Ferrous gluconate @- (FDC- List )
|
Ferric pyrophosphate @
|
|
Ferric hydroxide polysucrose complex @
|
Ferrous glycene sulphate @- (FDC- List )
|
|
Iron choline citrate/Iron salts ( *** ) @
|
Iron dextran
|
|
Colloidal iron
|
Ferric fructose @
|
|
Ferric ammonium citrate @
|
Iron complex- hydroxide polymaltose complex
|
|
Haemoglobin
|
Molgramostim-recomb Hum glanulocyte macrophage stim factor
|
|
Minerals and nutritional additives
|
Potassium salts ( ** ) @
|
|
Calcium salts ( *** ) @ -(FDC-List)- (Sep 2008)
|
Phosphrous
|
|
Fluoride @
|
Zinc salts @- (FDC- List )
|
|
Magnesium salts ( *** ) -@ (Dec 2008)
|
Manganese -@-
|
|
Sodium Salts ( * )- (FDC- List )-(June 2006)
|
Copper- Trace metals
|
|
Molybdenium - @-Trace metals
|
Chromium - @ - Trace metals
|
|
Selenium- @- Trace metals
|
Iodine -Trace metals
|
|
Mixed salts
|
Essential/non-essential amino acids
|
|
Disodium hydrogen citrate
|
Etidronate disodium- @ -Bisphonates
|
|
Multi Vitamins + Minerals
|
Multi Vitamins + Zinc
|
|
Calcitonin Salmon - @ -Hormones
|
Alendronate Sodium - Bisphosphonates- (FDC List) (Sep 1995)
|
|
Raloxifene Hcl ( * ) Selective Estrogen Receptor Modulator - Sex Hormones- (Dec 1982)
|
Zinc gluconate - @ Zinc supplements-(FDC - List )
|
|
VITAMINS
|
Vitamin A -( * )@Fat soluble vitamins- (FDC- List )
|
|
Vitamin B-1,B-2,B-6 ( * )@-Water soluble Vitamins
|
Vitamin B complex - @ -Water soluble Vitamins- (FDC- List )
|
|
Vitamin B complex + Vitamin C - Water soluble Vitamins
|
VitaminC (Ascorbic acid) - @- Water sol vitamins
|
|
Vitamin B-12 ( * )@ - Cyanocobalamin - ( FDC- List )
|
Vitamin D( ** )@-Fat soluble Vitamins
|
|
Vitamin D3- (FDC- List )
|
Vitamin A & D combinations- Fat soluble Vitamins
|
|
Multi Vitamins
|
Vitamin E - @(Antioxidant )
|
|
Mecobalamin- (FDC- List )- (Apr 2007)
|
Lactobacillus- (FDC- List )
|
|
Lactobacillus sporogenes
|
Folic acid ( ** ) @- (FDC- List )- (Jan 1969)
|
|
W-C2-hydroxydecene acid(royal jelly acid)
|
Alpha-Lipoic Acid @
|
|
Calcitrol @ Metabolic Disorders- (FDC-List)- (Aug 1993)
|
Fenfuramine - @ Anorexiants
|
|
Dexfenfluramine ( * ) - @Anorexiants
|
Phentermine Hcl - @ Anorexiants
|
|
Benzphetamine Hcl- @ Anorexiants
|
Phenmetrazine Hcl- @ Anorexiants
|
|
Phendimetrazine tartarate- @ - Anorexiants
|
Diethylproion Hcl -@Anorexiants
|
|
Mazindol - @ Anorexiants
|
Sibutramine @ Anorexiants- (Sep 2007)
|
|
Oxymethalone - @ Anabolic steroids
|
Stanozolol - @ Anabolic steroids
|
|
Oxandrolone - @ Anabolic steroids- (Aug 2006)
|
Food products
|
|
Saccharin sodium
|
RESPIRATORY SYSTEM
|
|
Respiratory stimulants
|
Bronchospasm relaxants
|
|
Ephedrine @ ( ** ) - Sympathomim - Bronchodilators
|
Sympathomimetics - @ Bronchodilators - Refer Ephedrine
|
|
Atropine methonitrate - @ Sympathomimetics - Bronchodilat
|
Orciprenaline sulphate - @ Sympathomimetics - Bronchodilat
|
|
Terbutaline sulphate @ - Sympathomim - Bronchodilators- (FDC- List)- (Oct 1982)
|
Salbutamol Sulphate @ - Sympathomim- Bronchodilators- (FDC- List )- (Mar 2000)
|
|
Metaproterenol sulfate @ - Sympathomim- Bronchodilators
|
Isoetharine @ Symapathomimetics- Bronchodilators
|
|
Ethylnorepinephrine @ - Sympathomim- Bronchodilators
|
Isoproternol @ - Sympathomim- Bronchodilators
|
|
Bitolterol mesylate @ - Sympathomim- Bronchodilators
|
Epinephrine @ - Sympathomimetics- Bronchodilators
|
|
Pirbuterol acetate @ - Sympathomim- Bronchodilators
|
Bambuterol hcl- Bronchodilator
|
|
Etophylline - @ Xanthine derivatives- (FDC -List )
|
Aminophylline ( *** ) - @ Xanthine derivatives- (1999)
|
|
Oxtriphylline (Choline Theophylline)- @ Xanth deriv- Bronch
|
Albuterol - Sympathomimetics- Bronchodilators
|
|
Theophyl ethanoate of piperazine - @ Xanthine derivatives
|
Dihydroxypropyl theophylline - @ ( Dyphylline) - Xanthin der
|
|
Salmeterol @ ( *** ) - Sympathomim- Bronchodilators- (FDC- List )- (Feb 1994)
|
Formoterol Fumarate- Sympathomimetics- Bronchodilators- (FDC- List) - (Aug 2003)
|
|
Formoterol + Budesonide
|
Theophyline ( *** ) - @- Xanthine derivatives- (FDC- List )- (June 1981)
|
|
Ketotifen - Mast cell inhibitors-(May 1991)
|
Sodium cromoglycolate @ -(Cromolyn Sod)-Mast cell inhibitrs
|
|
Budesonide @ - Intranasal steroids -(FDC-List)- (Feb 1994)
|
Montelukast - Singulair (1998) - Leukotriene Receptor Antagonists- Bronchodilators- (FDC- List )
|
|
Zafirlukast- Leukotriene Receptor Antagonists- (Dec 2001)
|
Ipratropium bromide - @ Anticholinergics- (FDC- List )- (Nov 1992)
|
|
Expecto.,cough supper.,mucolytic & decongestants
|
Codeine- @ Antitussive - Narcotic agonist analgesics- ( FDC- List )
|
|
Dextromethorphan - @Antitussive- (FDC- List ) (Nov 2007)
|
Benzonatate- @ Non- narcotic antitussives
|
|
Noscopine - Antitussive
|
Guaiphenesin -@ -Expectorant-(Aug 2008)
|
|
Ammonium Chloride - Expectorant-(FDC-List)
|
Bromhexine - Mucolytic
|
|
N-acetylcystein - Mucolytic
|
Tripolidine - @ Akylamines - Antihistamines
|
|
Ambroxol - Mucolytic Agents- (FDC List)- (Dec 1995)
|
Chlorpheniramine maleate @ ( ** ) - Akylamines -Antihistamine -(FDC-List)
|
|
Acetoaminophen ( ** ) - @ Analgesics
|
Pseudoephedrine hcl ( ** ) - @ - Nasal decongestant- (Sep 1992)
|
|
Carbosisteine - Mucolytics
|
Pipazethate
|
|
Phenoxdiazine- Bronchospasms
|
EAR,NOSE. AND OROPHARYNX
|
|
Phenylephrine @ - Sympathomimetics - Nasal decongestant
|
Oxymetazoline - @ Sympathomemitics - Nasal decongestant - ( FDC - List )- (Jan 2001)
|
|
Azelastine hcl @ Ophthalmic antihistamines- (July 1997)
|
Xylomethazoline @ Oropharyngeal agents- (FDC- List )- (Dec 2009)
|
|
Oropharyngeal prepartions
|
Benzalkonium chloride
|
|
Choline Salicylate @ Analgesics
|
Chlorhexidine - @ -Antiseptic-(FDC -List)
|
|
Matricaria chamomila ext- Herbal
|
Strontium chloride Sr 89- @- Radiopharmaceuticals - Bone disorders
|
|
Aural prepartions
|
Tyrothricin
|
|
Salicylic acid ( * ) @
|
4-carboxymetamine - 4-aminodiphenyl sulphone
|
|
Paradichlorobenzene
|
EYE
|
|
Naphazoline ( * ) @ -Sympathomimetics Decongest/ Mydriatics
|
Apraclonidine hcl- @ Sympathomimetics
|
|
Acetylcholine chloride- @ Intraocular- Miotics-direct actg - Agents for Glaucoma
|
Physostigmine ( * )- @ Miotics, Cholinesterase inhibitor
|
|
Demecarium bromide-@- Miotics,Cholinesterase inhibitor
|
Echothiophate iodide-@ Miotics, Cholinestersase inhibitor
|
|
Dorzolamide hcl- @ Glaucoma- Carbonic anhydrase inhibitors- ( FDC- List ) (Sep 1994)
|
Latanoprost-@Glaucoma-Prostaglandin agonist- (FDC - List )- (1998)
|
|
Dapiprazole Hcl-@Opthalmic alpha adrenergic blckg agents
|
Carbachol - @ Miotics- Direct Acting
|
|
Idoxuridine - ( IDU ) - @ Antiviral
|
1/10. Acyclovir ( * ) - @ Antiviral(Sep 2010)
|
|
Miotics
|
Pilocarpine,catachol- @ Cholinergic agonists
|
|
Timolol - @ - Beta- Adrenergic blocker- (FDC- List )- (Jan 2000)
|
Betaxolol @ - Beta- Adrenerg blockr - Adents for Glaucoma( May 1992)
|
|
Brimonidine tartarate- @ -Agents for Glaucoma- (FDC -List) (1996)
|
Mydratics and clycoplegics
|
|
Homotropine hydrobromide - @Cycloplegic mydriatic- ( FDC- List )
|
Scopolomine (Hyosine Hbr) - @ Cycloplegic mydriatic
|
|
Atropine sulphate @ - Cycloplegic mydriatic- (FDC -List)
|
Cyclopentolate @ - Cycloplegic mydriatic
|
|
Tropicamide @ - Cycloplegic mydriatic
|
Dipivefrin- @Sympathomimetics- Agents for Glaucoma
|
|
Fluorometholone - @ Ophthalmic Corticosteroids- (FDC- List )( July 1996)
|
Diagnostic and micellaneous prepartions
|
|
Catalin
|
Potassium iodide - @-
|
|
Fluroresin sodium @
|
Sodium hyaluronate - Physical Adjuncts- (FDC- List )- (June 1989)
|
|
Hydroxypropyl Methylcellulose (HPMC) @ Ophthalmic Agents
|
Indocyanine Green
|
|
Hydroxyethyl cellulose@ Ophthalmic Agents
|
Polyvinyl alcohol + Povidone @
|
|
Polyvinyl alcohol
|
Dimethidene maleate- Antihistamines
|
|
Ebastine @ Anti-histamine-(Sep 2001)
|
Mizolastine - Anti-histamines (Mar 2002)
|
|
Embramine - Antihistamines
|
Azatadine maleate - @ Piperidines- Antihistamines
|
|
Hydroxyzine@( ** )- Antianxiety agent- (Aug 2010)
|
Pheniramine maleate @ ( * )- Antihistamines
|
|
Antihistamines - Refer Chlorpheniramine maleate
|
Carbinoxamine maleate- @ Antihistamines
|
|
Pyrilamine maleate @ - Antihistamines
|
Tripelennamine Hcl - @ Antihistamines
|
|
Bromophenaramine maleate- @ Antihistamines
|
Phenindamine tartrate @ - Antihistamines
|
|
Fexofenadine hcl - @ - Antihistamines- (FDC- List )- (Jan 2007)
|
Dexchlorpheniramine maleate-@Akylamines- Anihistamines
|
|
Diphenhydramine@ ( ** ) -Ethanolamines - Antihistamin
|
Methdilazine ( * ) - @ Phenithiazines- Antihistamines
|
|
Clemastine fumarate @ - Ethanolamines- Antihistamine
|
Trimeprazine tartarate - @ Phenothiazines- Antihistamine
|
|
Loratidine@ -Antihistamines-(June 1992)
|
Cetirizine dihydrochloride @ - Antihistamines
|
|
Desloratadine@ Anti-histamine
|
Cetrizine + Pseudoephedrine + Paracetamol
|
|
Desensitising prepartions
|
SKIN
|
|
Soothing and protective prepartions
|
Synthetic & vegetable gums
|
|
Keraloytics and cleansers
|
Urea - @ - Osmotic diuretics- (FDC- List )
|
|
Anthralin ( Dithranol ) - @ - Anti-psoriatic Agents
|
Benzyl nicotinate
|
|
Selenium sulphide - @ Antiseborrheic product
|
Topic. non-ster. anti-pruritic & anti-inflam.prepns.
|
|
Tocopherol acetate
|
Topical antifungal& anti-infestive prepartions
|
|
Linolenic acid (evening primrose)
|
Policresulen- (FDC- List )
|
|
Crotamiton - @ Scabicide
|
Teraethylthiuram monosulphide
|
|
Gammabenzene hexachlor
|
Ciclopirox olamine - @ Topical Antifungal agent
|
|
Fusidic acid - Topical Anti-infectives(Mar 1992)
|
Tolnaftate - @ - Topical Antifungal agent- (FDC- List )- (Feb 1977)
|
|
Oxiconazole - @ Topical Antifungal agent- (Jan 2000)
|
Sulconazole - @ Topical Antifungal agent
|
|
Haloprogin - @ Topical Antifungal agent
|
Naftifine Hcl - @ Topical Antifungal agent
|
|
Topical anti-infective prepartion
|
Povidone Iodine - Antimicrobial agent-(Aug 2008)
|
|
Polyvinyl alcohol - Opthalmic lubricants- (FDC- List )
|
Cetrimide - Antiseptic- (FDC-List) (Feb 2009)
|
|
Bacitracin ( * ) - Antibacterial
|
Sodium fusidate
|
|
Silver sulphadiazine ( * ) - @ - Burn preparation- (Oct 2004)
|
Halcinonide hcl @ - Topical corticosteroids
|
|
Mupirocin @-(Pseudomonic A)- Topl anti-infective - Antibitc- (FDC- List )- (Sep 1991)
|
Psoriasis
|
|
Calcipotriene - @- Antipsoriatics
|
Tretinoin (al-trans-retonoic acid.Vit A acid) - @ Retinoids - Antineuoplastic Agents- (Aug 2008)
|
|
Methyl predisolone acetate @ - Topical corticosteroids- (FDC- List)- (June 2006)
|
29/08. Adapalene - @ antiacne -(FDC List)- (Oct 2008)
|
|
Azelaic acid - @ antiacne
|
Glycolic acid
|
|
Topical steriodal prepartions
|
Topical corticosteroids
|
|
Alcometasone dipropionate- Topical corticosteroids
|
Amicinonide- @ Topical corticosteroids
|
|
Desoximetasone -@Topical corticosteroids
|
Clocortolone pivalate - @ Topical corticosteroids
|
|
Diflorasone diacetate -@Topical corticosteroids
|
Fluocinonide - @ Topical corticosteroids
|
|
Flurandrenolide - @ Topical corticosteroids
|
Prednicarbate - @ Topical corticosteroids
|
|
Clotrimazole Combinations
|
Gentamicin + Beclomethasone + Clotrimazole
|
|
Gentamicin + Clobetasol propionate
|
Gentamicin + Betamethasone dipropionate
|
|
Gentamicin + Betamethasone dipropionate + Clotrimazole
|
Gentamicin + Beclomethasone + Econazole
|
|
Clobetasol propionate - @ Topical coticosteroids- (FDC-List) (Aug 1996)
|
Clostebol acetate - Dermatological product- (FDC-List)
|
|
Clobetasone - Topical corticosteroids
|
Clobetasone + Gentamycin
|
|
Clobetasone + Miconazole
|
Desonide - ( non-halgonated)-@Topical corticosteroids
|
|
Mometasone furoate- Asmanex Twisthaler (1987) @ - Topical corticosteroids- (FDC- List )
|
Miscellaneous skin prepartions
|
|
White soft paraffin
|
Psoralen,Trimethylpsoalen @- (FDC- List )
|
|
Allantoin- (FDC- List )
|
Podophylotoxin - @ Antimitotic
|
|
Ammoidine- (FDC- List)
|
Permethrine - @ - Scabicide- (March 1995)
|
|
Trioxsalen @
|
METABOLISM
|
|
Carcino-chematherapeutic drugs
|
Doxorubicin- (Doxil) - @- (2008) -Antracycline Antibiotic
|
|
Idarubicin hcl - @ Anthracycline antibiotics
|
Dactinomycin - @ Antineoplastics
|
|
Chlorambucil @ - Nitogen mustard- Alkylating agent
|
Dacarbazine-@Antineoplastics
|
|
Procarbazine hcl ( ** ) - @ Antineoplastics
|
Gemcitabine Hcl- @-Gemzar (1996)- Antineoplastics- (FDC-List )
|
|
Mitotane (o,p-DDD) ( * )- @ Antineoplastics
|
Pegaspargase - Oncaspar (Feb 1994) - @ Antineoplastics
|
|
Porfimer sodium - @ - Miscellaneous Antineoplastic Agents
|
Melphalan ( ** ) - @ Nitrogen mustard - Alkylating agent
|
|
Asparaginase-L - @ - Antineoplatics
|
Tamoxifen - @ Antiestrogen hormone- (June 2002)
|
|
Leuprolide acetate- @Gonadotropin Hormone analog- (Dec 1997)
|
Goserelin acetate- @- Gonadotropin Hormone analag- (Jun 1980)
|
|
Cisplatin - (CDDP) - @ Allkylating agent
|
Busulfan - @ Alkylating agent
|
|
Amifostine - (Mar 1996) -Chemotheraphy agents
|
Irinotecan - DNA Topoisomerase Inhibitors- (May 1997)
|
|
Topotecan hcl- Anti-Cancer- (June 1999)
|
Carboplatin - @ Alkylating agent (Mar 1989)
|
|
Mitoxantrone - @ - Antibiotic- (March 1989)
|
Methotrexate ( *** ) - @ Antimetabolites
|
|
Thioguanine (TG, Thioguanine) -@ Antimetabolite
|
Lactic Acid- (FDC- List )-(Apr 2008)
|
|
Fludarabine phosphate- @- Antimetabolite - (April 1991)
|
Five Fluorouracil - @ Antimetabolites
|
|
Hydroxyurea - @Antineoplastics
|
Aldesleukin ( Interleukin--2) ( ** ) Antineoplastics
|
|
Docetaxel -Antineoplastics(June 1996)
|
Interferon alfa-2a ( * ) - Antineoplastics- (May 1998)
|
|
Thiotepa @ - (TSPA,TESPA)- Alkylating agent
|
Bleomycin sulphate - @ - Antineoplastics
|
|
Mitomycin-C ( * ) - @- Antibiotic
|
Cyclophosphamide ( ** ) @ nitrogen mustard - Alkylatg agent
|
|
Flutamide - @ - Antiandrogens - Hormones
|
Ifosfamide @- Nitrogen mustard- Alkylating agent- ( FDC- List )- (July 1999)
|
|
Mesna(sod 2-mercaptoethane sulphonate)- @ - Cytoprotect Agent
|
Cytarabine @ ( Cytosine Arabinoside; ARA-C)- Antimetabolite (Feb 2010)
|
|
Etoposide @- Podophyylotoxin deriv.- Mitotic inhibitors -(1983)
|
Mercaptopurine -@- Antimetabolites-(Apr 2014)
|
|
Vincristine ( * ) - @-Mitotic inhibitors
|
Vinblastine ( * )-@Mitotic inhibitors
|
|
Teniposide - @ Mitotic inhibitors
|
Vinorelbine tartrate-@ - Vinca Alkaloids - Mitotic inhibitors- (Dec 1994)
|
|
Lomustine@-Notroureas-Alkylating agent
|
Carmustine (BCNU) - @ Nitrosoureas- Akylating agent-(Jan 2008)
|
|
Streptozocin - @ - Nitrosoureas- Akylating agent
|
Pipobroman - @ Akylating agents
|
|
Mustine hcl
|
Fosfestrol tetrosol - Carcino- Chemotherapeutic Agents
|
|
Daunorubicin-@Antibiotics
|
Paclitaxel - Abraxane (Dec 1992)- @ -Antineoplastics- (FDC- List )
|
|
Immunosuppresants - Refer Cyclosporine
|
Azathioprine ( ** ) - @ Immunosuppressive drug- (Dec 2008)
|
|
Tacrolimus (FK506) - @- Immunosuppressive drug- (April 1994)
|
Mycophenolate Mofetil-( *** ) @ Immunosuppressive drug- (May 1995)
|
|
Muromonab-CD3 - @ Immunosuppressive drug
|
Cyclosporine ( *** ) - @ Immunosuppressive drug- (June 2006)
|
|
Nevirapine - Antiretroviral agents-(June 2000)
|
Gout
|
|
Colchicine - @ Agents for Gout
|
Probenecid ( *** ) - @ Agents for Gout
|
|
Allopurinol ( *** ) - @ Agents for Gout
|
Sulfinpyrazone ( ** )- @ pyrazolidone der. Agents for Gout
|
|
Poisoning and metabolic dysfunction
|
Bezafibrate - Antihyperlipidemic agent
|
|
Gemfibrozil -(*) HNG- COA reductase inhibtrs- Antihyperlipmc -(Aug 1998)
|
Dimercaprol - Antidotes for Arsenic,Gold, Mercury,Lead
|
|
Edetate calcium disodium - Antidote for Lead
|
Sodium thiosulfate -Antidotes for Ardenic, Cyanide
|
|
Nalmefene hcl - Antidotes for Opiods
|
Flumazenil - @- Antidotes for Benzodiapines
|
|
Physostigmine salicylate - Antidotes for Tricyclic, Diazepam
|
Ipecac syrup - @- Antidotes -emetics
|
|
Charcoal, activated ( *** )- @ - Antidotes- emetics
|
Methylene Blue - @- Antidotes for cyanides
|
|
Leucovorin ( * )Antidotes-Folic acid antagonist
|
Glucosamine sulphate- (FDC- List ) (Sep 2002)
|
|
Pralidoxime Chloride - @ - Antidotes for organophaste po
|
Naloxone hcl - Antidote for Narcotic antagonists dote- (July 1992)
|
|
Desferrioxamine- @-Antidotes for Iron - Detoxification Agents
|
Lovastatin( ** ) @ - HMG-CoA reducts inhibt - Antihyperlpidemic -(FDC- List)- (1989)
|
|
Simvastatin @-HMG- COA reducts inhibitr - Antihyperlipemic- (FDC- List )- (Dec 1991)
|
Pravastatin -@ HMG-COG reducts inhibitr- Antihyperlipermic- (Oct 1991)
|
|
Fluvastatin- @ HMG-COG reducts inhibitr- Antihyperlipermic- (Dec 1993)
|
Dextrothyroxine sodium -@Antihyperlipermic
|
|
Clofibrate ( * ) - @ Antihyperlipermic
|
Atorvastatin @ - Antihyperlipmic- (FDC- List )- (2008-2013)
|
|
Drug dependance
|
Disulfiram ( * ) -@Antialcoholic
|
|
Naltrexone - @ Opoid antagonist - Antialcoholic
|
SURGICAL
|
|
Gallamine triethiodide- Neuromus blockr- Adjun to anesthes
|
Halothane General Anesthetics
|
|
Isoflurane - General Anesthetics- (July 1990)
|
Lignocaine- (FDC -List )
|
|
Bupivacaine Hcl - @ Local Anesthetics
|
Glycopyrrolate@-Quaternary anticholinergics- (FDC- List )- (Nov 2002)
|
|
Thiopentone sodium- Barbiturates- General anesthetics
|
Etomidate- General anesthetics
|
|
Midazolam - @- General anesthetics-(Apr 1997)
|
Propofol - @ General anesthetics- (FDC- List ) (May 1998)
|
|
Thiamylal sodium - General anesthetics
|
Ketamine - General anesthetics
|
|
Desflurane -@General anesthetics- (Sep 1992/Feb 2006)
|
Sevoflurane - @- General anesthetics- (1995)
|
|
Methoxyflurane - General anesthetics
|
Succinylcholine + Pancurinm br + Atracurium besylate
|
|
Pipecuronium bromide ( *** )- Nueromusc blockr-Adjun to anes
|
Vecuronium bromide (*** ) -Nueromusc blockr- Adjun to anest
|
|
Doxacuranium chloride( * )-Neuromus blockr-Adjun to anesths
|
Tobocurarine chloride - Neuromusc blockr- Adjun to anesthes
|
|
Mivacurium chloride (*** ) - Neuromusclr blokr- Adju to anes
|
Rocuronium bromide -Neuromuscular blockr- Adjun to anest
|
|
Cisatracurium besylate - Neuromuscular blockr- Adjunt to ane
|
Fentanyl citrate ( * ) - @ Narcotic agonist analgesics -(Apr 2006)
|
|
Surgical antibacterials
|
Mucolytic,proteolytic& other enzymes
|
|
Hyaluronidase - Physical Adjuncts
|
Beta-carotene @- (FDC- List )
|
|
Riluzole @ Tetrabennazine - Tremor and related disorders
|
Plasma expanders
|
|
Dextrose- (FDC- List )
|
Dextrose and sodium chloride,Sodium chloride soln
|
|
Polymer of degraded gelatin
|
Hemin ( * ) - enzyme inhibitor
|
|
Sodium phenylbutyrate
|
Mannitol
|
|
Human albumin
|
DIAGNOSTIC AGENTS
|
|
Antiserum
|
Gamma chain antiserum
|
|
Contrast media/Testing aids
|
Megulamine isothalmate
|
|
Iohexol
|
Gadodiamide- Contrast Media
|
|
Glucose and other detreminations
|
Glucose urine test kit - @ - (FDC- List)
|
|
DRESSING AND APPLIANCES
|
MEDICATED DRESSINGS
|
|
Zinc oxide/Zinc salts
|
Valdecoxib(**)- (FDC- List )
|
|
Perindopril + Indapamide - Antihypertensive
|
Levocetrizine - @ - Antihistamines- (FDC- List)- (Dec 2002)
|
|
Mefanamic + Tizanidine
|
Clopidrogel + Aspirin
|
|
Thalidomide - Immunosuppressants- (Aug 2002)
|
Letrozole - Aromatase Inhibitors- Hormones- (Mar 1998)
|
|
Tadalafil- Hormonal dysfunction-(Sep 2003)
|
Fenoprofen - @ Propionic derivative -. NSAID Agents
|
|
Colistimethate Sodium ( * ) - Polpeptide Antibiotics
|
Imipenem ( * ) - Cilastatin - Thienamycin antibiotic-
|
|
Antiaminoplastics- Refer Hydroxyurea
|
Aripiprazole Lauroxil - @-Aristada (Oct 2015) (2003) -Antipsychotic agent- Quinolinone derivative
|
|
Fosphenytoin @ Hydantoins- Anticonvulsants
|
Nebivolol - @ - Beta-Adrenergic blocker- (FDC- List )- (Sep 2004)
|
|
Prenoxdiazine- Anti-Tussive agent
|
119/02. Abacavir - Antiviral agent- (Mar 2002)
|
|
Loteprednol etabonate - Opthalmic Corticosteroids- (FDC- List )-(March 2002)
|
Terlipressin - Bleeding disorders- (July 1996)
|
|
Maprotaline ( *** ) - @ - Tetracyclic - Antidepressant
|
Oxcarbazepine- Anticonvulsant-(Oct 2001)
|
|
Topiramate - Anticonvulsants- (Aug 1999)
|
Pioglitazone + Metformin
|
|
Meropenem - Carbapenem- (FDC- List )-(Jan 2002)
|
Bimatoprost - @-Agents for glaucoma-(FDC-List) (July 2006)
|
|
Oxaliplatin- Anti-cancer Drugs -Platinum Coordination Complex-(Oct 1998)
|
Atovaquone @ ( * ) - Antiprotozoals
|
|
Hepatitis B immune Globulin @- (FDC -List )- (Jul 2000)
|
Rabies Immune Globulin- @-
|
|
Human Immune Globulin
|
Meningococcal Vaccine- @ -
|
|
Cholera Vaccine @
|
Measles (Rubeola Vaccine ) ( ** )
|
|
Mumps Virus Vaccine ( * )
|
Polio Virus Vaccine- @-(1992)
|
|
Plague Vaccine- @ -
|
Pneumococcal Vaccine- @ -
|
|
Influenza Virus Vaccine ( * )- (Aug 1996)
|
Rabies Vaccine- @-(March 1989)
|
|
Rubella Virus Vaccine ( ** )
|
Gas Gangrene Antitoxin
|
|
Diphtheria / Tetanus Antitoxin ( * )@- (FDC - List )
|
Anti Snake Venom
|
|
Human Anti D Immune Globulin
|
Hepatitis B Vaccine ( ** ) @ (Dec 1984)
|
|
Hepatitis A Vaccine @- (Feb 1998)
|
Typhoid Vaccine ( * ) - @- (Feb 1993)
|
|
Varicella - Zoster Virus Vaccine( * )@
|
Yellow Fever Vaccine( * )@
|
|
Quetiapine- Antipsychotic agent -Dibenzepine derivative- (May 2002)
|
Iron salts- Refer Ferrous Fumarate
|
|
Succinamides ( * ) - @ Succinamides Anticonvulsants
|
Tiotropin bromide monohdrate-(FDC- List )- (Apr 2003)
|
|
HMG-CoA Reductase Inhibitors- Refer Lovastatin
|
Alpha-1-adrenergic blockers- Refer Prazosin
|
|
Anastrazole - Hormonal Chemotherapy (Feb 2003)
|
Nitrates - Refer Isosorbide 5-mononitrate @
|
|
Carbonic Anhdrase Inhibitors - Refer Acetozolamide
|
Imatinab -Gleevec (2001)-@-Protein-Tyrosine Kinase Inhibitors
|
|
HERBAL PREPARATIONS
|
Hyperacidity, Reflux , Ulcers
|
|
Varatika
|
Sedatives, antispasmodics
|
|
Laxatives
|
Trivruth
|
|
Enzymes, digestive supplements
|
Guduchi
|
|
Prativisha
|
Hepatobiliary drugs
|
|
Himsra
|
Sarpagandha
|
|
Atorvastatin + Aspirin-(2008)
|
Haemostatics/Antihaemorrhagics
|
|
Lipid lowering agents
|
Guggul
|
|
Pamidronate disodium - @ - Bisphosphonates-(Feb 1995)
|
Putiha oil
|
|
Gonodal Hormones & Related Drugs
|
Urinary Antiseptics
|
|
Exenatide - Anti-Diabetic Agents -(July 2007)
|
Ertapenan - Carbapenem-(Jan 2008)
|
|
Etodolac @ NSAIDs Agents- (FDC- List ) (May 2007)
|
Anticholinergics - Antiparkinson Agents Refer- Biperiden
|
|
Antithrombin Recombinant - Antithrombin agent - Anticoagulan
|
Tolmetin sodium - @ NSAID Agents
|
|
Shilpauspha
|
Gokshura
|
|
Shantavari
|
Dhataki
|
|
Triphala
|
Nelfinavir - @ - Antiviral agent (Oct 1993)
|
|
Impotence drugs
|
Salabmisri
|
|
Jyotishmati
|
Latakasthuri
|
|
Kokilasksha
|
Madhu purified
|
|
Kumari
|
Harida
|
|
Rosuvastatin@ - HMG-CoA Reductase Inhibitors- Antihyperlipidemic Agents- (FDC- List )- (Nov 2008)
|
Aminoglutethimide ( * )- @ Adrenal Steroid inhibitor
|
|
Himplasia
|
Progestins @ Sex hormones
|
|
Trace Metals- Refer Copper
|
Para-aminobenzoic acid (PABA) @
|
|
Digoxin Immune Fab (Ovine)Antidote for Digitalis intoxif
|
1/03. Aceclofenac Plain @ NSAID drugs -( Sep 2003)
|
|
Diclofenac Sodium+Camylofin Dihcl
|
Ezetimibe- Fibric Acid Derivatives -Antihyperlipidemic agents- (FDC- List ) -(Apr 2007)
|
|
Zoledronic acid - Bisphosphonates - Metabolic Disorders - (Nov 2001)
|
Valsartan - Angiotensin II Receptor Antagonists- (FDC- List )- (Dec 2001)
|
|
Bisoprolol +Hydrochorthiazide
|
Fenoverine - Antispasmodics
|
|
Amlodipine-s (pure)- (FDC- List)
|
Hrivera
|
|
Valdecoxib +Tizanidine
|
Non-steroidal anti-inflammatory drugs (contd.)
|
|
Cisapride + Simethicone -(FDC-List)
|
Atenolol + Indapamide
|
|
Domperidone + Pantoprazole
|
Tranexamic acid + Mefanamic acid
|
|
Racecadotril - Antidiarrheals- (Oct 2001)
|
Gefitinib - @ - Epidermal Growth Factor Receptor Inhibitors - Antineoplastic Agents- (Feb 2004)
|
|
Rizatriptan-@Agents for migraine-(Jan 1993)
|
Amlodipine + Atorvastatin
|
|
Atorvastatin + Niacin - (FDC - List)
|
Tamsulosin + Finasteride @
|
|
Aceclofenac + Paracetamol -(FDC List)
|
Gatifloxcin + Ornidazole
|
|
Metronidazole + Povidone Iodine
|
Cefixime + Ambroxol + Lactobacillus
|
|
Roxithromycin+Serratiopeptidase( ** ) ( IRRATIONAL COMBN)
|
Domperidone + Esomeprazole
|
|
Gatifloxin + Ambroxol
|
Estramustine phosphate- @ -Estrogen / Nitrogen Mustard- Alkylating Agents
|
|
Etanercept - Immunomodulators - Immunologic Agents
|
191/04. Adefovir diplvoxil - Antiviral agent- (Mar 2004)
|
|
Sulbactam + Ceftriaxone Sodium - Anti- Infectives
|
Nimesulide + Racemethionine -(FDC- List )
|
|
Atorvastatin + Folic acid + Methylcbal + Pyridx ( FDC - List)
|
Sodium Feredetate
|
|
Sirolimus - Immunospressants- (July 2002)
|
Benfotiamine - Antihistamine
|
|
Risedronate - @ -Biophosphonates- (FDC- List )- (Dec 1983)
|
Sulbactam+ Cefotaxime - Anti-Infectives- (FDC- List)- (Apr 2000)
|
|
Imidapril - Antihypertensives-(Feb 2004)
|
Levofloxacin + Ambroxol
|
|
Drotrecogin Alfa Activated-Human Protein C- Thromolytic agents
|
Atorvastatin + Fenofibrate
|
|
Atorvastatin + Ezetimibe- (FDC -List)
|
Metadoxime - Hepatobiliary agent
|
|
Non -steroidal anti-infalammatory drugs ( contd.)
|
Parecoxib- Selective Cox-2 Inhibitors-(Nov 2002)
|
|
Duloxetine-@Serotin& norephinephrine reuptake inhibitors -(Nov 2004)
|
Tirofiban - Glycoprotein IIb inhibitr - Antiplatelet Agent- (Aug 2003)
|
|
Hylan- Anti-Inflammatory Agents- (Mar 2008)
|
Telmisatran + Hydrochlorthiazide
|
|
Simvastatin + Ezetimibe
|
Strontium ranelate
|
|
Benzithiazide + Triamterene - Thiazides and related diuretics
|
Levocarnitine-@Energy Supplement
|
|
Thiocolchicoside - Muscle Relaxants - Musculo- skeletal Disorders- (FDC- List )- (March 1996)
|
Cabergoline-@- Dopamine antagonist( Sep 2002)
|
|
Isotretinoin @ -Retiniods- Dematologic-(FDC- List -(Oct 2004)
|
Acitretin- Second generation Retinoids
|
|
Erdosteine- Mucolytic-(FDC -List) (Feb 2006)
|
Diacerin @ - NSAIDs Agents- (FDC- List - )- (Mar 2004)
|
|
Nebivolol +Hydrochlorthiazide - (Dec 2004)
|
Rabeprazole+ Itopride Hydrochloride
|
|
Amlodipine-S + Nebivolol
|
Tamsulosin +Dutasteride - (Jan 2006)
|
|
Anti-thymocyte globulin
|
Butenafine - @ Antifungal Agents
|
|
Aceclofenac+Chlorzoxazone + Paracetamol- (FDC List )
|
Lopinavir+Ritonavir- (FDC- List )-(2008/2015)
|
|
Isometheptene -@ -Agents for Migraine
|
Miglitol - Antidiabetic Agents- (FDC- List )- (Aug 2004)
|
|
Levetiracetetam- Anticonvulsants-(Feb 2006)
|
Faropenem - Carbapenem- Anti-infectives
|
|
Ceftriaxone + Tazobactam
|
Satranidazole- Imidazole derivatives- (FDC- List)- (Oct 2007)
|
|
Ciclesonide - Intranasal - Respiratory Inhalant Products- (FDC-List) (Feb 2006)
|
Losartan Potassium + Hydrochlorthiazide
|
|
Pregabalin - @ - Anticonvulsants- (FDC- List )- (May 2006)
|
Dexibuprofen - NSAIDs Agents- (FDC - List ) (Feb 2006)
|
|
Cefditoren Pivoxil @ Cephalosporin (Mar 2008)
|
Albenandazole + Ivermectin -(FDC List)
|
|
Montelukast + Levocetrizine
|
Atomoxetine hcl - @ -Psychotherapeutic agent- (Feb 2006)
|
|
Olmesartan medoxomil - @ - Angiotensin II antagonists- (FDC- List )- (May 2006)
|
Pramipexole -@ - Proton Pump inhibitors-(Oct 2010)
|
|
Temoporfin- Carcino- Chemotherapeutic agents - (July 2008)
|
Rifampicin + Isoniazid + Ethambutol
|
|
Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
|
Balsalazide @ - Antidiarrheals -(Nov 2002)
|
|
Dexibuprofen+Paracetamol
|
Gemifloxacin- @-(FDC- List )-(Jun 1995)
|
|
Eptifibatide - Glycoprotein IIb/IIIa Inhibitors- Antiplatelet Agents(Aug 1999)
|
Pycnogenol + Viamin C + Vitamin E
|
|
Pemetrexed disodium- (2008)
|
Teriparatide @ Parathyroid Hormone- Adrenocortical Steroids- (July1993)
|
|
Zonisamide - Anticonvulsant- (May 2006)
|
Ticlosan
|
|
Voriconazole -@Triazole Antifungals- (Sept 2004)
|
Ibandronic acid @ Bisphosphanates- (FDC- List )- (May 2004)
|
|
Capecitabine -@- Antimetabolite - Pyrimidine analogs (Oct 2000)
|
Doxofylline- Anti-asthmatic- (FDC- List ) (Feb 2006)
|
|
Ropinirole -Neurodegenerative diseases drug-(Dec-2001)
|
Palonosetron -@ - 5-HT3 Receptor Antagonists - Antiemetic /Antivertigo Agents- (Apr 2009)
|
|
Pegfilgrastim- Colony Stimulating Factors- Hematopoietic Agents
|
Rituximab - Monoclonal Antibodies - Antineoplastic Agents- (July 2000)
|
|
Tigecycline- Anti-infectives- (July 2006)
|
Cholecalciferol - Vitamins
|
|
Oseltamivir- @ - Antiviral Agents-(Apr 2006)
|
Orlistat- Lipase Inhibitors-(Oct 2004)
|
|
Halobetasol propionate @- Corticosteroids -Topical - (FDC- List)- (Feb 2007)
|
Glatiramer aceatate - Immunosuppressieves- Immunological Agents- (Feb 2007)
|
|
Oxaprozin - @ NSAID agents-(Oct 2007)
|
Sertaconazole - @ - Antifungal - Anti-infectives - Topical- (FDC- List )- (Nov 2007)
|
|
Rimonabant@- Anti-obesity drug- (Feb 2006)
|
Ranolazine - @ - Antianginal Agent- (Oct 2009)
|
|
Methimazole- @ - Antithyroid Drugs
|
Olopatadine - Anti-allergic drug- (June 2006)
|
|
3/17. Deflazacort- (EMFLAZA)-@- (Feb 2017)- to treat patients age 5 years and older with Duchenne muscular dystrophy(DMD)
|
Lornoxicam - NSAIDs Agents- (FDC- List )-(May 2007)
|
|
Beractant phopholipids
|
Memantine hcl - Neurodegenerative diseases drug- (FDC- List )- (July 2004)
|
|
Trandolapril- ACE @( Angiotensin - Converting Enzyme Inhib)- (FDC- List )- (2006)
|
Bortezomib -Velcade(2003)- @ -Proteasome Inhibitors - Antineoplastic Agents
|
|
140/08. Acebrophylline - Antiasthmatics-(May 2008)
|
Lenalidomide- (Revlimid)- @- (2005/2008/2013)-(Carcino-chemotherapeutic drugs
|
|
Rupatadine-(FDC- List) -(Nov 2009)
|
Milnacipran Hcl- Serotinin and Norepinephrine reuptake Inhibitors- Antidepressants -(May 2008)
|
|
Ibuprofen + Glucosamine
|
Benfotamine + L-carnosine
|
|
Dexketoprofen trometamol- Anti-inflammatory- ( FDC - List )- (Mar 2008)
|
Phenyramidol Hcl- Musculoskeletal- (Nov 2008)
|
|
Resveratrol-Cardioprotective
|
Atazanavir - Antiretroviral agents-(2003/2008)
|
|
Darifenacin Hydrobromide @ - Anticholinergics- (2004)
|
Solifenacin @ Urinary anti-spasmodics-(July 2006)
|
|
Erlotinib hydrochloride - (Tarceva)- @ -(May 2013)-Epidermal Growth Factor Receptor Inhibitors - Antineoplastic Agents
|
Vildagliptin- (FDC- List )- (2008)
|
|
Sorafenib tosylate - Nexavar (2005)- @ - Multikinase Inhibitor - Antineoplastic Agents
|
Darunavir
|
|
Naratriptan - @ Agents for Migraine-(July 1988)
|
Dexrabeprazole -@ - Proton Pump Inhibitors- ( FDC- List )- (June 2008)
|
|
Fluoxetine + Alprozolam
|
Sitagliptin- Antidiabetic Agents - ( FDC-List )- (Oct 2007)
|
|
Saxagliptin - Onglyza- Hypoglycemics-(July 2009)
|
Tolperisone Hydrochloride - Muscle relaxant- (FDC- List )- (2008)
|
|
Eperisone Hydrochloride - Muscle relaxant- (FDC- List )- (Aug 2006)
|
Febuxostat - Uloric Tablets- Agents for Gout-(Feb 2009)
|
|
Artemethar + Lumefantrine- Coartem- (FDC- List) (2009)
|
Desvenlafaxine-@Serotinin & norephinephrine reuptake inhb
|
|
Voglibose- Hypoglycemics -(FDC- List )- (Oct 1984)
|
Diclofenac Potassium +Rabeprazole Sodium
|
|
Ferrous Ascorbate + Folic acid- (FDC- List )- (Aug 2008)
|
Sodium Feredetate + Folic Acid + Vitamin B12
|
|
Ivabradine -Corlanor -@- (Apr 2015)- Anti-anginals drugs
|
Prasugrel - Effient -@- Anticoagulant- (FDC- List )-(July 2009)
|
|
Rasagiline - Neurodegenerative diseases drug- (Jan 2009)
|
Rifaximin - @-Antibacterial- (Aug 2006)
|
|
Nepafenac - Anti-inflammatory-(March 2008)
|
Bosentan monohydrate - @ -Vasodilators- (June 2009)
|
|
Flupirtine maleate - Anti-inflammatory
|
Levocetrizine Hcl + Montelukast Sodium @
|
|
Trospium chloride @ Anticholinergics
|
Thiocolchicoside + Diclofenac Sodium
|
|
Eplerenone @ - Selective Aldosterone Receptor Antagonists
|
Aliskiren - @ Direct Renin Inhibitors -(FDC List)- (May 2008)
|
|
Eprosartan mesylate - @ Angiotensin II Antagonists(Oct 2008)
|
Clevidipine Butyrate - Calcium Channel Blocker
|
|
Dofetilide - Antiarrhythmic agents @
|
Exemestane- Hormones
|
|
Arformetrol -@- Bronchospasm relaxant- (2006)
|
Cinacalcet Hydrochloride - @- Calcimimetics- Calciton- Salmon (2004)
|
|
Ibuprofen Lysine - Agents for Patent Dutus Arteriosus
|
Trichlormethiazide - @ Thiazides and related Diuretics
|
|
Silodosin - @ Antiadrenergic Agents - Periph Acting- (June 2011)
|
Alfuzosin Hcl -(May 2004)- Antiadrenergic Agents Periph Acting-
|
|
Tamsulosin Hcl - @ - Antiadrenergic agent - Periph Acting - ( FDC- List )- (April 2002)
|
Sodium Nitroprusside - Agents for hypertensive emergencies
|
|
Lanthanum Carbonate - Urinary Chlolinergics
|
Eletriptan - @ Agents For Migraine
|
|
Frovatriptan - @ Agents for Migraine
|
Zolmitriptan - @ Agents for Migraine- (May 2009)
|
|
Agents for Migraine - Information Summary
|
Levodropropizine - Non-Opioid Antitussive - (FDC- List )
|
|
Urokinase - @ Thrombolytic enzymes
|
Acetyl Salicylic acid (Aspirin)- Anti-platelet age @ - Refer Aspirin -(FDC List)
|
|
Enoxaparin- (Mar 1992) @ LMW Heparin - Anticoagulant
|
Dalteparin-@LMW Heparin- Anticoagulant- (Jan 2008)
|
|
Heparin - @ LMW Heparin - Anticoagulant- (FDC- List )- (Mar 2002)
|
Reviparin -@LMW Heparin- Anticoagulant
|
|
Nadroparin - @ LMW Heparin - Anticoagulant
|
Parnaparin - @ LMW Heparin - Anticoagulant
|
|
Genasaprin - @ LMW Heparin - Anticoagulant
|
Desirudin-Thrombin Inhibitor -Anticoagulant
|
|
Lepirudin-Thrombin Inhibitor-Anticoagulant
|
Agartroban - Thrombin Inhibitor- Anticoagulant
|
|
Bivalirudin - Thrombin Inhibitor- Anticoagulant
|
Penicillin Sensitive Organisms
|
|
Cephalosporins Sensitive Organisms
|
Fluoroquinolones Sensitive Organisms
|
|
Tetracyclines Sensitive Organisms
|
Macrolides Sensitive Organisms
|
|
Lincosamides Senstive organisms
|
Aminoglycosides Sensitive Organisms
|
|
Sulpha Drugs Susceptible Organisms
|
Anthelminitics Sensitive Organism
|
|
Eflornithine Hydrochloride -@- Dermatological agent -(Mar 2006)
|
Protriptyline Hcl - Tricyclic Antidepressants
|
|
161/08.Abatacept - Immunomodulators-(July 2008)
|
Anakinra - Immunomodulators
|
|
Adalimumab - Immunomodulator
|
Natalizumab- Immunologic agents
|
|
Infliximab- @ - Immunomodulators - Immunologic Agents
|
Moxonidine - Antihypertensives-(Feb 2007)
|
|
Certolizumab - Immunomodulators
|
Rilonacept - @- Immunomodulators
|
|
Daclizumab - @- Immunosuppressives - Immunological Agents
|
Palifermin - @ - Keratinocyte Growth Inhibitor- Antirheumatic agents
|
|
Retapamulin- Antibiotic- Anti-infectives - Topical
|
DISORDERS AND /OR ADVERSE REACTIONS - 5. HORMONES - SUMMARY
|
|
DISORDERS AND/OR ADVERSE REACTIONS - 8.Nutrition -SUMMARY
|
DISORDERS AND/OR ADVERSE REACTIONS - 9. RESPIRATORY SYSTEM - SUMMARY
|
|
DISORDERS AND/OR/ ADVERSE DRUG REACTIONS- 10. EAR,NOSE AND THROAT - SUMMARY
|
DISORDERS AND/OR ADVERSE REACTIONS - 11. EYE - OCULAR SYSTEM -SUMMARY
|
|
Butoform - Colon and Rectal acting agents
|
Glutaraldehyde - Antiseptic and Germicides - Topical- (FDC- List )
|
|
Penciclovir - Antiviral agent - Topical
|
Mafenide Acetate - @ - Burn preparation - Topical
|
|
Podofilox - @ - Topical destructive agents
|
Imiquimod - @ - Immunomodulators - Topical- (Dec 2004)
|
|
Pramoxine hydrochloride - Topical Local anesthestics
|
Bexarotene - Rexinoids - Antineiplastic Agents
|
|
Becaplermin - Topical wound healing agents
|
Caspofungi acetate - Anti-fungal agent
|
|
Sinecatechins - @ -Topical Wound Healing Agents
|
Interferon Beta - @ - Immunomodulators- (July 2007)
|
|
Interferon Alfacon - @ -1 Immunomodulators
|
Brinzolamide - Carbonic Anhydrase Inhibitors - Agents For Glaucoma
|
|
Bromfenac - Ophthalmic Agents - NSAIDs drugs
|
Disfluprednate - Ophthalmic - corticosteroids
|
|
Difluprednate - Ophthalmic Agents - Corticosteroids- ( FDC- List )
|
Rimexolone - Ophthalmic Agents - Corticosteroids
|
|
Pemirolast Potassium - @ - Ophthalmic Agents - Mast cell Stabilizers
|
Nedocromil sodium - @ - Ophthalmic Agents - Mast Cell Stabilizers
|
|
Dextranomer - @ -Wound Healing agents
|
Lodoxamide Tromthamine - @ - Ophthalmic Agents - Mast Cell Stabilizers
|
|
Cromolyn Sodium - Ophthalmic Agents - Mast Cell Stabilizers
|
Emedastine Difumarate - @ -Ophthalmic Agents - Ophthalmic Antihistamines
|
|
Epinastine Hydrochloride -@ - Ophthalmic Agents - Ophthalmic Antihistamines- (Sep 2006)
|
Trifluridine - @ - Ophthalmic Agents - Ophthalmic Antiviral Agents
|
|
Pegaptaninb sodium - @ - Opthalmic Injection - Selective vascular Endothelial Growth Factor Antagonist- (Feb 2006)
|
Ranibizunab -@- Ophthalmic agents - Selective Vascular Endothelial Growth Factor Antagonist
|
|
Verteporfin - Ophthalmic Phototherapy - Selective Vascular Endothelial Growth Factor Antagonist
|
Tyloxapol - Ophthalmic Agents - Ocular Lubricants
|
|
Proparacaine Hcl - Opthalmic Agents - Ophthalmic Anesthetics
|
Fluoresin sodium - @ -Ophthalmic agents - Ophthalmic diagnostic products- (Mar 2006)
|
|
Fluorexon - Ophthalmic Agents - Ophthalmic Diagnostic Products
|
Lissamine Green - Ophthalmic Agents - Ophthalmic Diagnostic Products
|
|
Mechloreththamine Hcl - @ -Nitorgen Mustard HN2 - Alkylating Agents
|
Bendamustine Hcl - @- Treanda (Oct 2008) and Tabs (Sep 2014) -Mechloretamine Derivative - Alkylating Agents
|
|
Floxurdine -@ - Pyrimidine Analogs - Antimetabolites
|
Rasburicase - Purine Analogs And Related Agents - Antimetabolites
|
|
Clofarabine - Purine Analogs and Related Agents - Antimetabolites
|
Ixabepilone - @ - Epothilones - Antimitotic Agents- (Sep 2008)
|
|
Valrubicin - @ - Antracyclines - Antibiotics
|
Nilutamide - @ - Antiandrogens - Hormones
|
|
Toremifene Citrate - Antiestrogens - Hormones
|
Fulvestrant - @ -Antiestrogens - Hormones - (Aug 2006)
|
|
Histrelin Acetate Implant - @ -Gonodrotropin - Releasing Hormone Analogs- Hormones
|
Chromic phosphate P 32- @ - Radiopharmaceuticals
|
|
Sodium Iodide I 131 - Radiopharmaceuticals
|
Samarium SM 153 Lexidronam - @ - Radiopharmaceuticals
|
|
emozolomide - @ - Imidazotetrazine Derivatives - Antineoplastics Agents- (Jan 2000)
|
Dexrazoxane Hcl -@ - Cytoprotective Agent - Antineoplastic Agents
|
|
Azacitadine - DNA Demethaltion Agents- @ - Antineoplastic Agents - (Apr 2014)
|
Nelarabine - @ - DNA Demethylation Agents - Antineoplastic Agents
|
|
Denileukin Diftitox - @ -Biological Response Modifiers - Antineoplastic Agents
|
Ibritumomab Tiuxetan - @- Monoclonal Antibodies - Antineoplastic Agents
|
|
Cetuximab - Monoclonal Antibodies - Antineoplastic Agents
|
Bevacizumab - Avastin /MASI ) soln for IV infus.-@- (2013,14 and 2017) - Monoclonal Antibodies - Antineoplastic Agents
|
|
Panitumumab - @ - Monoclonal Antibodies - Antineoplastic Agents
|
Trastuzumab - (Kadcyla)- @ -(2013)- Monoclonal antibodies- Antineoplastic Agents- (July 2000)
|
|
Gemtuzumab Ozogamicin - @ - Monoclonal Antibodies - Antineoplastic Agents
|
Alemtuzumab - Monoclonal Antibodies - Antineoplastic Agents
|
|
Tositumomab + Iodine 131 I - @ - Tositumomab - Monoclonal Antibodies - Antineoplastic agents
|
Dasatinib - @- Protein Tyrosine Kinase Inhibitors - Antineoplastic Agents- (Aug 2006)
|
|
Nilotinib Hydrochloride - @ - Protein- Tyrosine Kinase Inhibitors - Antineoplastic Agent
|
Sunitinib Malate - @ - Protein -Tyrosine Kinase Inhibitors - Antineoplastic Agents
|
|
Temsirolimus - @ - mTor Inhibitor - Antineoplastic Agents
|
Everolimus - Affinator - @ -mTOR inhibitor - Antineoplastic agents- (Aug 2004- Mar 2009)
|
|
Lapatinib Ditosylate -@- Tyrosine Kinase Inhibitors - Antineoplastic Agents- (2007)
|
Vorinostat - @ - Histone Deacetylase Inhibitors - Antineoplastic Agents
|
|
Arsenic Trioxide - Miscellaneous Antineoplastic Agents
|
Sterile Talc Powder - Miscellaneous Antineoplastic Agents
|
|
Sodium Iodide I 123 - Thyroid Function Tests - IN VIVO Diagnostic Aids
|
Thyrotropin Alfa - @ - Thyroid Function Tests - IN VIVO Diagnostic Aids
|
|
Gonadorelin Hydrochloride - @- Thyroid Function Tests - IN VIVO Diagnaostic Aids
|
Methacholine Chloride - @ - Thyroid Function Tests - IN VIVO Diagnostics Aids
|
|
Secretin Acetate - @ - Gastrointestinal Function Tests - IN VIVO Diagnostic Aids
|
Simethicone Coated Cellulose - @ - Gastrointestinal Function Tests - IN VIVO Diagnostics Aids
|
|
Sincalide - Gastrointestinal Function Tests - IN VIVO Diagnostics Aids
|
Regadenoson -@ - IN VIVO Diagnostics Aids
|
|
Arginine Hydrochloride - IN VIVO Diagnostic Aids
|
Corticorelin Ovine Triflutate - IN VIVO Diagnostics
|
|
Metyrapone -@ - IN VIVO Diagnostic Aids
|
Capromab Pendetide - IN VIVO Diagnostics Aids
|
|
Iobenguane Sulfate I 123 - IN VIVO Diagnostic Aids
|
Canida Albicans Skin Test Antigen - IN VIVO Diagnostics Biologicals
|
|
Coccidiodin - IN VIVO Diagnostic Biologicals
|
Histamine Phosphate - IN VIVO Diagnostics Biologicals
|
|
Histoplasmin - IN VIVO Diagnostic Biologicals
|
Allergen Patch Test - Skin Test Antigens, multiple
|
|
Tuberculin Purified Protein Derivative- @ -( Mantoux ) - Skin Test antigens - IN VIVO Diagnostic Biologicals
|
Doripenem - Carbapenem - @ - Systemic Anti-infectives
|
|
Dibucaine - Amide Local Anesthetics - Local Anesthetics - Topical
|
Emtricitabine - @ -Antiretroviral Agents
|
|
Epoetin Alfa Recombinant - @- Erythropoiesis Stimulating Agent - Hemotopietic Agents
|
Evening Promrose - Hormones and drugs
|
|
Heparinoid - Mucoplosaccharide polysufate - Anticoagulant
|
Hydroquinone - @ - Pigment Agents- (FDC- List )- (Jan 2008)
|
|
Hydroxyapatite compound - Calcium/Potassium salts - (FDC -List)
|
Insulin Detemir ( rDNA Origin ) - Antidiabetic agents
|
|
Insulin Glargine ( rDNA origin ) - Antidiabetic agents
|
Insulin Lispro ( rDNA Origin ) Antidiabetic agents
|
|
Levosalbutamol - Bronchodilators - Anti-asthmatics- (July 2004)
|
Levosulpiride - Ulcer healing Drugs- (FDC- List )- (May 2007)
|
|
Lumefantrine - Antimalarials
|
Lycopene - Anti-oxidant
|
|
Methoxsalen - @ -Anti-psoriatic -(March 2008)
|
Insulin Aspart - rDNA Origin - Antidiabetic Agents
|
|
Insulin Glulisine ( rDNA Origin ) - Antidiabetic Agents
|
Phytonadione ( Vitamin K ) - Haemostatic Agents
|
|
Oxybenzone - Topical Pigment agents
|
Octinoxate - Topical pigment agents- (FDC- List )
|
|
Tazobactum Sodium - Extended Spectrum Penicillins - Anti- Infectives
|
Tenofovir Disoproxyl Fumerate @ - Antiretroviral Agents- (FDC- List )- (Feb 2006)
|
|
Thiacetazone - Antituberculous Drugs
|
Thioridazine Hydrochloride - Sedatives and Tranquilizers
|
|
Tripotassium Dictrato Bismuthate - Bismuth Salts - Ulcer Healing Drugs - (Jan 1989)
|
Trisodium Citrate Dihydrate - Mineral supplements
|
|
Zirconium Dioxide - Anti-infectives
|
Paracetamol + Caffeine - Analgesics
|
|
Calcium Citrate Maleate + Vitamin D3 - Vitamin/Mineral supplements -(2008)
|
Paracetamol -Plain @ -( Acetoaminophen )- Analgesics- (FDC- List ) - (1972)
|
|
Calcium Aspartate Anhydrous - Calcium Salts- Mineral Supplements
|
Calcium Polystyrene Sulphonate - Calcium salts- Mineral Supplements
|
|
Vitamin E + L-Carnitine
|
Vitamin A + Vitamin D + Vitamin E + Vitamin C + Minerals - Vitamins and Mineral Supplements
|
|
Mecobalamin + Alpha Lipoic acid
|
Domperidone + Naproxen
|
|
Naproxen + Paracetamol
|
Cetyl Myristoleate - Rubefacients
|
|
Collagenase - topical - Enyme Preparations
|
Naproxen / Lanzoprazole - NSAIDs Combinations
|
|
Collagen Fleece Impregnated with antibiotic Gentamicin - Biomaterials
|
Cacium Citrate - Calcium salts
|
|
Dipyrone - NSAIDs Agents
|
Ofloxacin + Dexamethasone - Anti-Allergic Drugs
|
|
Carboxymethyl cellulose - @- Ophthalmic Agents
|
Dosulepin - Anti-depressants- (FDC- List ) (Apr 2010)
|
|
Doxylamine Succinate + Pyridoxine - Antiemetics
|
Lidocaine + Epinephrine - Local anesthestics
|
|
Tinidazole + Fluconazole - Antifungal agents
|
Flupentixol + Melitracen - Anti-depressants
|
|
Salmeterol + Fluticasone - Bronchospasm Relaxants
|
Imipenem + Cilastatin - @ - Anti-infectives-(FDC- List )
|
|
Retinol - Vitamins
|
Sulbactum + Ampicillin - Anti-Infectives
|
|
Sulbactam + Cefoperazone - Anti-Infectives
|
Suxamethonium Chloride - Muscle Relaxants
|
|
Trytophan - @ - Anti-depressants
|
Vinpocetine - Cerbro-vascular drug
|
|
Coenzyme Q 10 + Vitamin E
|
Etizolam - (Oct 2007)
|
|
Perindopril Erbumine + Amlodipine Besilate
|
Montelukast + Fexopfenadine Hcl
|
|
Omega -3 Ethyl Esters- (FDC- List )
|
Trypsin + Bromelain + Rutoside
|
|
Erythromycin Lactobionate - Macrolides
|
Telithromycin - @ - Ketolides - Macrolides Group - Anti-Infectives
|
|
Quinupristin/Dalfopristin - Streptogramins - Anti-Infectives
|
Daptomycin - @- Lipopeptides - Anti-Infectives- (Jan 2008)
|
|
Sulfisoxazole Acetyl - @ - Sulpha Drugs- Anti-Infectives
|
Fosfomycin Tromethane - @ -Anti-Infectives - (Oct 2008)
|
|
Micafungin Sodium -Mycamine (May 2005)- Echinocandine - Anti-Fungal Agents
|
Atovaquone + Proguanil Hydrochloride - Anti-malarial Agents
|
|
Rifapentine - Anti-tuberculosis Agents
|
Cidofovir - Antiviral Agents
|
|
Zanamivir - @ - Antiviral agents- (Jan 2008)
|
Entecavir - @ -Antiviral Agents- (FDC- List )
|
|
Tipranavir - Anti- Viral agents
|
Fosamprenavir Calcium - @ -Antiviral agents
|
|
Telbivudine - @ - Antiviral agents- (Aug 2006)
|
Lamivudine / Zidovudine - Antiviral agents
|
|
Abacavir sulfate/ Lamivudine /Zidovudine - Antiviral Agents
|
Emtrictabine /Tenofovir Disoproxil Fumarate - Antiviral Agents
|
|
Etravarine - @ -Antiviral Agents
|
Delavirdine Mesylate - @-Antiviral agents
|
|
Efavirenz / Emtricitabine / Tenofovir fumarate - Antiviral agents
|
Maraviroc - @ - cellular chemokine receptor (CCR5) antagonist - antiviral agent
|
|
Raltegravir -@ - Integrase inhibitors - Antiviral agents
|
Enfuvirtide - @ -Fusion Inhibitors - Antiviral agents
|
|
Pentamidine Isethionate - @ - Antiprotozoals
|
Dexlansoprazole - proton pump inhibitors
|
|
Omeprazole/Sodium bicarbonate - Proton pump inhibitors
|
Methscopolamine bromide - @ -Quaternary anticholinergics
|
|
Lubiprostone - @-Gastrointestinal agents-(Oct 2010)
|
Alvimopan - @ Gastrointestinal agents
|
|
Cascara Sagrada - Irritant or stimulant Laxative
|
Mineral Oil- Emolients - Laxatives
|
|
Glycerin - Hyperosmostic agents
|
Sodium Phosphate - Bowel Evacuants- (FDC -List )
|
|
Difenoxin Hcl with Atropine Hcl - Antidiarrheals
|
Cevimeline Hydrochloride -@ - Mouth and throat products
|
|
Amlexanox - Mouth and throat disorders- (May 2007)
|
Bismuth Subgallate - Systemic Deodorizers
|
|
Dequalinium - @ -Mouth and throat products
|
Doxapram Hydrochloride - @-Analeptics- CNS Stimulants
|
|
Asenapine maleate - Saphris- @ - Anti-depressants-(2009)
|
Aprepitant - @ - Antiemetics/ Antivertigo Agents- (FDC- List ) -(2006/2007)
|
|
Tioconazole - @- Imidazole derivatives - Vaginal Antifingal agents- (Mar 2011)
|
Armodafinil - @- Analeptics - CNS Stimulants
|
|
Dextroamphetamine sulfate - Amphetamines - CNS Stimulants
|
Dexmethylphenidate Hcl - CNS Stimulants
|
|
Lisdexamfetamine dimesylate - @ - Amphetamines - CNS Stimulants
|
Methamphetamine hcl - @ - Amphetamines - CNS Stimulants
|
|
Opioid Analgesics
|
Oxycodone -@- Opioid Analgesics
|
|
Propoxyphene Napsylate - Opioid Analgesics- (FDC- List )
|
Propoxyphene Hydrochloride - Opioid Analgesics
|
|
Remefentanil hydrochloride - Opioid Analgesics
|
Salsalate - ( Salicylsalicylic acid ) - Salicylates - General Analgesics
|
|
Butalbital/ Aspirin/ Caffeine - @ - Non narcotic Analgesics Combinations
|
Butalbital/ Acetoaminophen/ Caffeine @ - Non narcotic Analgesic Combinations
|
|
Zinconotide - @ - Analgesics
|
Dihydroergotamine mesylate - Ergotamine derivatives - Agents for Migraine
|
|
Ergotamine Tartrate - Ergotamine Derivatives - Agents for Migraine
|
5-HT3 Receptor Antagonists - Antiemetic/Antivertigo Agents
|
|
Alosetron Hcl - @ - 5-HT3 Receptor Antagonists - Antiemetic/Antivertigo Agents
|
Dolasetron Mesylate - @- 5-HT3 Receptor Antagonists - Antiemetic/ Antivertigo Agents
|
|
Fosaprepitant dimeglumine -@- Antiemetic /Antivertigo Agents
|
Nabilone - @ - Antiemetic/Antivertigo Agents
|
|
Antipsychotic agents - List of drugss
|
Galantamine Hydrobromide - @ - Cholinesterase Inhibitors
|
|
Sodium Oxybate -@ - Psychotherapeutic agents
|
Olanzapine/ Fluoxetine hcl - Psychotherapeutic Combinations
|
|
Perphenazine/ Amitriptyline Hcl - Pschotherapeutic Combinations
|
Ramelton - @ - Melatotin Receptor Agonist - Sedatives and hynotics, Nonbarbiturate
|
|
Dexmedetomidine -@ - Sedatives and Hynotics,Nonbarbiturate
|
Eszopiclone -@ - Sedatives and Hypnotics, Nonbarbiturate- (Feb 2007)
|
|
Methohexital sodium - Barbiturates- General Anesthetics
|
Fospropofol disodium -@ - General Anesthetics
|
|
Nitrous Oxide - Inhalation - Gases - General Anesthestics
|
Droperidol - General Anesthetics
|
|
Enflurane -@ - Volatile Liquids - General Anesthestics
|
Entacapone - @ - Antiparkinson Agents (Dec 2004)
|
|
Azelastine + Fluticasone - Anti-allergic - Antihistamines
|
Lidocaine hydrochloride - Amide Local Anesthestics
|
|
Prilocaine hydrochloride - Amide Local Anesthestics
|
Ropivacaine Hydrochloride - Amide Local Anesthetics
|
|
Chloroprocaine hydrochloride - Ester Local Anesthetics
|
Procaine hydrochloride - Ester Local Anesthetics
|
|
Tetracaine hydrochloride - Ester Local Anesthetics
|
Anesthetics - General - Group Summary
|
|
Methsuximide - Succinamides - Anticonvulsants
|
Rufinamide - @ - Anticonvulsants
|
|
Tiagabine hydrochloride - @- Anticonvulsants- (May 2004)
|
Acetomenaphthone + Rutin - Haemostatic Agents
|
|
Acetylcysteine - @ -Detoxifying Agents
|
Aminacrine - Topical anti-scabies preparations
|
|
Furosemide + Triamterene - Diuretics Combination
|
Arteether - Antimalarials
|
|
Levodopa/Carbidopa/Entacapone - Antiparkinson Agents Combination
|
IIoperidone - Antipsychotic Agents
|
|
Tapentadol - Nucynta ( 2008) -@- Analgesics
|
Telmisartan + Ramipril - Angotensin II Antagonists Combination
|
|
Nimesulide - Non-steroid anti-inflammatory drugs- (Jan 1995 DCGI)
|
Human Placenta Extract
|
|
Sports - drug usage
|
Isosorbide mononitrate + Aspirin
|
|
Tolcapone - @ - Antiparkinson agents
|
Apomorphine Hydrochloride -@- Dopaminergics - Anti-Parkinson Agents- (Nov 2007)
|
|
Ambenonium Chloride - @ -Anticholenesterase Muscle Stimulants - Cholinergic Muscle Stimulants
|
Edrophonium Chloride -Anticholinesterase Muscle Stimulants - Cholinergic Muscle Stimulants
|
|
Edrophonium Chloride/Atropine Sulphate -Anticholinesterase Muscle Stimulants - Cholinergic Muscle Stimulants
|
Guanidine Hydrochloride - @ - Cholinergic Muscle Stimulants- Cholinergic Muscle Stimulants
|
|
1/14.Acamposate Calcium - @ - Antialcoholic Agents(Dec 2002)
|
Nicotine Polacrilex - Smoking Deterrents
|
|
Varenicline Tartrate - @ - Smoking Deterrents- (May 2007)
|
Hyalurronic Acid Derivatives -@- Physical Adjuncts- (FDC- List )- (Jan 2008)
|
|
Calcium Hydroxylapatite - Implant - @- Physical Adjuncts
|
Poly -L- Lactic Acid - @- Physical Adjuncts
|
|
Ipratropium Bromide/ Albuterol Sulfate - Anticholinergics- Combinations
|
Zileuton - @- Leukotriene Formation Inhibitor -Leukotriene Receptor Antagonists
|
|
Omalizumab - @ - Monoclonal Antibodies- Leukotriene Formation Inhibitors
|
Dornase Alfa- (Recombinant human deoxyribonuclease -DNase -@- Mucoltytics- Respiratory Inhalant Products
|
|
Budesonide/Formoterol fumarate - Respiratory Inhalant combinations
|
Fluticasone Propionate/ Salmeterol - Respiratory Inhalant Combinations
|
|
Alpha 1- Proteinase Inhibitor ( Human ) @- Respiratory Enzymes- Nasal Decongestants
|
Calfactant - Lung Surfactant
|
|
Poractant Alfa- Lung Surfactants
|
Brompheniramine - Alkylamines, Nonselective- Antihistamines
|
|
Dexchlorpheniramine Maleate - Alklamine, Nonselective - Antihistamines
|
Dextromethorphan Polistirex - Nonnarcotic Antitissues
|
|
Dimethyl Sulfoxide - (DMSO) -@- Interstitial Cysitis Agents
|
Yohimbine Hydrochloride - Impotence Agents
|
|
Vardenafil Hydrochloride - Phosphodiesterase Type 5 inhibitors - Impotence Agents
|
Acetohydroxyamic Acid- @- Genito-urinary Agents
|
|
Tioprotin - Cystine- @ - Depleting agents
|
Fesoterdine Fumarate - @ -Anticholinergics
|
|
Butoconazole Nitrate - Vaginal Antifungal Agents - Vaginal Preparations
|
Sulfanilamide Vaginal - @ - Miscellanous Anti-infectives- Miscellaneous Vaginal Preparations
|
|
Nesiritide - Human- B- Type Natriuretic Peptide- Periphral Vasodilators
|
Ambrisentan - @ -Endothelin Receptor Antagonist - Vasodilators(Feb 2010)
|
|
Iloprost - Inhalation - @- Prostacyclin Analog- Vasodilators
|
MethylDopa + Methyldopate hydrocholoride - Antiadrenergic Agents combinations
|
|
Mecamylamine Hydrochloride -@- Antiadrenergics/Sympatholytics
|
Cholestyramine - @ - Bile Acid Sequestrants - Antihyperlipidemics Agents -(Mar 2006)
|
|
Colestipol hydrochloride -@ - Bile acid Sequestrants - Antihyperlidermic agents
|
Simvastatin + Niacin - Antihyperlidermic Combinations
|
|
Midodrine Hydrochloride - @ - Vasopressors Used in Shock
|
Ethanolamine Oleate - Sclerosing Agents -
|
|
Sodium Tetradecyl Sulfate - Sclerosing Agents
|
Morrhuate Sodium - Sclerotic Agents
|
|
Lovastatin and Niacin - Anthyperlipemic Combinations
|
Apixaban - Eliquis - @- (2012)- Coagulation Factor Inhibitor - Anticoagulant
|
|
Betamethasone + Clotrimazole
|
Calcium Folinate - Antidotes- Metabolic disoders
|
|
Calamine - @ - Dermatological Product- (FDC-List)(Feb 2009)
|
L-Carnitine - Metabolic Disorders
|
|
Cetrimide + Chlorhexidine
|
Citicoline - Neurotrophics Drug-(FDC-List) (Aug 2004)
|
|
Clidinium bromide + Chlordiazepoxide - Ulcer healing drugs
|
Cyproterone - Acne- Dermatological product(June 2003)
|
|
Sunitinib - Carcino- Chemotherapeutic Drugs - (April 2007)
|
Estropipate -( Piperazaine Estrone Sulfate )- Estrogens- Sex Hormones
|
|
Estrogen/Progestin combination- Progestins- Sex hormones
|
Etonogestrel -@ - Implant- Contraceptive Hormones- Sex hormones- (FDC- List )
|
|
Nafarelin Acetate- @ - Gonadrotropin -Releasing Hormones- Sex Hormones
|
Ganirelix acetate -@- Gonadotropin Hormone Antagonists - Sex Hormones
|
|
Degarelix -@ - Gonodotropin -Releasing Hormones - Sex hormones
|
Methylergonovine Maleate - Uterine Stimulants - Uterine- Active Agents
|
|
Tiludronate Disodium - Bisphosphanates
|
Pramlintide Acetate -@- Amylin Analog - Antidiabetic Agents
|
|
Liothyroxine Sodium - Thyroid Hormones- Thyroid Drugs
|
Liotrix - Thyroid Hormones- Thyroid Drugs
|
|
Mecaserin (rDNA origin )- @- Insulin Growth Factor - Thyroid Drugs
|
Conivapatan Hydrochloride - @- Vasopressin Receptor Antagonist
|
|
Lanreotide Acetate - @-Somatuline Depot Inj. (Dec 2014)- @ - Somatostatin Analogs
|
Pegvisomant - @ - Somatostatin Analogs
|
|
Dabigatran Etexilate -Pradaxa @- Thrombin Inhibitor- Anticoagulant (Oct 2010)
|
Laronidase - @ -Somastatin Analogs
|
|
Galsulfase -@ - Somastatin Analogs
|
Idursulfase -@- Somatostatin Analogs
|
|
Agalsidase Beta - Somastostatin Analogs
|
Miglustat - @- Somastatin Analogs
|
|
Nitisinone -@- 4-Hydroxyphenylpyruvate Dioxydenase Inhibitor
|
Alglucerase - Enzymes- Inhibitor
|
|
Imiglucerase - @ - Enzymes - Inhibitor
|
Alglucosidase Alfa - Lumizyme-@- Enzyme - Inhibitor (May 2010)
|
|
Betaine Anhydrous - @ -Endrocrine/ Metabolic Disorders
|
Cysteamine Bitartrate - @ - Endrocrine /metabolic Disorders
|
|
Sodium Benzoate/Sodium Phenylacetate - @ - Endocrine/Metabolic Disorders
|
Probenecid + Colchicine - Agents For Gout
|
|
Pentetate Zinc Trisodium (Zn-DTPA ) - @ - Chelating agents - Detoxification Agents
|
Trientine Hydrochloride - @ - Chelating Agents - Detoxification Agents
|
|
Prussian Blue- @ - Chelating Agents - Detoxification Agents
|
Hydroxocobalamin - @ - Antidotes - Detoxification Agents
|
|
1/11.Abiraterone Acetate - Zytiga -@- Carcino-chemotherapeutic Drugs (Apr 2011)
|
Sodium Nitrite - Antidotes- Detoxification Agents
|
|
Fomepizole ( 4-Methylpyrazole ; 4-MP ) - Antidotes- Detoxification agents
|
Sapropterin Dihydrochloride -@- Phenylketounuria - Detoxification Agents
|
|
Glyburide (Glibenclamide) + Metformin - Antidiabetic Combination Products
|
Pioglitazone Hydrochloride + Glimepiride - Antidiabetic Combination Product
|
|
Rosiglitazone + Glimepiride - Antidiabetic Combination Products
|
Sitagliptin Phosphate + Metformin Hydrochloride - Antidiabetic Combination Products
|
|
Repaglinide + Metformin Hydrochloride - Antidiabetic Combination Products
|
Methoxy Poythene Glycol -Epoetin -Beta- @- Hemotopoietic agents
|
|
Romiplostim -@- Thrombopoietin Mimetic Agents - Hematopoietic Agents
|
Sargramostim - Granulocyte Macrophage Colony Stimulating Factor GM- CSF - Hematopoietic Agents
|
|
Plerixafor -@ - Stem Cell Mobilizers- Hematopoietic Agents
|
Oprelvekin ( Interleukin II;IL -II ) - @- Interleukins - Hempopoietic Agents
|
|
Eltrombopag -Promacta ( 2008, Apr 2014 and Aug 2015) - @- Thrombopoietin Receptor Agonist - Hematopoietin Agents
|
Anagrelide Hydrochloride - Glycoprotein IIb/IIIa Inhibitors - Antiplatelet Inhibitors
|
|
Retleplase Recombinant - Tissue Plasminogen Activators- Thrombolytic Agents
|
Reteplase Recombinant - Tissue Plasminogen Activators- Thrombolytic Agents
|
|
Tenecteplase - Tissue Plasminogen Activators - Thrombolytic Agents
|
Protein C Concentrate (Human)- @ - Human protein C- Thrombolytic Agents
|
|
Factor VIIa Coagulation Factor - Recombinant -@- Antihemophilic Agents
|
Anti-Inhibitor Coagulant Complex- @- Antihemophilic Agents
|
|
Fibrinogen Concentrate ( Human) - @- Systemic - Hemostatics - (FDC - List)
|
Thrombin - Topical - Hemostatics
|
|
Microfibrillar Collagen Hemostat - Topical - Hemostatics
|
Absorbable Gelatin -Sponge - Topical - Hemostatics
|
|
Oxidized Cellulose - Topical - Hemostatics
|
Albumin Human ( Normal Serum Albumin ) - Plasma Protein Expanders - Plasma Expanders
|
|
Hetastarch ( Hydroxyethyl Starch ) HES- Plasma Expanders
|
Dextran Low Molecular Weight (Dextran 40) - Plasma Expanders-(FDC- list )
|
|
Dextran High Molecular Weight ( Dextran 70 and 75 ) - Plasma Volume Expanders
|
DISORDERS AND/OR ADVERSE REACTIONS - 13.SKIN -DERMATOGICAL SYSTEM -SUMMARY
|
|
DISORDERS AND/OR ADVERSE REACTIONS - 12. ALLERGY- SUMMARY
|
DISORDERS AND/OR ADVERSE REACTIONS - 14. METABOLISM - SUMMARY
|
|
Amoxycillin Trihydrate + Dicloxacillin Sodium
|
Bromhexine Hcl + Terbutaline Sulphate + Guaiphenesin
|
|
Metronidazole + Nalidixic Acid
|
Domperidone + Rabeprazole
|
|
Amlodipine + Metoprolol - (FDC List)
|
Benoxinate- Diagnostic for opthalmic procedures
|
|
Quinapril + Hydrochlorothiazide
|
Valsartan + Hydrochlorothiazide
|
|
Decitabine - Carcino-chemotherapeutic drugs(2006)
|
Quiniodochlor - Anti-fungals/ Anti-amoebics
|
|
Clioquinol (Iodochlorhydroxyquin) - @ -Topical Anti-fungal Agents
|
Omidazole - Anti-amoebics
|
|
Nitrofurazone - Topical Anti-infective- (FDC- List )- (Aug 1973)
|
Hypromellose - Ophthalmic Agents
|
|
Dihydrallazine sulphate- Anti-hypertensives
|
Boric Acid- Miscellaneous Agents
|
|
Sodium Fluoride - @ - Anti-Infectives
|
Paracetamol +Metoclopromide - Vasoconstrictors
|
|
Yeast Extract -Nutritional Product- (FDC- List )
|
Diloxinide Furoate + Metronidazole - Anti-amoebics
|
|
Trabectedin-Yondelis- @- (Oct 2015) -Carcino-chemotheraphy drugs
|
Cetrizine Dihydrochloride - Anti-allergic drugs- (FDC-List)(June 1993)
|
|
Glycopyrronium Bromide - Neuromuscular drugs
|
Hydroxy-carbamate - Carcino-chemotherapeutic drugs
|
|
Organisms- Gram Positive-Susceptible to certain Drugs
|
Organisms- Gram Negative-Susceptible to Certain Drugs
|
|
Organisms- Anaerobic- Susceptible to Certain Drugs
|
Organisms- Susceptible to Certain Sulpha Drugs
|
|
Organisms- Susceptible to Certain Anthelmintics
|
Laboratory Values of Clinical Importance
|
|
Orphan Drugs
|
Isoxicam- NSAIDs - Investigational drugs
|
|
L-5-Hydroxytrytophan (L-5HTP) - Investigational Drugs
|
Vindesine sulfate - Antineoplastic- Investigational Drugs
|
|
Pirenzepine Hcl- Anti-ulcer agent- Investigational Drugs
|
Inosiplex - An immunomodulating agent- Investigational Drugs
|
|
Fenoterol Hbr -Beta agonist- Anti-asthmatic - Investigational Drug
|
Pinacidil- Antihypertensive agent- Investigational Drug
|
|
Carprofen -NSAIDs- Investigational Drugs
|
Acecainide - Antiarrhythmic agent- Investigational drug
|
|
Cifenline Succinate- Antiarrhythmic agent- Investigational drug
|
Tolrestat - An Aldose reductase inhibitor- Investigational drug
|
|
Dilevalol- Beta- Adrenergic blocking agent- Investigational drugs
|
Indecainide Hcl - Antiarrhythmic agent- Investigational drugs
|
|
Cilazapril - Non- sulfhydryl- containg ACE inhibitor- Investigational drugs
|
Terolidine Hcl - Agent for urinary incontinence - Investigational drugs
|
|
Remoxipride- Antipsychotic agent- Invetigational drug
|
Gepirone Hcl - Anxiolytic and Antidepressant - Investigational drug
|
|
Velnacrine - Cholinesterase inhibitor for Alzheimers disease- Investigational Drugs
|
Viloxazine - Bicyclic Antidepressant- Investigational Drugs
|
|
Halofantrine Hcl - @ - Antimalarial - Investigational Drugs
|
Hexoprenaline sulphate- Tocolytic agent- Investigational Drug
|
|
Vigabatrin - Sabril- Anticonvulsant Agent- Investigational Drugs(2009)
|
Vesnarinone - Inotropic Agent for CHF- Investigational Drugs
|
|
Tirlizad- Antioxidoxant - Investigational Drug
|
Tenidap- An anti-inflammatory cytokine inhibitor - Investigational Drugs
|
|
Sertindole - Antipsychotic Agent- Investigational Drugs
|
Propiram - An Opioid Analgesic- Investigational Drugs
|
|
Trospectomycin - An aminocylitol antibiotic- Investigational drugs
|
Ritanserin- Central serotonin S2- antagonist- investigational Drugs
|
|
Amifloxacin - Fluroquinolone antibiotic- Investigational Drugs
|
Acetorphan - An enkephalinase inhibitor- Investigational Drugs
|
|
Investigational Drugs
|
Telmisatran + Amlodipine
|
|
Leuprorelin - Hormones(Jan 1980)
|
Paricalcitol- Fat soluble vitamins
|
|
Doxercalciferol- Fat-soluble Vitamins-(May 2008)
|
Methylnaltexone Bromide- Opioid Antagonist- Antialcoholic
|
|
Attapulgite - @ - Antidiarrheals
|
Bentiromide - @ - Gastrointestinal function Tests- Diagnostic Aids
|
|
Benznidazole - @ -Antiprotozoals
|
Biotin -@ - Dietary supplement
|
|
Botulinium Toxin Type A - @ - Ophthalmic agents
|
Buserelin - @ - Carcino-chemotherapeutic drugs
|
|
Capsaicin- Qutenza -@ - Rubefacients (Nov 2010)
|
Carbol-Fuchsin- @ - Antifungals
|
|
Cellulose Sodium Phosphate - @ - Renal disorders
|
Chenodiol -@ - Gall stone treatment
|
|
Chlophedianol- @ - Mucolytic
|
Chloroxine -@- Dermatologicals
|
|
Cholecystographic agents- @ - Diagnostic agents
|
Cholecystokinin - @ - Diagnostics agents
|
|
Chymopapain - @- Neuromuscular drugs
|
Cinoxacin- @ - Urinary antiseptics
|
|
Coal tar @- Dermatologic
|
Cocaine- @ -Local mucosal anesthetic
|
|
Colistin+ Neomycin+ Hydrocortisone -@- Otic
|
Colony Stimulating Factors - @-Antineoplastic agents
|
|
Copper Intrauterine Devices (IUDs) - @- Contraceptives
|
Diethyltoluamide- @- Insect repellent
|
|
Amprenavir- Anti- viral
|
Acetate - Anti-Schizophrenia
|
|
Aclarubicin - Anti-cancer
|
Amineptine - Anti-depressant
|
|
Cerivastatin - Lipid Lowering Agent
|
Cilomilast - Respiratory Agent
|
|
Colesevelam- Cardiovascular Agent
|
Cusapride- Gastro-intestinal agent
|
|
Dalfopristin + Quinupristin - Antibiotics & Antifungals
|
Amitraz- Veterinary
|
|
Amsacrine - Anti-cancer
|
Astemizole - Anti-allergic
|
|
Bacillocid Special - Disinfectant (Surface)
|
Biphenyl-acetic acid- NSAID
|
|
Butalex- Veterinary Drug
|
Butafosfane + Cyanocobalamine - Veterinary- (FDC-List)
|
|
Closantel - Veterinary Drug
|
Centropazine - Antidepresant
|
|
Colfosceric Palmitate- Respiratory
|
Cephacetril Sodium - Veterinary Drug
|
|
Chandonium Iodide- Non- Steroidal Blocking Agent
|
Complex 15 cream- Phospholipid
|
|
Cumophos - Veterinary Drug
|
Creatine Phosphate- Coajuvant for Cardiac Muscles
|
|
Diazinon - Veterinary Drug
|
Danofloxacin- Veterinary Drug
|
|
Dovamectin- Veterinary drug
|
Babies Vaccine - Vaccine
|
|
Basiliximab- Immuno Suppressant
|
Chelated Amino Acid- (FDC- List)
|
|
Coligen- Veterinary Drug
|
Cypermethrin- Veterinary Drug
|
|
Decapeptide - Vitiligo Drug
|
Dexarazonane - Cardio Protective Agent
|
|
Disodium Pamidronate - Anti-cancer
|
DPT-ACT HIB Vaccine- Vaccine
|
|
Dacliximab- Biopharmaceuticals
|
Eerioplast- Haemostasis Agent
|
|
Enrofloxacin- Veterinary Drug
|
Equino Infuenza & Equine Rhinopneumonitis Vaccine - Veterinary Drug
|
|
Farvovirus Vaccine - Vaccine
|
Firarubicin Hcl Injection- Anti-cancer
|
|
Flavophospholipol - (Flavomycin) - Antibiotic Veterinary
|
Fleroxacin - Antibiotics
|
|
Flumethrin- Veterinary Drug
|
Formestane Depot - Anti-cancer
|
|
Fortison Liquid/Powder- Nutritional Product
|
Fotemustine IV injection- Anti-cancer
|
|
Fluextine - CNS Drug
|
Gadopentetic acid Dimeglumine salt- Contrast Media
|
|
Genirelix - Fertility Drug
|
Genotropin Injection- Growth Hormone
|
|
Grepafloxacin - Antibiotic
|
Haemophilus Type b Congugate Vaccine- Influenza Vaccine
|
|
Haltrexone- Alcohol dependence
|
Horse Antihuman Lymphocyte Globulin- Blood product
|
|
Idebenone - Cerebral Arteriosclerosis
|
Immucyst (Bacillus Calmette & Guerin Vaccine - Vaccine
|
|
Iobitrol - Contrast medium
|
Iomeprol- Contrast media
|
|
Iopromide (Ultravist) - Contrast media
|
Ioversol Injection- Contrast media
|
|
Isepamicin- Antibiotics
|
Itrolan (Isovist) - Contrast media
|
|
Ironotectcan Hcl- Cancer/Oncology
|
Korsolex - Instrument Disinfectant
|
|
Levovist- Contrast media- (FDC- List )
|
Levoprolide Acetate Depot - Anti-cancer
|
|
Lofepramine Decanonate - Anti Depressant
|
Madramicin - Veterinary
|
|
Metabolite - Respiratory
|
Melagenina Lotion - Leukoderma
|
|
Melitracen Hcl - Anti Depressant
|
Meparticin- Anti-cancer
|
|
Miltefosine - For Kalazar-(Apr 2008)
|
Insulin Monocomponent -Lispra (rDNA) - Anti diabetic
|
|
16/18. Moxidectin (MOXIDECTIN) - (Jun 2018)- to treat onchocerciasis due to Onchocerca volvulus ry
|
Nadifloxacin - Anti-Bacterial (Syn.Quinolone)- (FDC- List )- (May 2006)
|
|
N-butyl-2-cyanoCrylate- Skin Infections
|
Nicotine Transdermal therapeutic System- @ - Anti-Smoking
|
|
Nitroscanate- Veterinary
|
Octylonium Bromide - Gastrointestinal
|
|
Orthoclone Sterile (OKT3)- Immunosuppressant
|
Omapatrilat- Cardiovascular
|
|
Paspat Injection- Respiratory
|
PCEC Vaccine (Rabies HEP Flurystrain)- Vaccine
|
|
Penflundol- Neuroleptic Agent
|
Piperacillment Tazabactum- Respiratory
|
|
Polysacharide pneumococal Vaccine - Vaccine
|
Promegestone - Hormone
|
|
Propoxur + Flumethrin - Veterinary- ( FDC- List )
|
Purified chick Embryo Tissue Culture Rabies Vaccine - Vaccine
|
|
Palivizumab- Immunosuppressant
|
Pitavastatin - Livalo Tablets- @- Cardiovascular (Aug 2009)
|
|
Pranlukast- Respiratory
|
Rabbit Anti-Human Tissue Type Plasmogen Activator- Anticoagulant
|
|
Reloxifen- NSAIDs
|
Recombinant Human Tissue Type plasmogen activator Inj (Actilyse) - Anticoagulant
|
|
Retrodrine Hcl- Blood Products- Toxaemia
|
Rimenidine dihydrogen Phosphate - Antihypertensives
|
|
Rowachol- Hepato-Billary Disorders
|
Roflumilast- Daliresp-@- Respiratory (Feb 2011)
|
|
Rotavirus Vaccine - Vaccine
|
Sometropin recombinant DNA origin- Health supplement
|
|
Saccharomyces boulardi - Gastro-intestinal- (FDC- List )
|
Salinomycin- Veterinary
|
|
Salmon CalCalcitonin Inj- Pagets disease
|
Semduramycin Sodium- Veterinary
|
|
Serenda Repcus- Cardiovascular
|
Sexfenfluramine Hcl- Anti-Obesity
|
|
Sorbister - Nephrological
|
Spenglersan- Immuno-modulator
|
|
Sterillium Rubin Disinfectant- Dermatological
|
Sulpha Chloropyrazine sodium- Veterinary
|
|
Neo Minophagen-C- Hepatic Drug
|
Sulpiride- Anti-depressant
|
|
Sultamicilline- Anti-microbial agent
|
Rilmenidine Dihydrogen Phosphate- Antihypertensives
|
|
Tagaserod - Gastrointestinal
|
Telethromycin- Antibiotics & Antifungals
|
|
Teprenone- Gastrointestinal
|
Transtuzumab- Immunomodulator
|
|
Troglitazone- Anti-Diabetic
|
Trovafloxacin- Antibiotics
|
|
Taurolidine - Antimicrobial- (FDC- List)
|
Teratolol Hcl- Anti-hypertensives
|
|
Terfenadine- Anti-histamine-(FDC- List)
|
Tetra Chlorodecaoxide - Immunomudulator
|
|
Thymogen - Anti-Cancer
|
Tiaprost Trometamol- Veterinary
|
|
Tolfenamic Acid- NSAID
|
Toltrazuril- Veterinary
|
|
Trapdil - Cardiovascular
|
Triclabendazole - Veterinary- (FDC- List )
|
|
Triflusalcaps- Cardiovascular
|
Tromantadine Hcl- Anti-viral
|
|
Xylazine Hcl- Veterinary Drug
|
Zuclopenthixole - CNS Drug
|
|
Zoplrestat- Diabetes
|
Dyphylline- Bronchodilator
|
|
Cerebrolysin - Cerebral Disorders
|
Deferasirox - Iron Antidote- (2006/2007)
|
|
Tulobuterol - Bronchodilators
|
Regorafenib - Stivarga (Sept 2012) -Chemotherapeutic Agent
|
|
Alogliptin - Hypoglycemics
|
Axitinib- Inlyta (Jan 2012) and Tabs (Sep 2014)- Chemotherapeutic Agent
|
|
Ulinastatin - Chemotherapeutic Agents
|
Canagliflozin - Hypoglycemics
|
|
Umeclidinium and Vilanterol - Bronchodilators
|
Sofosbuvir -Sovaldi-@-(Dec 2013)- Anti-Viral
|
|
Simeprevir -Olysio- @- (Nov 2013)- Anti-Viral
|
Luliconazole - Anti-fungals-(Nov 2013)
|
|
Ibrutinib - Imbruvica - @- (Nov 2013)-Chemotherapeutic Agents
|
Eslicarbazepine acetate- Aptiom-@- Anti-convulsant (Nov 2013)
|
|
Obinutuzumab-Gazyva -@- (Nov 2013)- Chemotherapeutic Agent
|
Flutemetamol F 18 -Viamyl- @-(Oct 2013)- Diagnostic Agents
|
|
Macitentan - Opsumit-@-(Oct 2013)- Anti-hypertensives
|
Riociguat - Adempas- @- (Oct 2013)-Anti-hypertensives
|
|
Conjugated estrogen/bazedoxifene-Duavee- @- Hormones (Oct 2013)
|
Vortioxetine - Brintellix- @-(Sept 2013)- Anti-depressants
|
|
Dolutegravir - Tivicay- @- (Aug 2013)- Anti-viral
|
6/13. Afatinib- (Gilotrif tablets )- (July 2013)- Chemotherapeutic Agents
|
|
Trametinib-Mekinist Tablets- @-(Jan 2013/Jan 2014)- Chemotherapeutic Agents
|
Dabrafenib- (Tafinlar)- @- (May 2013)-Chemotherapeutic Agents
|
|
Radium Ra 223 dichloride -@- (May 2013)- Chemotherapeutic Agents
|
Fluticasone furoate and Vilanterol - Breo Ellipta - @- Bronchodilators- (2013)
|
|
Dimethyl Fumarate- Tecfifdera- @- (Mar 2013) -Immunomodulator
|
Gadoterate meglumine- Doctarem-@- (Mar 2013)- Diagnostic agents-(FDC- List)
|
|
Technetium Tc 99m tilmanocept- Diagnostic Agents
|
Ospemifene- Osphena- @- (Feb 2013)- Genito-urinary system
|
|
5/13.Ado-transtuzumab emtansine- Kadeyla - (Feb 2013)- Chemotherapeutic agents
|
Promalidomide - Chemotherapeutic Agents
|
|
Pomalidomide -(Pomalyst)- @- (Feb 2013) Chemotherapeutic Agents
|
Mipomersen sodium - Antihyperlipidemic
|
|
Crofelemer- Fulzaq-@- (Dec 2012)- Anti- Viral
|
Bedaquiline - Sirturo- @- (2012)- Anti-Tubercular
|
|
Lomitapide- Antihyperlipidemic
|
Teduglutide - (Gattex- @- (Dec 2012)- Gastro-intestinal
|
|
Pasereotide- Signifor - @- (Dec 2012)- Cushings disease
|
Raxibacumab- Respiratory
|
|
Ponatinib- Iclusig -@-(Dec 2012)- Chemotherapeutic agent
|
Cabozantinib- Cometriq- @- (Nov 2012) - Anti-cancer drug
|
|
Tofacitinib- Xeljanz- @- (Nov 2012)- Anti-rheumatic agent
|
Omacetaxine mepesuccinate - Anti-cancer drug
|
|
Perampanel - Fycompa - @- (Oct 2012)- Anti- convulsant
|
Ocriplasmin- Jetrea- @- (Oct 2012) - Ophthalmic
|
|
Choline C11 injection- Diagnostic agent
|
Teriflunomide- Aubagio- @- (Sep 2012) -Immunomodulator
|
|
Bosutinib- Bosulif - @- (Sept 2012) Anti-cancer drug
|
Enzalutamide - Anti-cancer drug
|
|
Linaclotide- Linzess - @- (Sep 2012) -Gastro-intestinal product
|
Tbo-filgrastim- Chemotherapy
|
|
Elvitegravir/Cobicistat/Emtricitabine/Tenofivir disoproxil/Alafenamide - Genvoya (Nov 2015)- Anti-viral
|
Ziv-Alfibercept- Chemotherapy
|
|
Aclidinium bromide- Broncho-dilators
|
Carfilzomib- Kyprolis- @- (July 2012)- Chemotherapy
|
|
Sodium Picosulfate/Magnesium Oxide/Citric acid- Gastrointestinal
|
Mirabegron- Myrbetriq - @- (June 2012)- Urinary
|
|
Lorcaserin hydrochloride- Anti- Obesity drug
|
Pertuzumab- (Perjeta) -@- (June 2012)-Chemotherapy
|
|
Taliglucerase Alfa- Elelyso -@- (2012)- Metabolic disorder
|
Avanafil- Stendra- @- (Apr 2012)- Sexual Stimulant
|
|
Florbetapir F 18- Amyvid - @- (Apr 2012) - Diagnostic agent
|
Peginesatide- Omontys- @- (Mar 2012) - Nephrological
|
|
Lucinactant- Bronchodilator
|
Tafluprost- Zioptan -@- (Feb 2012) - Ophthalmic agent
|
|
Ivacaftor- Kalydeco- @- (Jan- 2012)- Metabolic disorder
|
Vismodegib- Erivedge -@- (Jan 2012)- Anti-cancer
|
|
Ingenol mebutate - Dermatological
|
Glucarpidase- Voraxaze - @- (Jan 2012)- Urinary product
|
|
7/11. Aflibercept-( Eylea)- (Nov 2011) Metabolic disorder
|
Asparagininase Erwina chrysanthemi - Erwinase -@- Anti-cancer (Nov 2011)
|
|
Ruxolitinib - Jakafi -@- Chemotheraphy (Nov 2011)
|
Deferiprone- Ferriprox- @- Iron Antidote (2011)
|
|
Crizotinib - Xalkori-@- Anti-Cancer (Aug 2011)
|
Icatibant - Firazyr-Cardiovascular (Aug 2011)
|
|
Brentuximab Vedotin - Adcetris -@- Anti-cancer ( Aug 2011)
|
Vemurafenib- Zelboraf - @- Anti-cancer (Aug 2011)
|
|
Ticagrelor-Brilinta- @- Cardiovascular- (July 2011)
|
Indacaterol Inhalation powder- Arcapta Neohaler- Respiratory- (FDC- List ) (Apr 2010)
|
|
Belatacept-Nulojix -@- Genito-urinary product (June 2011)
|
Ezogabine- Potiga - @-Anti-convulsant (June 2011)
|
|
Fidaxomicin- Dificid -@- Gastro-Intestinal product (May 2011)
|
Telaprevir- Incivek - @- Anti-viral (May 2011)
|
|
Rilpivirine - Edurant -@- Anti-viral (May 2011)
|
Boceprevir - Victrelis- @- Anti-viral (May 2011)
|
|
Linagliptin- Tradjenta - @- Hypoglycemics-@- (FDC- List )-(May 2011)
|
Vandetanib- Caprelsa - @- Anti-cancer (Apr 2011)
|
|
Ipilimumab- Yervoy- @- Anti-cancer (Mar 2011)
|
Gadobutrol- Godavist- @- Diagnostic agents (Mar 2011)
|
|
Belimumab- Benlysta- @- Immunomodulator (Mar 2011)
|
Azilsartan medoxomil- Edarbi- @- Cardiovascular- (Feb 2011)
|
|
Vilazodone hydrochloride- Viibryd- @- Antidepressant (Jan 2011)
|
Spinosad- Natroba- @- Dermatological product (Jan 2011)
|
|
Ioflupane i-123 -Datscan- Diagnostic agents (Jan 2011)
|
Dalfampridine - Ampyra -@- Immunomodulator (Jan 2011)
|
|
Liraglutide - Victoza- @-Hypoglycemics (Jan 2010)
|
Velaglucerase Alfa- Vpriv- @- Metabolic disorder (Dec 2010)
|
|
Carglumic Acid - Carbagu- Nutriontional (Mar 2010)
|
Polidocanol- Asclera -Cardiovascular (March 2010)
|
|
Estradiol Valerate/Dienolest- Natazia- @- Hormone (May 2010)
|
Cabazitaxel- Jevtana- @- Anti-cancer (June 2010)
|
|
Vilasta Ophthmalmic Solution-Lastacraft- @-Ophthalmic product (July 2010)
|
Uilipristal Acetate- Ella- Contraceptive(2010)
|
|
Fingolimod Hcl - Fingolimod Hcl Oral Caps- Immunomodulator (Sep 2010)
|
Lurasidone Hcl- Lurasidone HCl-Anti-convulsant (Oct 2010)
|
|
Ceftaroline Fosamil- Ceftaroline Fosamil for Injection -Dermatological (Oct 2010)
|
Tesamorelin- Egrifta -Metabolic disorder (Nov 2010)
|
|
Erbulin Mesylate - Anti-cancer
|
Tocilizumab- Actemra -@- Musculo-skeletal (Jan 2010)
|
|
Collagenase Clostridium Histolyticum - Metabolic Disorder
|
Denosunab- Prolia @- (June 2010) and (Xgeva) - @- (July 2013)- Anti-cancer
|
|
Incobotulinumoxina -Xeomin- @- Immunomodulator (July 2010)
|
Pegloticase - Krystexxa - @-Immunomodulator (Sep 2010)
|
|
Iloperidone- Fanapt- Antidepressants (May 2009)
|
Tolvaptan - Samsca- @- Selective Vasopressor V2 Antagonist- (May 2009)
|
|
Besifloxacin- Besifloxacin Hcl - @- Ophthalmic agent (May 2009)
|
Dronedarone Hcl- Multaq -@- Anti-arrhythmic drug -(July 2009)
|
|
Bepotastine Besilate - Bepreive - @- Ophthalmic agent (Sept 2009)
|
Telavancin- Telavancin- @- Anti-Bacterial (Sep 2009)
|
|
Pralatrexate Injection- Folotyn -@- Metabolic Disorder (2009)
|
Pazopanib - Votrient - @- Anti-cancer (Oct 2010)
|
|
Romidepsin - Anti-cancer
|
Golimumab- Simponi - @- Immunomodulator (Apr 2010)
|
|
Abobutulinumtoxina - Dysport- Neurological Disorders (Apr 2010)
|
Canakinumab- IIaris - @- Metabolic Disorder (June 2010)
|
|
Usterkinumab- Dermatology
|
Ofatumumab- Aezerra Injection- @- ( Oct 2010)-Anti-cancer drug
|
|
Ecallantide- Kalbitor- Cardiovascular (Dec 2010)
|
Acipimox - Anti-diabetic
|
|
Acrivastine - Anti-histamine
|
162/08. Actarit - Anti-inflammatory -(July 2008)
|
|
Ademetionine - Hepato-billiary drug
|
Adenosylcobalamin - Multivitamins
|
|
Agomelatine - Antidepressants
|
Alpha Lipoic Acid- (FDC List)
|
|
Amino acid, Glucose parentral solution- Nutritional - (FDC List)- (2008)
|
Etretinate- @ -Dermatological
|
|
Amorolfine - Anti-fungal
|
Amtolmetin Guacil - Anti-inflammatory drug- (Mar 2008)
|
|
Anidulafungin -@- Dermatological-(2006)
|
Gallium Nitrate- @
|
|
Arterolane Maleate - Antimalarial
|
Bacillus Clausii spores- Antibacterial- (July 2008)
|
|
Balofloxacin - Antibacterial
|
Bemiparin sodium- Haemostatics- (June 2006)
|
|
Bendrofluazide - Diuretic
|
Benzoyl peroxide medicated solution- Acne - (FDC-List)- (May 2008)
|
|
Bifonazole - Anti-fungal
|
Boswella Serrata - Dermatological- (Mar 2008)
|
|
Bromfenac Sodium- Ophthalmic product-(Aug 2008)
|
Broncho-vaxom - Antiasthmatic
|
|
Butaphosphan - Veterinary drug- (FDC-List)
|
Butraphenol Tartarate- Opoid Analgesic
|
|
Butarphenol Tartarate - Opoid Analgesic -(Nov 2007)
|
Blonanserin - Antidepressants
|
|
Calcipotriol - Dermatological
|
Calf Lung Surfactant- Respiratory Agent
|
|
Camostat Mesylate - Gastro-intestinal Agent- (Jan 2008)
|
Interferon Gamma- @-Immunomodulator
|
|
Inulin- Diagnostic Aids
|
Carboinoxamine maleate- Expectorant- (Dec 2008)
|
|
Caroverine - Gastro-intestinal- (Aug 2006)
|
Kaolin and Pectin-@ - Antidiarrheals
|
|
Cefovecin Sodium- Veterninary drug
|
Levocarbastine- @ -Ophthalmic
|
|
Lypressin - @ - Diuretics
|
Masoprocol- @- Dermatological
|
|
Cefpirome sulphate @- Cephalosporin- (FDC-List) (Sep 1997)
|
Ceftiofur - Veterinary -(Sep 2008)
|
|
Centbucridine - Rectal and colon acting agents- (FDC-List)
|
MRI Contrast agents - @ - Diagnostic
|
|
Cimetropium bromide- Gastrointestinal- (Jan 2008)
|
Cinitapride - Gastrointestinal-(Jan 2008)
|
|
Rabeprazole sodium + Levosulpiride -
|
Narcotic Analgesics- @ Analgesics
|
|
Nicotinyl Alcohol- @ -Vasodilators
|
Pancrelipase - @ -Digestive enzyme
|
|
Pegademase - @ - Immunological product
|
Pentagastrin -@ - Diagnostic agents
|
|
Pentostatin - @ - Antimetabolites
|
Perflubron - @- Diagnostic Agents
|
|
Phenolsulfonphthalein - @ -Diagnostic Aids
|
Phenylpropanolamine - @ - Nasal decongestant- (FDC- List )
|
|
Phosphates- @- Dietary Supplements
|
Piperazine - @ - Anthelmintics
|
|
Plicamycin- @ -Anti- cancer
|
Podophyllum- @ -Skin disorder
|
|
Probucol- @ - Antihyperlipermic
|
Pyrethrins- @ - Dermatological
|
|
Pyrithione - @ - Dermatological
|
Pyrvinium - @ - Anthelmintics
|
|
Clostimethate Sodium - Anti-infectives- (Jan 2008)
|
Clostridium Botullinum type -A haemagglutin cplx (Apr 2008)
|
|
Clenbuterol Hcl - Veterinary product
|
Azaranari + Ritonavir Kit - Anti-viral- ( FDC- List )- (Apr 2007)
|
|
Coseal Surgical Sealant - Surgical Aid
|
Deltamethrin + Piperonyl Butoxide - Veterinary Product
|
|
Doxifluridine - Anti-cancer -(Jan 2008)
|
Drosperinone + Ethinylestradiol- Contraceptive- (FDC- List )- (Mar 2008)
|
|
Eberconazole - Antifungals -(FDC- List )- (Mar 2007)
|
Eplerstat- Cardiovascular
|
|
Rhinopneumonitis Vaccine- Veterinary
|
Eribulin mesylate - Eribulin Mesylate -Anti-cancer (Jan 2012)
|
|
Estemestane- Antineoplastic
|
Iodized Fatty Acids of Poppy Seeds- Diagnostic Agent
|
|
Euphorbia Prostrata Dry Extract- Haemorrhoids- (Feb 2008)
|
Epalrestat - Diabetic Neuropathy- (FDC- List )
|
|
Gatifloxacin + Dexamethasone - Ophthalmic
|
Valdecoxib + Paracetamol- Anti-Inflammatory
|
|
Fenofovir Disproxil Fumarate- Anti-viral- (FDC- List )- (July 2008)
|
Feracrylum- Mouth and throat products-(FDC- List )- (Sep 2006)
|
|
Ferric Carboxymaltose - Iron preparation
|
Racemethionine - @- Urine Acidifier
|
|
Radiopaque Agents- @ - Diagnostic Agents
|
Radiopharmaceuticals -@- Diagnostic
|
|
Rauwolfia Alkaloids - @ - Anti-hypertensives
|
Resorcinol -@ Dermatological
|
|
RHo(D) Immune Globulin- @- Vaccine
|
Vitamin B2- (Ribloflavin) -@- Water Soluble vitamins
|
|
Simethicone -@- Anti-flatulant
|
Succimer - @- Diagnostic Aids
|
|
Sulfapyridine -@- Dermatological
|
Sulfonamide - @ - Ophthalmic
|
|
Sulfonamide and Phenazopyridine - @ - Anti-infective
|
Testolactone - @- Anti-cancer
|
|
Tetanus Toxoid- @- Anti-viral
|
Theophylline, Ephedrine, Guaifenesin, and Phenobarbital - @- Bronchodilator
|
|
Trilostance - @-
|
Trimethrexate- @- Anti-bacterial
|
|
Undecylenic acid compound- @ - anti-fungal
|
Vidarabine -@- Ophthalmic product
|
|
Vitamins and Fluoride - @-
|
Ferrous Bisglycinate - Iron salt- (FDC- List )
|
|
Forskolin - Ophthalmic product- (July 2006)
|
Gadobenate - Diagnostic Agent
|
|
Gadoversetamide - Diagnostic agent
|
Garenoxacin Mesylate - Anti-bacterial
|
|
Glutathione - Hepato-billiary drug
|
Haemodialysis powder/liquid - Dialysis
|
|
Halometasone monohydrate- Anti-fungal-(Sep 2008)
|
Human Insulin(R-DNA) - Hypoglycemics- (Aug 2006)
|
|
Hydroxyethyl starch (HES)- Plasma expanders
|
Ibopamine Hcl- Ophthalmic
|
|
Icodextrin- Dialysis-(June 2006)
|
Idaravone - Neurological- (July 2007)
|
|
ILaprazole - Ant-ulcer
|
Imidacloprid + Moxidectin- Vetererinary
|
|
Human Recombinant Granulocyte Colony Stimulating Factor- Haemopoietic Stimulant
|
Iron(III) Isomaltoside - Anemia- (FDC- List )
|
|
Irsogladine Maleate- Gastro-intestinal
|
ISMN+ Atenolol - Anti-anginal- (FDC- List ) (July 2006
|
|
Isoflupredone Acetate- Veterinary
|
Isomaltose - Anemia
|
|
Isopropyl Unoprostone - Ophthalmic
|
Iron Amino acid chelate - Iron complex- (FDC- List )
|
|
L-lysine Hcl- Topical- (Aug 2006)
|
Lactitol- Laxative- (May 2007)
|
|
Lafutidine - Gastro-intestinal
|
Lecithin - Hepato-billiary drug- (FDC- List )- (2008)
|
|
Levobetaxolol - Ophthalmic
|
Levocloperastine Fendizoate- Anti-histamine
|
|
Levosimendan - Cardiovascular
|
Levprolide acetate- Anti-Cancer
|
|
Livetiracetam - Anti-epiletic-(May 2007)
|
Loxoprofen Sodium- Anti-Inflammatory- (Aug 2008)
|
|
Lumiracoxib- Anti-inflammatory- (Aug 2006)
|
Melatonin - Hormone
|
|
Methyl Cobalamin - Vitamins- (FDC- List )- (Jan 2008)
|
Methyl Paraben- Dermatological- (FDC- List )
|
|
Mucotrol - Gastro-intestinal
|
Naftopidil- Diuretic related compound-(July 2010)
|
|
Neotame- Artificial sweeteners- (Apr 2004)
|
Ozagrel Hcl- Respiratory- (Jan 2008)
|
|
Edoxaban Tosylate- Savaysa -@- (Jan 2015) - Cardiovascular
|
Cilnidipine - Anti-hypertensives-(June 2007)
|
|
Cilnidipine + Chlorthalidone
|
Cefixime + Ornidazole
|
|
Benfotiamine +Metformin
|
Palbociclib- Ibrance -@- (Feb 2015 ) - Anti-cancer
|
|
Lenvatinib- Lenvima-@- (Feb 2015) - Anti-cancer
|
Panobinostat- Farydak- @- (Feb 2015) - Anti-cancer
|
|
Ceftazidime Avibactam- Avycaz -@- (2015) - Anti-Bacterial
|
Isavuconazonium Sulfate- Cresemba (Mar 2015)- Anti-fungal
|
|
Cholic Acid- Cholbam-@-(Mar 2015)
|
Deoxycholic Acid- Kybella (Apr 2015)
|
|
Eluxadoline- Viberzi- @- (May 2015) -Gastro-Intestinal
|
Cangrelor- Cardiovascular
|
|
Secukinamab- Cosentyx-@- (Jan 2015) - Dermatological
|
Parathyroid Hormone- Natpara -@- (Jan 2015) - Thyroid hormone
|
|
Dinutuximab-Unituxin- @-(Mar 2015)- Anti-Cancer
|
Sonidegib-Odomzo -@- (July 2015)- Anti-cancer
|
|
Ramucirumab- @-Cyramza Injection (with Docetaxel) (Dec 2014) - Anti-cancer
|
Nivolumab- Opdivo -@-(Dec 2014) -Anti-cancer
|
|
Olaparib - Lynpara -@- (Dec 2014) - Anti-cancer
|
Blinatumomab - Blincyto- @- (Mar 2014 and July 2017 ) - Anti-cancer
|
|
Pembrolizumab- Keytruda -@-(Sep 2014 ) - Anti-cancer
|
Idelalisib- Zydelig - @-(July 2014) Anti-cancer
|
|
Belinostat- Anti-cancer
|
Ceritinib- Anti-cancer
|
|
Siltuximab-Sylvant Injection-@-(Apr 2014) Anti-cancer
|
Pazufloxacin Mesylate- Anti-Infective-(July 2008)
|
|
Perflutren- Diagnostic agent-(May 2006)
|
Calcium Chloride Dihydrate- Dialysis Solution- (FDC- List )
|
|
Pholcodeine - Anti-tissue- (July 2007)
|
Pidotimod - Bronchodilators
|
|
Pirfenidone - Respiratory
|
Otilonium Bromide - Antispasmodics
|
|
Polonosetron Hcl - Gastro-intestinal- (March 2007)
|
Polythene Glycol -Ophthalmic- (FDC- List )
|
|
Premetrexed Disodium - Anti-cancer- (March 2008)
|
Probio & Prebio - Anti-diarrheals- (FDC- List )
|
|
Propanol 1-ol + Ethanol - Surgical disinfectant- (Nov 2007)
|
Propfol injection- Anesthetic agent- (May 1998)
|
|
Propionyl L-carnitine- Cardiac agent-(March 2006)
|
Prulifloxacin - Urinary tract- (Oct 2007)
|
|
Pygenum Africum - Male Sex Hormones & Antagonistst
|
Ramosetron - Gastro-intestinal
|
|
Renolazine - Anti-anginal- (June 2007)
|
Sapogrelate Hcl- Cardiovascular drug
|
|
Selamectin - Veterinary Product
|
Seratrodast- Respiratory
|
|
Sevelmer Carbonate - Urinary Antocholergic- (Apr 2008)
|
Sofalcone - Anti-Flatulant- (June 2008)
|
|
Triglycerides- Parentral Nutrition- (FDC- List )
|
Sphaeranthus Indicus Extract- Dermatolgical product
|
|
Sucralose- Sweetening agent
|
Sulphur Hexachloride Powder- Diagnostic Agent- (Sep 2007)
|
|
Surgical sealant- Surgical aids
|
Tacalictol- Dermatological product
|
|
Tegafur - Anti-cancer-(FDC- List )- (Aug 2007)
|
Tiapride Hcl- Neurotropic drug
|
|
Tiobolone - Hormones
|
Tiropramide Hcl - Gastro-intestinal- Aug 2006)
|
|
Thymosin Alfa- Immunomodulator
|
Tofisopam - Sedative
|
|
Triticum vulgare- Dermatological
|
Trimethoxysilyl Quarternary Ammonium Chloride - Disinfectant
|
|
Troxipide - Gastrointestinal
|
Tylvalosin Tartrate - Veterinary- (Oct 2008)
|
|
Udenafil - Impotence Agents
|
Valganciclovir - Ant-viral
|
|
Vitamin C (Ascorbic acid) - @- Water sol vitamin- (July 2006)
|
VSL # Combination of Lactic Acid Bacteria # 3- * (Jan 2008)
|
|
VSL# (Probiotic Blend) Sachet- Gastrointestinal
|
Yttrium -90 Microsphere Injection- Anti-cancer
|
|
Zotepine - Sedative
|
Lesinurad- Zuampic (Dec 2015)- Agent for Gout
|
|
Selexipag- Uptravi (Dec 2015)- Antihypertensives
|
Sugammadex- Bridion (Dec 2015)- Neuromuscular Drugs
|
|
Alectinib- (Alecensa) (Dec 2015)- Anti-Cancer drug
|
Sebelipase Alfa- Kanuma (Dec 2015)- Metabolic disorder
|
|
Elotuzumab- Empliciti (Nov 2015) - Anti-cancer
|
Necitumumab- Portrazza -@- (Nov 2015)- Anti-cancer
|
|
Ixazomib- Ninlaro -@- (Nov 2015)- Anti-cancer
|
Daratumumab- Darzalex -@-(Nov 2015)- Anti-cancer
|
|
Osimertinib- Tagrisso -@- (Nov 2015)- Anti-cancer
|
Cobimetinib - Cotellic -@-(Nov 2015)- Anti-cancer
|
|
Mepolizumab- Nucala -@-(Nov 2015)- Respiratory
|
Asfotase alfa- Strensiq- @- (Oct 2015) Metabolic Disorder
|
|
Patiromer for Oral Suspension- Veltassa -@-(Oct 2015) - For Hyperkalemia
|
Idarucizumab - Praxbind -@- (Oct 2015) - Anticoagulant
|
|
Insulin Degludec Injection- Tresiba (Sep 2015)- Anti-diabetic agents
|
Trifluridine and Tipiracil (Lonsurf) -@-(Sep 2015)- Anti-Cancer Drug
|
|
Cariprazine - Vraylar (Sep 2015) - Anti-psychotic Agents
|
Uridine triacetate- Xuriden (Sep 2015) - Metabolic Disorder
|
|
Rolapitant - Varubi -@-(Sep 2015)- Antinemetic
|
Evolocumab- Repatha -@- (Aug 2015) - Hyperlipidemics
|
|
Flibanserin- Addyi (Aug 2015) - Sexual disorder
|
Daclatasvir- Daklinza -@-(July 2015) - Antiviral
|
|
Alirocumab- (Praluent )-(July 2015) - Antihyperlipidemics
|
Brexpiprazole - Rexulti-@- (July 2015) - Antipsychotic
|
|
Sacubitril/Valsartan- Entresto- @-(July 2015) - Anihypertensives
|
Lumacaftor/ Ivacaftor- Orkambi- @-( July 2015)- Respiratory
|
|
Canegrelor- Kengreal -@- (June 2015)- Anti-coagulant
|
Flucticasone Furoate/ Vilanterol - Corticosteroids
|
|
Amifampridine- (BNF)- Neuromuscular drug
|
Fampridine- (BNF)- Neuromuscular drug
|
|
Botulism Antitoxin-(BNF) - Vaccines
|
Carbetocin- (BNF)- gynaecology and urinary tract disorders
|
|
Articaine Hcl with Adrenaline (BNF) - Local Anesthetics
|
Catumaxomab- (BNF)- Antineoplastic drugs
|
|
Darbepoetin Alfa- (BNF) - Erythropoietins
|
Enoximone-(BNF)- Cardiovascular drugs
|
|
Ergocalciferol- (Calciferol- Vitamin D2) -( BNF)
|
Flucloxacillin- (BNF)- Penicillins
|
|
Fludroxycortide (Furandrenone -(BNF)- Topical corticosteroids
|
Flumethasone Pivate -(BNF)- Corticosteroids
|
|
Gemiprost-(BNF)- Gynaecological and urinary tract disorders
|
Hexetidine-(BNF)- Oropharyngeal anti-infective
|
|
Ichthmmol -(BNF)- Topical preparations
|
Indoramin- (BNF)- Alpha-adrenoceptor drugs
|
|
Pizotifen- (BNF)- Anti-migraine drug
|
Prucalopride- (BNF)- Gastro-intestinal
|
|
Retigabine -(BNF)- Anti-epileptics
|
Eptacog alfa (activated) -(BNF)- Factor VIIIa Recombinant
|
|
Levofolinic acid -(BNF)- Cytotoxic drugs
|
Levomeprozine -(BNF)- Antipsychotic drugs
|
|
Lixisenatide- (BNF)- Anti-diabetic drug
|
Loprazolam- (BNF)- Hypnotics
|
|
Lormetazepam- (BNF)- Hynotics
|
Pixantrone- (BNF)- Antimetabolite
|
|
Oxybuprocaine Hydrochloride- (BNF)- Local anesthetics
|
Pipotiazine Pamitate- (BNF)- Anti-psychotic drug
|
|
Alkyl dimethyl benzoyl ammonium chloride- Veterinary- (FDC List)
|
Alpha Chloropyridine sodium - Veterinary- (FDC List)
|
|
Amylobarbitone +Trifluperazine Dihydrochloride - (FDC- List)
|
Biclotymol -(FDC- List)
|
|
Broxyquinoline + Brobenzoxalidine (FDC-List)
|
Elbasvir and Grazoprevir - Zepatier -@- (Jan 2016)- Antiviral agent
|
|
Brivaracetam- Briviact -@- (Feb 2016) - Anticonvulsant
|
Obiltoximab- Anthim -@-(March 2016)- Antibacterial
|
|
Ixekizumab- Taltz -@- (March 2016)- Anti-psoriatics
|
Reslizumab- Cinquair -@-(March 2016)- Bronchodilators
|
|
Defibrotide Sodium- Defitelio -@- (2016)- Hepatobilliary drug
|
Venetoclax- Venclexta -@- (Nov 2016)- Anti-cancer
|
|
Primavanserin- Antipsychotic drugs
|
Atezolizumab- Tecentriq (May 2016)- @-Anti-cancer
|
|
Daclizumab - Zinbryta -@-(May 2016)- Skeletal disorders
|
Obeticholic acid - Ocaliva-@- (May 2016)- Hepatic disease
|
|
Fluciclovine F-18- Axumin-@- (May 2016)- Diagnostic agent
|
Gallium Ga 68 dotatate - Netspot - @-(Jan 2016)- Diagnostic agent
|
|
Piperaquine tetraphosphate - Antimalarials - (FDC- List )
|
Tiletamine Hydrochloride- General Anesthesia- (FDC- List
|
|
Nintedanib - Respiratory
|
Dapagilflozin - Farxiga-@- (2014)- Antidiabetic Agent
|
|
Emphagliflozin - Antidiabetic agent
|
Atosiban acetate
|
|
Ledipasvir + Sofosbuvir - Harvon (2014) - Anti-viral
|
Fibinolysin + Desoxyribonuclease - (FDC- List )
|
|
Fluprednidene Acetate - (FDC- List )
|
Gestodene- (FDC-List )
|
|
Ishghula - Gastrointestinal - (FDC- List)
|
Medronic acid + Stannous Chloride- Antic-cancer drug - (FDC-List )
|
|
Meglunine Ioxaglat sodium + Sodium Ioxaglate - Diagnostic Aid- (FDC- List )
|
Methyl Valerate + Quinine Anhydrous - Anti-smoking agent - (FDC- List )
|
|
Glycyrrhizin -(Mono Ammonium Glycyrrhizinate ) - Hepato- Billiary Drug - (FDC- List )
|
Raubasine + Ailmitrine - Nervo- Stimulent (FDC- List )
|
|
Sodium Pyrolidone Carboxylic Acid- (FDC- List )
|
Sofosbuvir and Velpatasvir- Epclusa-@-(June 2016) - Anti-Viral
|
|
Lifitegrast Ophthalmic solution-Xildra-@- (July 2016- Ophthalmic
|
Lixisenatide- Adlyxin-@- (July 2016)- Anti-diabetic drug
|
|
Eteplirsen- Exondys 51-@- (Sep 2016)- Musculo-skeletal
|
Olaratumab- Lartruvo-@- (Oct 2016)- Anti-cancer
|
|
Bezlotoxumab-Zinplava -@- (Oct 2016)- Anti-infective
|
Acotiamide Hydrochloride- Anti-flatulent
|
|
Fenticonazole Nitrate - Antifungal Agents
|
Phospholipids From Lungs- Respiratory
|
|
Trolamine- Dermatological-(Mar 2004)
|
Primcrolimus- Dermatological
|
|
Rebamipide - Antiulcerant- (July 2004)
|
Calcium Polycarbophil- Laxative- (Feb 2004)
|
|
Sodium Pidolate- Bisphosphonates
|
Sertanidazole - Anti-diarrhoeals- (Nov 2007)
|
|
Pimavanserin- Nuplazid -@- (2016)- Anti-psychotic drugs
|
Crisaborole - Eucrisa -@- (Dec 2016)- Dermatological
|
|
Rucaparib -Rubraca -@-(Sep 2016)- anti-cancer
|
Nusinersen - Spinraza- @- (Dec 2016) - Musculoskeletal
|
|
Vaccine Human Papillomavirus Type 16 and 18 (Recombinant )- Vaccine
|
Ttetanus Immunoglobulin- Vaccine
|
|
Tetanus Immunoglobulin - Vaccine
|
Luvistin- Anti-histamine
|
|
Cromoglicic acid- Ophthalmic agent
|
1/17. Plecanatide- (TRULANCE)-@- (Jan 2017) to treat idiopathic Constipation (CIC) in adult patientsiopathic Constipation
|
|
2/17. Etelcalcetide- (PARSABIV)-@- (Feb 2017) - to treat secondary hyperparathyroidism in adult patients in adults Drugs
|
4/17. Brodalumab- (SILIQ)-@- (Feb 2017)- to treat adults with moderate-to-severe plaque psoriasis
|
|
5/17. Telotristyl ethyl -(XERMELO)-@- (Feb 2017) to treat carcinoid syndrome diarrhea stro-intestinal product
|
6/17. Ribocicib -(KISQUALI)-@- (March 2017)- to treat postmenopausal women with a type of advanced breast cancer
|
|
7/17. Safinamide- (XADAGO)-@- (March 2017) to treat Parkinson's disease-
|
Avelumab - Bavencio-@-(Mar 2017)- Anti-cancer
|
|
Naldemedine - Symproic-@- (Mar 2017)- Gastro-intestinal
|
Niraparib - Zejula-@- (Mar 2017)- Anti-cancer
|
|
Dupilumab - Dupixent-@- (2017)- Dermatological
|
Ocrelizumab - Ocrevus-@- (March 2017)- Neuro-muscular drug
|
|
Deutetrabenazine- Austedo-@-(Mar 2017)- Neurological disorders
|
Valbenazine - Ingrezza-@- (2017)- Neuromuscular disorders
|
|
Cerliponase alfa- Brineura-@- (Apr 2017)- Neurological disorders
|
Brigatinib - Alunbrig-@- (Apr 2017)- Anti-cancer
|
|
Midostaurin- Rydapt-@- (2017)- Anti-cancer
|
18/17. Abaloparatide - (TYMLOS)-@- Hormonal disorders (Apr 2017)
|
|
Durvalumab- Imfinzi-@- (2017)- Anti-cancer
|
Edaravone - Radicava-@- (May 2017) - Neurological disorders
|
|
Sarilumab- Kevzara-@- (2017) - Anti-rheumatic agent
|
Delafloxacin - Baxdela -@- (June 2017)- Dermatological- Antibacterial Agent
|
|
Betrixaban -Bevyxxa -@- (June 2017)- Cardiovascular Drug
|
Dicycloverine Gastro-intetestinal
|
|
Alverine citrate- (BNF 68- 2015)- Gastro-intestinal product
|
Sterculia- (BNF 68- 2015- Bulk- Forming laxatives
|
|
Dantron- Gastro-intestinal- (BNF 68- 2015)
|
Moxisylate- Sympathomimetics- (BNF 68 -2015)
|
|
Danaparoid Sodium- Anti-coagulant- (BNF 68 - 2015)
|
Argatroban Monohydrate- Anti-coagulant- (BNF-2015)
|
|
Benperidol- Anti-psychotic drug- (BNF 68 -2015)
|
Pericyazine- Antipsychotic drugs-(BNF 68-2015)
|
|
Diamorphine Hydrochloride - Opioid Analgesic- (BSF 68- 2015)
|
Dipipianone Hydrochloride- Opioid Analgesics-(BNF 68- 2015)
|
|
Meptazinol- Opioid Analgesics- (BNF 68- 2015)
|
Levetiracetam- Anti-epileptic drug-(BNF 68- 2015)
|
|
Ritigotine - AntiParkinsons agents- (BNF 68 - 2015)
|
10/19. Tafamidis Meglumine- (VYNDAQEL) -(May 2019) - Treat heart disease (cardiomyopathy)
|
|
Lofexidine hydrochloride- (BNF 68 -2015)- Opioid Dependence
|
Temocillin- Penicillins- (BNF 68- 2015)
|
|
Sodium Stibogluconate -Leshmaniacides- Kala- azar -(BNF 68- 2015)
|
Nortriptyline -Palliative care (PCF4)
|
|
Methylphenidate- Psychostimulant- Palliative care (PCF-4)
|
Modafinil- Psychostimulant - Palliative Care-(PCF4)
|
|
Guselkumab -Tremfya-@- (July 2017)- Dermatogical
|
Neratinib Maleate - Nerlynx -@- (July 2017)- Anti-cancer drug
|
|
Sofosbuvir,Velpatasvir and Voxilaprevir - Vosevi-@- (July 2017) - Anti-viral
|
Enasidenib - Idhifa-@- (Jan 2017) Anti-cancer drug
|
|
Glecaprevir and Pibrentasvir - Mavyret-@- (Mar 2017)- Anti-viral
|
Inotuzumab Ozogamin - Besponsa-@- ( Aug-2017) - Anti-cancer drug
|
|
Elvitegravir/Cobicstat/Emcitabine/Tenofovir- disoproxil fumarate -Stribild (Aug 2012) - Antiviral
|
Meropenenem and Vaborbactam- Besponsa-@- (Aug 2017) - Anti-infective drug
|
|
Benznidazole - Benznidazole-@- (Aug 2017)- Anti-microbial
|
Copanlisib- Aliquopa-@- (Sep 2017) - Anti-cancer
|
|
Secnidazole- Solosec-@- (Sep 2017)- Anti-Microbial drug
|
34/17. Abemaciclib-(VERZENIO)- (Sep 2017) - to treat certain advanced or metastatic breast cancers
|
|
Acalabrutinib- Anti-cancer drug- Calquence - (2017)
|
Acalabrutinib- Anti-cancer drug- (Calquence - 2017)
|
|
Latanoprostene bunoid ophthal sol (Vyzulta) -@- 2017
|
Letermovir- Anti-infective- Prevymis -@-(2017)
|
|
Calquence- Acalabrutinib- Anti-cancer drug (2017)
|
Benralizumab- Anti-asthmatic- Fasenra -@- (Nov 2017)
|
|
Vestronidase alfavjbk- Sly syndrome- Mepsevii -@-(2017)
|
Emicizumab- Factor VII inhibitor- Hemlibra -@- (Nov 2017)
|
|
1/18. Lutetium Lu 177 Dotatate -(LUTHAERA)- (2018)- Anti-cancer
|
2/18. Bictegravir,Embitcitabine,Tenofovir Alafenamide - (BIFENAMIDEKTARYVY)-@- (Feb- 2018)- to treat infection in adults who have no antiretrovral treatment
|
|
Tezacaftor,Ivacaftor- Symdeko (2018)
|
4/18. Apalutamide- Anti-cancer-( ERLEADA)-@- (Feb- 2018)
|
|
5/18. Ibalizumab uiyk-(TROGARZO)- (Mar 2018)- to treat HIV patients who have limited options
|
6/18. Tildrakizumab -(IIUMYA)- (Apr 2018)- to treat adult patients with moderate to severe plaque psoriasis
|
|
Fluorouracil- Anti-cancer drug
|
Ivacaftor/Tezacaftor - Symdeko-@- ( Feb- 2018)
|
|
7/18. Fostamatinib- (TAVAKISSE)-@- (Apr- 2018) - To treat thrombocytopenia in adult patients
|
8/18. Burosumabtwza- (CRYSVITA)- @- (Apr- 2018)- To treat adults and children 1 year and older with linked hypophostoshatemia
|
|
9/18. Fosnetupitant and Palonosetron - (AKYNZEO) -@-( Apr- 2018)- to prevent nausea and vomitting hihly emetogenic cancer therapy
|
10/18. Lofexidine hydrochloride - (LUCEMYRA)-@- (May- 2018)- Opioid withdrawal symptoms in adults
|
|
11/18. Erenumab - aooe- (AMOVIG) -@- (May- 2018)- preventive treatment of migrainegraine
|
12/18. Sodium zirconium cyclosilicate - (LOKEMIA) -@- (May- 2018)- Hyperkalemia TREATMENT
|
|
13/18. Avatrombopag- (DROPTELET)-@- (May-2018)- to treat low platelet count (thrombocytopenia) in adults
|
14/18. Pegvaliasepqpz- (PALLYNZIQ)-@- (May- 2018)- Genetic disorders known as serious phenylketonurial (PKU)
|
|
15/19. Baricitinib- (OLUMIANT)-@-(May- 2018)- to treat moderately to severly active rhrmutoid arthiritis
|
3-O-acetyl-11-keto-beta-boswellic acid (AKBA)- Osteoarthritis
|
|
Willow Bark Extract- Osteoarthiritis
|
Lacquence- Anti-cancer drug-@-(Oct 2017)
|
|
Zykadia- Ceretinib-Anti-cancer-@- (2014)
|
Beleodaq- Belinostat- Anti-cancer drug-(2014)
|
|
Milnacipran Hcl- Savella Tablets (Jan 2009)
|
16/18. Moxidectin- (MOXIDECTIN)-@- to treat oncchocerciasis due to Onchocerca voluvulus in patients aged 12
|
|
17/18. Cannabiodiol- (EPIDIOLEX)-@- Anti-epileptic - (June-2018) to treat rare forms of epilepsy
|
18/19. Plazomicin- (ZEMDRIL)- @- (June 2018)- to treat adults with complicated urinary tract infections
|
|
19/18. Binimetinib- (MEKTOVI)-@- (June 2018)- to treat unrescetable or metastatic melonoma
|
20/18. Encorafenib- (BRAFTOVI)- ( June 2018)- to treat unresectable or metastatic melanoma
|
|
21/19.Tecovirimat- (TPOXX) - @-( July- 2018) to treat small pox
|
22/18. Ivosidenib- (TIBSOVO)- @- (July- 2018) - To treat patients with relapsed refractory acute myeloid leukemis
|
|
23/18. Tafenoquine- (KRINTAFEL)- @- ( July - 2018)- for the radical cure( prevention of relapse of Plasmodium vivax malaria
|
24/18. Elagolix sodium- (ORILISSA)- ( July- 2018) - for the management of moderate to severe pain associated with endometriosis
|
|
25/18. Fish oil triglycerides- (OMEGAVEN)-@- ( July- 2018) - as a sourse of calories and fatty acids in pediatric patients with parentral nutriotion- associated cholestatasis
|
26/18. Lusutrombopag- (MULPLETA) -@- ( July- 2018) - to treat thrombocytopenia in chronic liver disease
|
|
27/18. Mogamullizumab kpkc- (POTELIGEO) -@- (Aug 2018) - to treat rare types of no-Hodgkin Lymphoma
|
Patisiran- (ONPATTRO)- @- ( Aug- 2018) to treat the polyneuropathy of heriditary amyloidosis patients
|
|
29/19. Segesterone acetate/ ethynyl estradiol -(ANOVERA)- @- ( Aug- 2018)- New vaginal ring to prevent pregnancy
|
30/19. Migalastat- (GALAFOLD)-@- ( Aug- 2018)- To treat adults with fabry disease
|
|
31/19. Stiripentol- (DIACOMIT) @ - ( Aug- 2018) to treat seizures associated with Dravet syndrome
|
32/18. Cenegerrmin- bkbj- (OXERVATE)- @- ( Aug- 2018)- TO Treat neurotropic keratitis
|
|
Lanadelumab- Takhzyro- Angio-edema- @-( Aug-2018)
|
34/19. Eravacycline- (XERAVA)-@- ( Aug-2018)- To treat complicated intr-abdominal infections in 18 years older
|
|
35/18. Doravirine- (PIFELTRO)- ( Aug-2018) - To treat HIV infection in adults
|
36/18. Moxetumomab pasudotox-(LUMOXITIL)-@- ( Sept-2018)- To treat hairy cell leukemia
|
|
37/19.Fremanezumab - (AJOVY)- @- ( Sept-2018)- For the prevention of migraine in adults
|
38/19. Duvelisib- (COPIKTRA)- (Sep 2018)-@- Relapsed chronic Lymphocytic Leukemia
|
|
39/18. Galcanezumab- (EMGALITY)- @- ( Sep-2018)- For the preventive treatment of migrainea
|
40/18. Dacomitinib-( VIZIMPRO)- @- ( Sep-2018)- Treat metastatic non-small -cell lung cancer
|
|
41/18. Cemiplimab-rwlc-(LIBTAYO)- ( Sep-2018)- to treat cutaneous cell carcinoma(CSCC)
|
42/18. Sarecycline- (SEYSARA)-@- ( Oct-2018)- to treat inflamatory lesions of non-modular severe acne
|
|
43/18. Omadacycline- (NUZRA)-@- ( Oct-2018) - To treat community acqauired bacterial pneumoniaed
|
44/18. Elapegadmase-lvlr- @-(REVCOVI)- (Oct 2018) - to treat Adenosine Deaminase- severe combimed immunodeficiencymmunological product-( Oct-2018)
|
|
45/18. Inotersen- (TEGSEDI)-@- ( Oct-2018) - to treat polyneuropathy of heriditary transthyretin aamyloidosis
|
46/18. Talazoparib-(TALZENNA)- @-(Oct-2018)- for the treatment of locally advanced or metastatic breast cancer
|
|
Medical Information- Evidence-Based Medicine
|
Medical Information- Facts on Finger Tips
|
|
Medical Information- Disorders
|
Dulaglutide- Antidiabetic drug
|
|
Sodium Chloride- Nasal decongestant
|
47/18. Baloxavir Marboxil- (XOFLUZA)- @- (Oct- 2018)- for the treatment of acute uncomplicated influenza
|
|
48/18. Lorlatinib - (LORBRENA)- @- (Nov 2018)- to treat of patients with anaplastic lymphoma kinase cancer
|
49/18. Revefenacin- (YUPERI)- @- (Nov-2018)- to treat patients with chronic obstructive pulmonary disease
|
|
50/18. Rifamycin- (AEMCOLO)- @-(Nov 2018) - to treat traveller's diarrhea
|
51/18. Emapalumab-lzsg- (GAMIFANT) -@- (Nov 2018)- to treat primary hemophagocytosis (HLH)
|
|
52.Glasdegib- (DAURISMO)- -@- (Nov- 2018)- to treat newly diagnosed acute myeloid(AML)- in adults patients
|
53/18. Larotrectinib- (VITRAKVI)- @-(Nov -2018)- to treat patients whose cancers have a specific genetic feature(biomarker)
|
|
54/18. Amifampridine - (FIRDAPASE)- @- (Nov- 2018)- to treat patients whose cancers have a specific genetic feature
|
55/18. Gilterinib - (XOSPATA)- @- (Nov- 2018)- to treat patients with relapsed or refractory acute myeloid leukemia
|
|
56/18. Prucalopride- (MOTEGRITY) - @ - (Dec- 2018)- to treat idiopathic constipation
|
57/18. Calaspargase pegol-mknl - (ASPARIAS) - @- (Dec- 2018)- to treat lymphoblastic leukemia(ALL) in pedeatric young adult patients 1 month to 21 years
|
|
58/18. Tagraxofusp-erzs- (ELZONRIS)- @- (Dec - 2018)- to treat plasmacytoid dendritic cell neoplasm (BPBCN)
|
59/18. Ravulizumab- (ULTOMIRIS) -@- (Dec- 2018)- to treat paroxysmal nocturnal hemoglobinria (PNH)
|
|
Oxaceprol- anti-arthritics
|
Monosulphiram - anti-fungal
|
|
Silver Nitrate - Burn preparations
|
1/19. PrabotulinumtoxinA- @-(JEUVEAU ) - (Feb- 2019)- Neuromuscular blocking agent
|
|
2/19. Caplacizumab-yhdp-@-(CABLIVI ) -(Feb- 2019)- Metabolic disoder
|
3/19. Triclabendazole-@-(EGATEN) -(Feb- 2019)- Anthelmintic drug
|
|
4/19. Brexanolone-@-(ZULRESSO)-(Mar- 2019)- Antidepressamt
|
5/10. Solriamfetol- (SUNOSI )-@-(Mar-2019) * Narcotic drug
|
|
6/19. Siponimod- (MAYZENT)-@-(Mar-2019) - Musculo-skeletal
|
7/19. Romosozumab-aqqg- (EVENITY) @ (Apr-2019)- Anti-arthritic
|
|
Erdafitinib- Balversa- (Apr- 2019)- Anti-cancer drug
|
Risankizumab-rzaa-@- (SKYRIZI)- (Apr-2019)-Skin disorders
|
|
Tafamidis Meglumine- (Vyndaquel) @ (May- 2019)- Cardiac disorders
|
11/19. Alpelisib-(PIRQRAY)@ (May-2019)- Anti-cancer
|
|
12/19. Polatuzmab Vedotin-piiq (POLIVY) @ (Jun-2019)- Anti-cancer
|
Mometasone furorate monohydrate- Nasal product
|
|
13/19. Bremelanotide- (VYLEESI) @ (June- 2019)- Metabolic Disorder
|
14/19. Selinexor- (XPOVIO) @ ( June 2019)- Multiple Myeloma
|
|
15/19. Imipenem, Celastin and Relebactam- (RECARBRIO) @ (July 2019)- Urinary tract infections
|
16/19. Ferric Maltol- (ACCRUFER)-@- (July 2019)- 2019)- Iron deficiency Anemia
|
|
17/19. Darolutamide -(NUBEQA)-@- (July 2019)- Anti-cancer drug
|
18/19. Pexidartinib- (TURALIO)-@- (Aug 2019)- Anti-tumor drug
|
|
Pertomanid- (Aug-2019)- Anti-tubrtcular drug
|
20/19. Pitolisant - (WAKIX)- @-(Aug- 2019)- Narcotic drug
|
|
21/19. Entrectinib- (ROZLYREK )-@- (Aug- 2019)- Anti-cancer drug
|
Fedratinib- (Inrebic )-@- ( Aug-2019)- Metabolic disorders
|
|
Updacitinib- (Rinvoq) - (Aug-2019)- Anti-rhrumatic drug
|
24/19. Lefamulin-(XENLETA)-@- (Aug-2019)- Anti-bacterial drug
|
|
25/19. Ga-68- Dotatoc- (Ga -68- DOTAC)-@- (Aug 2019)- Neuroendocrine Tumors
|
26/19. Istradefylline - (NOURIANZ)-@- (Aug-2019)- Parkinsons Disease
|
|
8/19. Erdafitinib-(BALVERSA)- (Apr-2019- Anti-cancr drug
|
19/19. Pretomanid- @- ( Aug-2019)- Anti-tubercular drug
|
|
27/19. Tenapanor- (IBSRELA)- @-(Sept 19)- Irritable bowel syndrome
|
Trifarotene-( AKLIEF)-@- (Oct- 2019)- Acne treatmenttreatment
|
|
29/19. Brolucizumab- dbll- (BEOVU)-@- (Oct-2019)- Muscular degenerationo
|
30/19. Afamelanotide- (Scenesse)-(Oct-2019)- Pain free Phototoxic Reactor Skin damage drug
|
|
Fluorodopa F 18- (Oct- 2019) - Parkinsinsonian
|
Flurodopa F 18- (Oct-2019) Parkinson
|
|
Diagnostic Agent- Fluorodopa F !8- (Oct- 2019)- Anti-Parkinsonium drug
|
32/19. Lasmiditan- (REYVOW)-@- (Oct-2019)- Migraine treatment
|
|
33/19. Elexacaftor/Ivacaftor/ Tezaxaftor--@- (TRIKAFTA) - Oct-2019_
|
Inrebic)- Fedratinib- @- (Aug-2019)-primary or secondary myelofibrosis
|
|
23/19. Upadacitinb- (RINVOQ)- @- (Aug-2019- Anti-rheumatic drug
|
DOPA- Fluorodopa F-18- @- Anti-Parkinson
|
|
35/19. Luspatercept-aamt-@- (REBLOZYL)- (Nov 2019- Treatment of Anemia
|
36/19. Zanubrutinib- (BRUKINSA)- @ -(Nov- 2019) -Anti-cancer Drug
|
|
37/19. Cefiderocid- (FETROJA) -@- (Nov-2019) - Urimary Tract Infections
|
38/19. Crizankizumab-@- (ADAKVEO) (Nov - 2019) - Sickle Cell Disease
|
|
39/19. Givosiran(GIVLAARI) -@-(Nov-2019)- Blood Disorder
|
Cenobamate - (Xcopri) -(Nov 2019)- Partial Seizures
|
|
41/19. Voxelotor-(OXBRYTA)- @-(Nov 2019)- Sickle cell disease
|
42/19. Golodirsen- (VYONDYA 53)-@-(Dec 2019)- Muscular Dystrophy
|
|
43/19. Enfortumab- Vedotin -ejfv- (PADCEV)- @- (Dec 2019)- Refractory Bladder Cancer
|
Brilliant Blue G Ophthalmic Solution(Tissue Blue)-@- (Dec 2019)- Dye used in eye surgery
|
|
Lumateperone Tosylate- (Caplyta)- @-(Dec 2019)- Schizophrenia
|
46/19. Lemborexant- (DAYVIGO)-@- (Dec-2019)- Insomnia
|
|
Fam-Trastuzumab deruxtecan- nxki -@-(Enhertu) -(Dec -2019)- Metastatic Breast Cancer
|
49/19. Ubrogepant- (UBRELVY)- @-( Dec 2019) - Migraine with or without Aura
|
|
Xcopi - Cenobamate-@- ( Nov 2019)- Partial seizures
|
1/20. Avapritinib-(AYVAKIT)- (Jan 2020)- @-Gastrointestinal Stromal Tumor
|
|
3/20.Tazemetostat-(TARVERIK)-@-(Jan -2020)- Epitheliod sarcoma
|
4/20. Lactitol- (Pizensy)-@- (Feb 2020)- Chronic Idiopathic constipation
|
|
5/20. Bempedoic- (Nexletol)- Feb- 2020)- Hetrozygous Familial Hydercholesterolemia or Cardiovascular disease
|
Eptinezumab-jjmr- (VYEPTI)-@-(Feb 2020)- Preventive Treatment of Migraine
|
|
7/20. Amisulphide -(BARHEMSYS) -@-(Feb 2020)- Prevent Nausea and Vomiting After surgery
|
8/20. Rimegepant-(NURTEC ODT)- (Feb -2020)- To treat Migraine
|
|
Isatuximab- (SARCLISA) -@- (Mar 2020)- Treat Multiple Myloma
|
Tepezza- Teprotumumab-trbw-@-(Jan 2020) - Thyroid eye disease
|
|
Treat Multiple Myloma -Isatuximab-(Sarclisa) @ (Mar 2020)
|
Treatment forThyroid Eye Disease- Teprotumumab-trbw-(Tepezza) @ (Jan 2020)
|
|
10/20. Osilostat-(ISTURIA) @ (Mar 2020) - To treat Cushings disease
|
11/20. Ozanimod- (EPOSIA)- @- (Mar -2020)- TO Treat Relapsing Form of Multiple Sclerosis
|
|
12/20. Selumetinib-(KOSELUGO)-@- (Apr-2020)- To treat Neuro Firbromatosis Type 1- A Genetic Disorder
|
Corona Virus Disease (COVID-19) US FDA Information
|
|
Tcatinnib-(TUKYSA) -@- (Apr- 2020)- Metastatic Breast Cancer
|
13/20.Tucatinib -(TUKYSA)(Apr 2020)- Metastatic Breast Cancer
|
|
Pemigatinib- (PEMAZYRE) @ (Apr 2020)- Cholangio carcinoma- rare form of Cancer
|
15/20.Sacituzumab -(TRODELVY) @ (Apr 2020)- Metastatic Cancer disease
|
|
16/20. Opicapore- (ONGENTYS) @ ( Apr 2020)- Parkinson's Disease
|
Gatinib- Pemigatinib (PEMAZYRE) @ (Apr 2020) Anti-cancer drug
|
|
COVID 19 INFORMATION
|
Selpercatinib-(RETEVMO) @ (May 2020)- Thyroid cancer drug
|
|
17/20.Capmatinib( TABRECTA) @ (May 2020) - Non small lung cancer drug
|
Eretinib-(Qinlock)- (May 2020)- Gastro-Intestinal Tumors
|
|
19/20.Ripretinib- (QINLOCK)-(May 2020) -Advanced Gastro-Intestinal Tumors
|
20/20 .Fluoroestridol- (Cerianna) (May 2020) @ -Imaging Agent for Patients with Breast Cancer
|
|
Severe Malaria-Artesunate-@ (May 2020)
|
22/20. Flortacipir- (TAUVID) @ (May 2020)- Alzheimers Disease
|
|
Imaging Agent for Breast Cancer-Fluoroestridol (Cerianna)@ (May 2020)
|
23/20. Inebilizumab-cdon- (VPLIZMA) @(June 2020)- Neuromyletis Opima spectrum disorders
|
|
24/20. Lurbinectidin -(Zepzeica) @ (June -2020)- Metastatic small lung cancer
|
25/20. Triheptanoin- (DOJOLVI) @ (June -2020)- Molecular long Chain Oxidation disorder
|
|
26/20. Remimazolam-(BYFAVX)- @ (July 2020)- For Sedation
|
27/20. Fostemsavir- (RUKOBIA) @ (July 2020)- Treat HIV
|
|
Itolizumab- Biocon India- New Drug- COVID 19
|
28/20. .Decitabine and Cedazuridine-(INQOVI ) @ (July 2020)- Mylodyplastic syndrome
|
|
30/20. Tafasitamar-(MONJUVI) - (July 2020)- Relapsed or Refractoty Diffuse Large B Cell Lymphoma
|
31/20. Belantamib Mafodotin-(BLENREP)- (Aug- 2020)- Treat Multiple Myloma
|
|
32/20. Nifurtimox- (LAMPY)- (Aug 2020)- Chagas Disease -Pediatric drug
|
33/20. Risdiplam- (EVRYSDI)-(Aug 2020)- To treat spinal disease
|
|
Novel Drug Approvals by FDA
|
Novel Drug Approvals for 2004/2006
|
|
Novel Drug Approvals for 2020
|
Thyroid Eye Disease- @Teprotumumab- trbw- ( Tepezza)- (Jan 2020)
|
|
Novel Drug Approvals for 2019
|
Novel Drug Approvals for 2018
|
|
Novel Drug Approvals for 2017
|
Novel Drug Approvals for 2016
|
|
Novel Drug Approvals for 2014
|
34/20. Oliceridne -(OLINVYK)- (Aug 2020)- Management of Pain
|
|
35/20. Viltolarsen - (VITEPSO)-(Aug 2020)- Treat Duchene muscular dystrophy
|
36/20. Satraliumab-(ENSPRYNG)- (Aug 2020)- Neuromyelitis disorder
|
|
37/20. Clascoterone- (WINLEVI)-(Aug 2020) - Treatment of Acne
|
38/20. Somapacitan (SOGROYA)- (Aug 2020)- Growth Hormone
|
|
39/20. Copper Cu 64-(DETECTNET)- (Sep 2020)- Neuroendocrine Tumors
|
Novel Drug Approvals for 2013
|
|
40/20. Pralsetinib-(GAURETO) (Aug 2020)-Treat small lung cancer(Sept 2020)
|
inPharmation Plus- a) Health Quotes
|
|
inPharmation Plus- b) Health Tips
|
inPharmation Plus - c) Nutrition and Good Health
|
|
inPharmation Plus- d) Vitamins and Minerals
|
inPharmation Plus- e) Health and Relaxtion
|
|
inPharmation Plus- f) Aging Gracefully
|
Atoltivimab,Maftivimab & Odesivimab- (Oct 2020)- To treat Eloba Virus
|
|
19/20. Ripretinib-Qinlock -(May 2020)- Advanced Gastrointestinal -stromal tumorss
|
42/20. Remdesvir- (VEKLURY)- (Oct 2020)- To treat Covid-19
|
|
Lonafarnib- Zokinvy- (Nov 2020)- To treat rare condition of premature aging
|
44/20. Lumasiran- (OXLUMO)- (Nov 2020)- To treat Hyperoxaluria type 1
|
|
45/20. Setmelanotide-(IMCIVREE)- ( Nov 2020)- To treat obesity and the control of hunger associated disorder
|
46/20. Naxitamab-gqgk- (DANZELY) -(Nov 2020)- To treat high-risk refractory relpased neuroblastoma
|
|
47/20. Gallium Ga 68- PSMA 11- (GALLIUM 68 PSMA 11)- (Dec 2020)- for detection and localization of Prostrate Cancer
|
Berotralstat - Orladeyo-(Dec 2020)- to treat patients with Heriditary Angioedema
|
|
Sample Presentation
|
ZG- Another aspect of patient information
|
|
49/20. Tribanibulin -(KLISYRI)- ( Dec (2020)- To treat Actinic kerotosis of face or scalp
|
50/20. Margentuximab-(MARGENZA)- (Dec 2020)- To treat Herz and Breast Cancer
|
|
ZG- 1. Health Tips
|
ZG-2- Healthy Aging
|
|
ZG-3. Health and Relxation
|
51/20. Relugolix- (ORGOVYX)- (Dec 2020) - To treat advanced Prostrate Cancer
|
|
Ansuwimab-zyki(Dec 2020)- To treat Ebola
|
53/20. Vibegron- (GEMTESA)- (Dec 2020)- To Treat Over Active Bladder
|
|
Covid-19 New Products Launched
|
New Release- Covid 19
|
|
Ebanca- Ansuvimab- (Dec 2020)- treat Eloba
|
PEMAZYRE- Pemigatinib-(Apr 2020)- Anti-cancer drug
|
|
SARCLISA- Isatuximab-(Feb 2020)- To treat Multiple myloma
|
Fluoroestrdiol F18-Cerianna- (May 2020)- Imaging agent for Breast Cancer
|
|
Cerianna-Fluoroestriol F-18(May-2020)- Diagnostic imaging agent for breast cancer
|
21/20. Artesunate- Artesunate(May 2020)- To treat severe malaria
|
|
Novel drug Approvals for 2021
|
Cabotegravir and Rilpivirine-(Cabenuva) (Jan 2021)- To treat HIV
|
|
01/21.Patient Counselling Information -(2021) - No.1. Vericiguat -(VERQUVO) -(Jan 2021)
|
Patient Counselling Information -( 2021) - No. 2. Cabotegravir and Ripivirine (CABENUVA)- ( Jan 2021)
|
|
Patient Counselling Information-(2021) - No.3.- Voclosporin (LUPKYNIS) -(Jan 2021)
|
01/20.Patient Counselling Information -( 2020) -.No. 1. Avapritinib- (AYVAKIT ) - (Jan 2020)
|
|
02/20.Patient Counselling Information -( 2020) -.No. 2.Teprotumumab- trbw- (TEPEZZA) -(Jan 2020)
|
03/20. Patient Counselling Information -( 2020) -.No. 3.Tazemetostat -(TAZVERIK) -(Jan 2020))
|
|
04/20.Patient Counselling Information- (2020)- No.4. Lactitol -(PIZENSY- ( Feb 2020)
|
05/20. Patient Counselling Information- (2020)- No.5 Bempedoic acid -(NEXLETOL )- (Feb 2020) .
|
|
06/20. Patient Counselling Information- (2020)- No.6. Eptinezumab-jjmr- (VYEPTI )- (Feb 2020)
|
07/20. Patient Counselling Information- (2020)- No.7. Amisulphide (BARTHEMSYS) -(Feb 2020).
|
|
08/20. Patient Counselling Information- (2020)- No.8. Rimegepant - ( NURTEC ODT) - (Feb 2020)
|
10/20.Patient Counselling Information- (2020)- No.10 Osilodrostat - (ISTURISA) - (Mar 2020)
|
|
09/20. Patient Counselling Information- (2020) - No.9. Isatuximab - (SARCLISA)- (Mar 2020)
|
Sarclisa -Isatuximab- (Feb 2021)
|
|
11/20.Patient Counselling Information- (2020)- No.11.Ozanimod -(ZEPOSIA)- (Mar 2020).
|
12/20.Patient Counselling Information- (2020)- No.12.Selumetinib -( KOSELUGO) - (Apr 2020).
|
|
13/20.Patient Counselling Information- (2020) - No.13. Tucatinib -( TUKYSA)- (Apr 2020)
|
14/20.Patient Counselling Information- (2020) - No.14.Pemigatinib- (PEMAZYRE) -(Apr 2020)
|
|
Patient Counselling Information- (2020- No.16.Opicapone- (ONGENTYS) - (April 2020)
|
Patient Counselling Information- (2020- No.17.Capmatinib- (TABRECTA)- (May 2020)
|
|
15/20. Patient Counselling Information- (2020- No.15.Sacituzumab Govitecan-hziy-(TRODELVY)- (April 2020)
|
Patient Counselling Information- (2020- No.18.Selpercatinib- (RETEVMO)- (May 2020)
|
|
Patient Counselling Information- (2020)- No.19. Ripretinib- (QINLOCK)- (May 2020)
|
Patient Counselling Information- (2020)- No.20. Fluorostradiol - (CERIANNA)- (May 2020)
|
|
Patient Counselling Information- (2020)- No.21. Artesunate -(ARTESUNATE )- (May 2020)
|
22/20. Patient Counselling Information- (2020) - No.22.Flortaucipir F18 -( TAUVID)- (May 2020)
|
|
Finerfenone- (KERENDIA)- (July 2021)
|
4/21. Tepotinib- (TEPMRTKO)- (Feb 2021)- Treat small lung cancer
|
|
5/21. Umbralisib-( UKONIQe)- (Feb 2021)- Treatment of follicular lyphomas
|
6/21. Evinacumab-dgnb- (EVKEEZA)- (Feb 2021)- To treat homozygous familial hypercholesteromia
|
|
7/21. Trilacicilib-(COSELA)- (Feb 2021)- Chemotherapy induced myelosuppression in small lung cancer
|
8/21. Casimersin- (AMONDYS 45)- (Feb 2021)- Duchenne muscular dystrophy
|
|
9/21. Fosdenopterin -(NULIBRY)- (Feb 2021)- Treat patients with rare genetic disease
|
10/21.Melphalan Flufenamide -(PEPAXTO)- (Feb 2021)- Treatment of elapsed or refractory multiple myeloma
|
|
11/21.Serdexmethylphenidate- (AZSTARYS)-(Mar 2021)- Attention Deficit Hyperactivity
|
12/21. Tivozanib- (FOTIVDA)- (MAR 2021)- treat patients with renal cell carcinoma
|
|
13/21.Ponesimod- (PONVOY)- (Mar 2021)- To treat patients with relapsing forms of multiple sclerosis
|
14/21.Dasiglucagon-(ZEGALOGUE)- (Mar 2021)- To treat severe hypoglycemia
|
|
15/21.Viloxazine- (QELBREE)- (Apr- 2021)- For the treatment of attention deficit hperactivity disorder
|
16/21.Drosperenone and Esterol tablets-(NEXTELLIS)- (Apr- 2021)- To prevent pregnancy
|
|
18/21.Loncastuximab tesirine-lpyl-(ZYNLONTA)- (Apr- 2021)- Treat certain type relapsed B- cell lymphoma
|
20/21.Pegcetacoplan- (EMPAVELLI)- (May 2021)- to treat adult patients with paroxysmal nocturnal hemoglobinuria
|
|
21/21.Amivantamab-vmjw- (RYBREVANT)- (May 2021)- treat aduts with subset of non-small cell lung cancer
|
22/21.Piflufolastat F 18- Injection- (PYLARIFY)- (May- 2021)- For positron emission tomography imaging of with prostrate cancer
|
|
23/21. Sotorrasib- (LUMAKRAS)- (May 2021)- Treat adult with non-small lung cancer
|
24/21. Infigratinib- (TRUSELTIQ)- (May 2021)- Treat adult with cholangiocarcinoma
|
|
25/21. Olanzapine/samidorphan -(LYBALVI)- (May 2021- Treat schizophrenia in adults with biplor 1 disorder
|
26/21.Ibrexafungerp tablets- (BREXFEMME)- (June 2021)- To treat vulvovaginal candidiasis in adult females
|
|
27/21.Aducanumab- (ADUHELM)- (June 2021)- Treatment of Alzheimer's disease
|
Dostarlimab-gxly-* (JEMPERLI)- (Apr 2021)- Treat endometrial cancer
|
|
17/21.Dostarilimab-gxly- (JEMPERLI)- (Apr- 2021)- - To treat endometrial cancer
|
Asparaginase erwinia chysanthemi- (RYLAZE) -(Jun 2021)- To Treat Lymphoblastic leukemia
|
|
29/21. Finerenone -(KERENDIA)-(July 2021)- To reduce risk of kidney compliactions in chronic kidney disease
|
Fexinidazole -(FEXINIDAZOLE)- (July- 2021)- to treat human African trypanosomiasis caused by parasite
|
|
32/21.Odevixibat-(BYLVAY) -(July- 2021)- To treat pruritus
|
33/21.Anifrolumab-fnia -(SAPNELO)- (July 2021)- To treat moderate to-severe- systemic lupus erythematousus along with standard therapy
|
|
34/21.Avaglucosidase alfa- ngpt-( NEXVIAZYME)- (Aug - 2021)- To treat late-onset Pompe disease
|
35/21.Belzutifan- (WELIREG)- (Sep 2021)- To treat Von Hippal -Lindau(VHL) disease under certain coniditions
|
|
36/21.Difelikefalin- (KORSUVA)- (Aug -2021)- To treat moderate to severe Pruritus to severe Pruritus associated with certain Kidney disease
|
37/21.Lonapegsomatropin- (SYTROFA)- (Aug 2021)- To treat short stature due to inadequate secretion of endogenous growth hormones
|
|
38/21.Mobocertinib- (EXKIVITY)- (Sep 2021)- To treat advances on Metastatic no-small lung cancer with epidermal growth factor
|
27/17.Acalbrutinib-( CALQUENCE)-(May 2017) -Mantle cell lymphoma
|
|
CALQUENCE - Acalabrutinib- (Oct 2017) -Tp treat mantle cell lymphoma
|
39/21.Tisotumab Vedotin - tftv- (TIVDAK)- (Sep 2021)- to treat recurrent or metastatic cancer
|
|
40/21.Atogepant- (QULIPTA)- (Sep 2021)- to prevent Episode Migraine
|
41/21.Maralixbat-(LIVMARLI)-(Sep 2021)-to treat cholestatic pruritis ass. with Alagille syndrome
|
|
42/21.Avacopan-(TAUNEOS)- (Oct 2021)- to treat active Anti-neutrophil cytoplastic Antibody
|
Muscular disorders
|
|
Metaboilic disorders- 1.patient information
|
Patient Drug information- Advice to patients
|
|
Patient Drug Information- Antacids
|
Antacids
|
|
Patient Drug Information- Anticholinergics/ H2 Antagonists
|
43/21. Asciminib- (SCEMBIK)- (Oct 2021)- to treat Philadelphia Chromosome -positive myeloid Leukemia
|
|
44/21.Roperginterferon alfa-2b-njft(BESRIMI) (Nov 2021)- to treat Polycythemia vera a blood disease
|
Patient Drug Information- Antianginal
|
|
Vericiguat- (VERIQUVO)-(Jan -2021)- To treat chronic Heart Failure
|
VERQUIVO- Vericuguata- (Jan 2021)- To treat heart failure
|
|
3/21. Voclosporin- Lupkynis- (Jan- 2021 )- To treat lupus nephritis
|
Patient Drug Information- Anticoagulants
|
|
Patient Drug Information- Analgesics and Antipyretics
|
Patient Drug information- Sedatives and Tranquillisers
|
|
Patient Drug information- Antidepressants
|
Patient Drug information- NSAIDS
|
|
Patient Drug Information- Hormones
|
Patient Drug Information- Antidiabetic -Hypo-Hyperglycemics
|
|
Patient Drug Information- Antidiuretics
|
Patient Drug Information- Antibiotics-Antibacterial
|
|
Patient Drug Information- Vitamins
|
45/21. Vosoritide- (VOXZOGO) (Nov 2021)- To improve growth in children
|
|
46/21.Maribavir- (LIVTENCITY)- (Nov 2021)- to treat post transition Clitomegalovirus (CMV) infection
|
47/21.Pafolacianine (CYTALUY)- (Nov 2021)- to help identify cancer lesions
|
|
Patient Drug Information- Sympathomimetics
|
Patient Drug Information- Antiarrhythmics
|
|
Patient Drug Information- Antiasthmatics
|
Patient Drug Information- Anticonvulsants
|
|
Telzepelumab- (TELSPIRE)- (Dec 2021)- To treat Asthma
|
49/21.Efgartigmud-(VYGART)- (Dec -2021)- To treat Generalised Myasthenia Gravis
|
|
50/21.Inclissiran- (LEGVIO) - (Dec 2021)- To treat Heterozygous Familial Hypercholesterolemia
|
Inositol Nicotinate-BNF(2015)
|
|
Rotigotine- (BNF-Mar 2015)
|
Remifentanil- (BNF- Mar 2015)- enhancement of Anesthesia
|
|
Patient Drug Information-Antihypertensives
|
Novel Drug Approvals for 2022
|
|
1/22. Daridorexant- ((QUVIVIQ) -(Jan 2022)- To treat insomnia
|
2/22.Abrocitinib-(CIBINQO)- (Jan 2022)- To treat refractory atopic dermatitis
|
|
Patient Drug Information- Antidiarrheal
|
Patient Drug Information- Antidote
|
|
Patient Drug Information- Antidyskinetic
|
Patient Drug Information- Antidysmenorrheal
|
|
Patient Drug Information- Antiemetic
|
Patient Information -Antifungal
|
|
Patient Drug Information- Antifungal
|
Patient Drug Information- Antihistamines
|
|
Patient Drug Information- Anti-inflammatory
|
3/22. Tebentafusptebn ( KIMMTRAK) (Jan 2022)- To treat unresectable ot metastatic unveal melanoma
|
|
4/22. Faricimab-svoa (VABYSMO) (Jan 2022)- To treat neovacular diabetic macular edema
|
5/22. Sutimlimab -jone (ENJAYMO) (Feb 2022)- To decrease the need for blood transfusion due to hemolysis in cold agglutin disease
|
|
6/22. Mitapivat- (PYRUKYND)- (Feb 2022)- To treat hemolytic anemia in Pyrivate Kinase Defiency
|
7/22. Pacritinib- (VONJO)- (Feb 2022)- To treat Intermittant or High Risk Primary Or secondary Myelo Fibrosis in adults
|
|
Pacritinib-(VONJO)- (Feb 2022)- To treat intermediate or high risk primary or secondary primary myelofibrosis
|
Pacritinib-(VONJO)
|
|
8/22. Ganaxolone- (ZYTALMY)- (Mar 2022)- to treat seizures in cyclic-dependent kinase like deficiency
|
9/22. Nivolumab & Relatimab- (OPDULAG)- (Mar 2022)- to treat unresectable or Metastatic Melanoma
|
|
10/22. Lutetium (PLUVICTO) (Mar 2022)- To treat Prostrate Specific Membraine Antigen Positive Metastatic Castration Resistent Cancer
|
Amroloifine
|
|
Amorolifine
|
Ostesonazole- (VIVJOYA)- (Apr 2022)- To remove the incidence of recurrent Vulvovaginal Candiadasis in Females
|
|
12/22. Mavacamten (CAMZYOS)- (Apr 2022)- To treat classes of Obstructive Hypertrophic Cardiomyopathy
|
13/22. Vonoprazan- (VOQUEZNA)- (Mar 2022)- TO Treat Helicobacterial Pylori Infection
|
|
14/22. Tirzepatide- (MOUNJARO)- (May 2022)- To improve blood sugar control in Diabetes, in addition to Diet and Excercise
|
15/22. Tapinarof- (VTAMA)- (May 2022)- To treat psoriasis
|
|
16/22. Vutrisiran -(AMVUTTRA)- (June 2022)- To treat Polynervopathy or Heriditary - Mediated Amyloidosis
|
Alefacept - Immunosuppresent
|
|
Aliretinoin- Topical- Retinoids dermatolgical
|
Eculizumab-- Injection- Monoclonal antibody
|
|
New product- august 2022
|
17/22. Olipudase Alfa- (XEPOZYME)- (Aug 2022)- To treat acid Sphingomyelinase deficiency
|
|
18/22. Spesolimab- (SPEUIGO)- (Sep 2022)- To treat generalised postulat psoriasis
|
19/22. Daxibotulinumtoxina- (DAXXIFY)-(Sep 2022)- treat moderate to severe glablellar lines
|
|
Dabotulinumtoixna-ianm-(DAXXIFY)- (Sep 2022)- to treat moderate to severe glabellar lines associated with corrugation
|
Dabotulinumtoixna- (DAXXIFY)- (Sep 2022)- to treat moderate to severe Glabellar lines
|
|
Decravacitinib -(SOTYKU)- (Sep 2022)- to treat severe plaque sporiasis
|
Elapegrastin- (ROLVEDON)- (Sep 2022)- to decrease the incidence of infection in patient with myeloid malignancies
|
|
22/22. Terlipressin- (TETLIVAZ) -( Sep 2022) -to improve kidney function in patients with hepato dyndrome
|
23/22. Gadopiclenol- (ELUCIREM)- (Sept 2022)- to detect and visulize lesions to gether with MRI for abnormal vascularity in central nevous system
|
|
24/22. Oomidenepag- (OMLONTI)- (Sep 2022)- to reduce elevated intraocular pressure in patients with open Glaucoma
|
1A.PATIENT DRUG INFORMATION - (REGROUPED) - Antacids, Antireflux agents
|
|
1B. PATIENT DRUG INFORMATION- (REGROUPED)- Git regulators, Antiflatulants, Anti-inflammatories
|
Levamlodipine-antihypertensive drug
|
|
26/22. Futibatinab- (LYTGOBL)- ( Sep 2022)- to treat intrahepatic Cholango carcinima
|
Tremelimumab -( IMJUDO)- (Oct 2022)- to treat unrescectable hepacellular carcinoma
|
|
28/22. Teclistab-cqyr- (TECVAYLI)- (Oct 2022)- to treat relapsed or refractory multiple myeloma among adults
|
Sodium Phenyl Butyrate/Taurusodiol -(RELYURIO)- (Sept 2022)- to treat amyotrophic Later Sclerosis
|
|
29/22. Mirventuximab sorvatansine gynx- (ELAHERE ) - (NOV 2022)- TO Treat patients with recurrent ovarian cancer
|
Mesalazine- Ulcrative colitis
|
|
30/22. Teplizumib- (TZIELD)- (Nov 2022)- to delay the onset of stage 3 type 1 diabetic
|
31/22. Olutasidenib- (REZLIDHIA)- (Dec 2022)- to treat adult with relapsed or acute Leukemia
|
|
33/22. Lenacapvir-(SUNLENCA)- (Dec 2022)- to treat live HIV infection
|
34/22. Mosunetuzmab- axgb- (LUNSUMIO)- (Dec 2022)- to treat adults with relapsed lymphoma
|
|
Ubiltuximab- Xe129 -(XENOVIEN)- (Dec 2022) - to treat relapsing forms of multiple scalerosis
|
37/22. Anacaulase -bcdb-(NEXOBRID)- (Dec 2022)- to remove Eschar in adults with deep partial thickness or full thickness therapy burns
|
|
35/22. Hyperpolarized Xe-1 9 -(XENOVIEW)-(Dec 2022)- to evaluate pulomonary function and imaging
|
Ublituximab-xiiy- (BRIUMVI)- (Dec 2022)- to treat relapsing mulitiple sclerosis
|
|
32/22. Adagrasib- (KRAZATI)- Dec 2022)- to treat KRAS G12C -Mutated locally advanced small lung cancered
|
Patient Councelling Instructions- (2020)
|
|
Patient Councelling Instructions-(2021)
|
18/20. Selpercartinib-(RETEVMO)- (May 2020- to treat lung and thyroid cancers
|
|
20/20. Fluoroestradiool -(CERIANNA) -(May 2020)- Diagnostic imgaing agent for certain patients with breast cancer
|
27/20. Fostemsavir - (July 2020)- To treat HIV
|
|
29/20. Abametapir -(XEGLYZE)- (July 2020)- to treat head lice
|
41/20. Atoitivimab- (IMMAZEB)- (Oct 2020)- To treat Ebola Virus
|
|
43/20. Lonfarnib- (ZOKINVY)- (Nov 2020)- To treat Rare conditions to premature aging
|
48/20. Berotralstat- (ORLADEYO)- (Dec 2020)- To treat patients with Heridatary Angioedema
|
|
52/20.Ansuvimab- zykl-(EBANGA)- (Dec 2020)- To treat Elola
|
DaxibotulimtoiixnA-lanm-(DAXXIFY)- (Sep 2022)- To treat moderate to-severe glabellar lines associated with Corrugator muscle acivity
|
|
20/22. Deucravacitinib-(SOTYKU)- (Sep 2022)- To treat severe plaque psoriasis
|
21/22. Eflapegrastim-(ROLVEDON)- (Sep 2022)- To dreacrease the incidence of infection in patiemts with non-myeloid malignancies
|
|
1/23.Lecanemab-irmb-(LEGEMBI)- (Jan 2023)- To treat Alzheimer's disease
|
2/23 .Bexagliflozin -(BRENZAVVY)-(Jan 2023)- To improve glycemic control in adults with type 2 diabetes as an adjunct and excercise
|
|
3/23 .Pirtobrutinib-(JAYPIRCA)- (Jan 2023)- To treat relapsed or refractory mantle cell lymphoma in adults
|
4/23.Elacestrant- (ORSERDU)- (Jan 2023)- To treat estrogen receptor-positive,human epidermal growth factor 2-negative ,ESRI-mutated,advanced or metastatic breast cancer
|
|
5/23.Daprodustat-(JESDUVROQ)- (Feb 2023)- To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months
|
6/23.Velmanase alfa-tycv -(LAMZEDE)- (Feb 2023)- To treat central nervous system manifestations of alpha-mannosidosis
|
|
7/23.Sparsentan-(FILSPARI)-(Feb 2023)- To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of of rapid disease progression
|
8/23.Omaveloxolone-(SKYCLARYS)-(Feb 2023)- To treat Friedrich's Ataxia
|
|
Novel Drug Approvals for 2023- (1 to 10)
|
Novel Drug Approvals for 2023
|
|
9/23.Zavegepant-(ZAVPRET)- (Mar 2023)- To treat migraine
|
10/23.Trofinetide -(DAYBUE)- (Mar 2023)- To treat Rett syndrome
|
|
11/23 .Retifanlimab-dlwv -(ZYNYZ)- (Mar 2023)- To treat metastatic or recurrent locally advanced market cell carcinoma
|
13/23. Leniolisib- (JOENJA)- (Mar 2023)- To treat activated Phosphinositde -3-kinase delta Syndrome
|
|
12/23. Rezafungin- (REZZAYO)- (Mar 2023)- To treat carcinoma and invasive candidasis
|
Novel Drug Approvals for 2017-New
|
|
Novel Drug Approvals for 2016- New
|
Novel Drug 2016- New
|
|
Novel Drug 2017- New
|
Rezafungin -(REZZAYO)- (Mar 2023)- To treat Metastastic or Recurrent Cell carcinoma
|
|
14/23. Tofersen-(OSLSODY)-(Apr 2023)- To treat amtrophic lateral sclerosis in adults
|
15/23.Pegunigalsadase alfa- (ELFABRIO)-(May 2023)- To treat fabry disease
|
|
16/23.Fezolinetant- (VEOZAH)- (May 2023)- To treat severe hot flashes caused by menopause
|
11/22. Oteseconazole-(VIVJOA)- (Apr- 2022)- To reduce the incidence of recurrent Vulvova candidiasis vulvo
|
|
15/22. Tapinorof (VTAMA)-(May 2022)- To treat plaque psoriasis
|
25/22. Sodium phenylbutyrate/taurursodial- (RELYVRIO)- (Sep 2022)- To treat amytropic lateral sclerosis.ther with abnormal variation in central nervous system
|
|
1/21. Veriguat-(VERQUVO)- (Jan 2021)- to treat chronic heart failure
|
28/21. AsargToinase erwina ((RYLAZE)-(June 2021)- to treat acute lymphoblastic lymphoma
|
|
30/21. Feximidazole-(FEXINIDAZOLE)-(Jul 2021)- to treat African trypoanosomiasis caused by
|
31/21. Belumosudil- (REZUROCK)- (Jul 2021)- to treat chronic graft-versus-host disease after failure of at least two prior therapy
|
|
48/21. Tezepelumab-(TEZPIRE)-(Dec 2021)- to treat severe asthma
|
45/21. Vovzogo- (VOSORITIDE)- (Nov 2021)- to improve growth in children five years of age and older with achondrolasia and Epiphyses
|
|
19/21.Sedexmethylphenidate and Dexmethyl phenidate (AZASTARYS)- (May 2021)- to treat attentn defecit hyperactivity disordr
|
51/21. Tralokinumab- (ADBRY)- (Dec 2021)- To treat moderate to severe dermatitis
|
|
2/21.Cabotegravir- (CABENUVA)- To treat HIV
|
2/21. Cabotegravir-(CABENUVA)- (Jan 2021)- To treat HIV
|
|
2/21.(CABENUVA)-Cabotegravir - (Jan 2021)- To treat HIV
|
2/20. Teprotumab- (TEPEZZA)- (Jan 2020)- to treat thyroid eye disease
|
|
6/20. Epitinezumab- (VYEPTI)- (Feb 2020)- For the prevention of treatment of migraine in adults
|
8/20. Isatuximab-(SARCLISA)-(Mar 2020)- to treat multiple myloma
|
|
9/20. Isatuximab- (SARCLISA)- (Mar 2020)- to treat multiple myloma
|
14/20. Pemigatinib- (PEMAZYRE)- (Apr 2020)- to treat certain patients with rare Carcinoma
|
|
5/19. Solriametol- (SUNOSI)- (Mar 2019)- Excessive sleepness in adults
|
5/19. (SUNOSOL)- Solriametol- (Mar 2019)- Excessive sleeopness in adults
|
|
22/19. (INREBIC)- Fedratinib- (Aug 2019)- to treat patients with high risk primary or secondary myelofibosis
|
31/19. Fluorodopa F 18- (Oct 2019)- Adiagnostic agent for use in positron emission tomography to help patients with Parkinsonian Syndrome
|
|
34/19. (ExEm Foam)- ExEm Foam Air Olymer Type A - (Oct 2019)- diagnostic agent to assess fallopian tube patency(openess) in women
|
34/19. Air polymer-type A- (Ex EmFoam)- (Nov- 2019)- Diagnostic agent to assess Fallopian Tube Function
|
|
40/19. Cenobamate - (XCOPRI)- (Nov 2019)- to treat partial onset of seizures
|
44/19. Brilliant Blue G- (TISSUE BLUE)- (Dec 2019)- to treat reractory bladder cancer
|
|
47/19. Transtumab- (ENHERTU)- (Dec 2019)- to treat metastatic breast cancer
|
45/19. Tumateperone- (CAPLYTA)- (Dec 2019)- to treat schizophrenria
|
|
3/18. Tezacaftor- (SYDEKO)- (Feb 2018)- to treat fibrosis in patients age 12 years and older
|
15/18. Baricitinib- (OLUMIANT)- (May 2018)- to treat moderately to severely active rheumatoid arthiritis
|
|
17/18. Cannabidiol- (EPIDOLEX)- (June 2018)- to treat severe forms of epilepsy
|
18/18. Plazomicin- (ZEMDRIL)- (June 2018)- to treat adults with complicated urinary tract infections
|
|
21/18. Tecoviramat- (TPOXX)- (July 2018)- to treat small pox
|
22/18. Ivosidenib- (TIBSOVO)- (July 2018)- to treat relapsed or refractory leukemia
|
|
23/18. Tafenoquine- (KRINTAFEL)- (July 2018)- for the radical cure of Plasmodium vivax malaria
|
24/18. Elagolixx sodium- (ORILISSA)- (July 2018)- for the management of moderate to severe pain asociated with endometriosis
|
|
25/18. Fish oil- (OMEGAVEN)- (July 2018)- as a spurrse of calories and fatty acids in pediatric nutrition associated cholestasis
|
26/18. Lustrobopag- (MULTPLETA)-(July 2018)- to treat thrombocytopenia patients
|
|
27/19. Tenapanor-
|
28/17. Patisiran -(ONPATTO)- (Aug 2018)- to treat plyneuropathy of heriditary medicated amyoloidsis in adult patients
|
|
30/18. Migalastat- (GALAFORD)- (Aug 2018)- to treat adults with Fabry disease
|
31/18. Stirpentol -(DIACOMIT)- (Aug 2018)- to treat seizures associated with Dravet syndrome
|
|
33/18. Tanadelumab- ( TAKHZYRO)- (Aug 2018)- to treat types 1 and II heriditary angioedema
|
34/18. Eravacycline -(XERAVA)- (Aug 2018)- to treat intra-abdominal infections
|
|
q35/18. Doravirine -(PIFELTRO)- (Aug 2018)- to treat HIV 1 infections in adults
|
37/18. Fremanezumab - (AJOVY)- (Sep 2018)- for the preventive treatment of migraine in adults
|
|
29/18. Segesterone -(ANNOVERA)- (Aug 2018)- New vaginal ring used to prevent pregnancy for an entire year
|
38/18. Duvelisib- (COPIKTA)- (Sept 2018)- to treat relapsed or refractory chronic lymphocytic leukemia and follicular lymphoma
|
|
17/23. Perfluorhexyloctane-(MIEBO)- (May 2023)- to treat signs and symptoms of dry eye disease
|
18/23. Epcoritamab-bysp- (EPKINLY)- (May 2023)- to treat relapsed or refractory diffuse large B cell lymphoma
|
|
19/23. Sulbactam/Durlobactam- (XACDURO)- (May 2023)- to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
|
20/23. Nirmatrelvir(PAXLOVID)- (May 2023)- to treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19
|
|
22/23. Sota gliflozin
|
22/23. Sotagliflozin- (INPEFA)- (May 2023)- to treat heart failure
|
|
23/23. Glofitamab-gxbm- (COLUMVI)- (June 2023)- to treat diffuse large B-Cell lymphoma arising from follicular lymphoma
|
24/23. Ritlecitinib- (LITFULO)- (June 2023)- to treat severely patchy hair loss
|
|
25/23. Rozanolxizumab- (RYSTGGO)- (June 2023) 20230- to treat generalized muasthenia gravis
|
DRUGS- SYSTEM WISE CLASSIFICATION -(Summary)
|
|
Olsalazine Sodium- (BNF-68)- a Gastro-intestinal Product
|
Pivmecillinam Hydrocholride- (BNF-68)
|
|
Treosulfan- (BNF-68)-
|
21/23. Flotufolastat-F -18-(POSLUMA)- (May 2023)- to use with positron emission tomography imaging in certain patient with prostrate cancer
|
|
26/23. Somatrogen-(NIGENIA)-(June 2023)- to treat growth failure due to inadequate secretion of endogenous growth hormone
|
27/23. Nirsevimab- (BEYFORTUS)- (July 2023)- to prevent respiratory syncytial (RSV) disorder
|
|
28/23. Quizartinib- (VANIFLYTA)- (July 2023)- to use part of a treatment regimen for newly diagnosised active myeloid leukemia
|
29/23. Lotilaner -(XDEMVY)- (July-2023)- to treat Demodex blepharitis
|
|
30/23. Zuranolone-(Zurzuvae)- (Aug 2023)- to treat Postparetum depression
|
31/23. Avacincaptad pegot- (IZERVAY)- (Aug 2023)- to treat geopraphic atropy secondary to related macular defeneration
|
|
30/26. Zuranolone- (ZUZUVAE)- (Aug 2023)- to treat postpartum depression
|
33/23. Elrantamab-bcmm- (ELREXFIO)- (Aug 2023)- to treat adults with relapsed refractory multiple myloma who have received at least four prior therapy
|
|
34/23. Talquetamab- tgus-(TALVEY)-(Aug 2023)- to treat adults with relapsed or refractory multiple myloma who received at least four lines of therapy
|
SYSTEMS CLASSIFICATION- (Summary)
|
|
32/23 . Talquetamab tgus -(TALVEY)- (Aug 2023)- to treat adults with relapsed or refractory multiple myeloma who have received at least four lines of therapies
|
35/23. Pozelimb-bbfg-(VEOPOZ)- (Aug 2023)- to treat 1 year and older with CD-SS - defient protein losing entropathy (PLE)-also known as as Chaple Disease
|
|
11/23.Retifanlimab-dlww-(ZYNYZ)-(Mar 2023)- To treat metastatic or recurrent locally advanced markey cell carcinoma
|
27/22.Temeli
|
|
27/22. Tremilimumab-acti-(Sep 2022)
|
36/23 Motixaformide - (APHEXDA)- (Aug 2023)- to mobilize stem cells for peripheral blood collection
|
|
3/23. Mometinib- (OiiJARA)- (Aug 2023)- to treat imtermediate on high risk myelofibrosis in adults with anemia
|
37/23. Mometinib- (OiiJARA)- (Aug 2023)- to treat intermediate high risk mylobrosis adults
|
|
38/23. Gerirone- (EXXURA)- (Aug 2023)- to treat major depresive disorder
|
39/23- Cipaglucoside alfa alfa-( POMGILITI)- (Aug 2023)- to treat late on set pompll diseaset major depressive disorder
|
|
40/23. Nedosiram -(RIVFLOZA)- (Aug 2023)- to lower urinary oxylate in patients 9 year older with primary hyperoxaluria
|
48/19. Ubrogepant- (Dec 2019)
|
|
47/19- Fam -Transtuzumab- (Dec 2019)
|
Cenobamate
|
|
(XCOPRI)- Cenobamate- (Nov 2019)
|
31/19.Fluorodopa F18- (Oct 2019)
|
|
28/19- AKIIEF- (April 2019)
|
28/19- AKIIEF- (April 2019) ****
|
|
22/19- Fedranib- (Aug 2019)
|
15/19- Impenim, Cilastin,Relebactin- (July- 2019)
|
|
3/18. Tezacaftot- (SYDEKO)- (Feb 2018)- tio treat fibrosis in patients age 12 years and older
|
3/18.Tezacaftor,Ivacaftor- (Feb 20180
|
|
3.Tezacaftor, Ivacaftor- (SYMEDEKO)- (Feb 2018)- to cystic fibrosis
|
3/18. Tezacaftor, Ivacaftor- (Feb 2018)
|
|
3/18. (SYDEKO)- Tezacaftor/Ivacaftor -(Feb 2018)- to treat fibrosis in patients age 12 years and older
|
3.Tezacaftor, Ivacaftor- (Feb 2018)- to treat fibrosis in patient 12 yeas and older
|
|
3/18. Tezacaftot- (SYDEKO)- (Feb 2018)- at fibrosis in patients age 12 years and older
|
3. Tezacaftor,Ivacaftor- (Feb 2018)
|
|
3/18. Tezacaftot- (SYDEKO)- (Feb 2018)
|
3/18. Tezacaftot-
|
|
5. Ibalizumab-ulyk- ( March 2018)
|
5/18. Ibalizumab- (March 2018)
|
|
11/18. Erenumab - (May- 2018)-
|
11/18. Erenumab - (May- 2018)
|
|
11/18 - Erenumab- (May 2018)
|
11/18. Erenumab - ( ALMOIG) - (May- 2018)-
|
|
11/18 Erenovig - (AIMOVIG)- (May 2018)
|
11.Erenumab-(May 2018)
|
|
44. Vamorolone-(AGAMREE)- (Oct 2023)
|
46. Toripalimab- tpzi- (LOQTRZI)- (Oct 2023)- to trea recurrent or metastatic nasopharyngeal carcinoma when used toether with or following therapies
|
|
46. Toripalimab- tpzi- (LOQTRZI)- (Oct 2023)
|
28/18.Patisiran- (ONPATTRO)- (Aug 2018)- to treat the polyneuropathy y of heriditary transthyrethyretin- mediated amyloidosis in adult patients
|
|
41/23. Etrasimod- (VELSIPITY)- (Oct 2023)- to treat moderately to severely active ulcerative colitis in adults
|
42/23. Zilucoplan- (ZILBRYQ)- (Oct 2023)- to treat generalized myastina gravis in adults who are anti-acertlchloine eceptor (AChR)- antibody positive
|
|
43/23. Bimekizumab- (Oct 2023)- to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
|
44/23. Vamarolone- (AGAMREE)- (Oct 2023)- to treat Duchenne muscular dystrophy
|
|
45/23. Mirikizumab- (OMVOH)- (Oct 2023)- to treat ulcerative colotis
|
46/23. Toripalimab-tpzi- (LOQTORZI)- (Oct 2023)- to treat recurrent or metastatic nasopharryngeal carcinoma when used together with or following therapis 202
|
|
47/23. Fruquintinib- (FRUZAGLA)- (Nov 2023)- to treat refractory metastatic colorectal cancer
|
48/23. Taurolide, Heparin- (DEFENCATH)- (Nov 2023)- to treat the incidence of catherter related blood stream infections in adults with kidney failure
|
|
49/23. Repotrectinib - (AUGTYRO)- (Nov 2023)- to treat rosi positive non small cell ling cancer
|
50/23. Efbemalenograstin- (RYZNEUTA)- (Nov -2023)- to treat neutropenia
|
|
51/12. Capivaserib- (TRUQAB)- (Nov 2023)- to treat breast cancer that meets certain disease criteria
|
51/23. Capivaserib- (TRAQUAB)- (Nov 2023)- to treat breast cancer that meets certain disease criteria
|
|
49/23. Repotrectinib - (AUGTYRO)- (Nov 2023)- To treat Rosi postive non - small -small cell lung cancer
|
52/18. Glasdegib- (DAURISMO)- (Nov 2018)- to treat newly diagnosed acute myeloid(AML) in adult patients
|
|
52/18. Glasdegib- (DAURISMO)- (Nov 2018)- to treat newly diagnosed acute myeloid(AML) in adult patients
|
52/23. Nirogacestat- (OGSIUEO)- (Nov 2023)- to treat adults with processing desmoid tumors who require systemic trearment
|
|
53/23. Iptacopan- (FABHALTA)- (Dec 2023)- to treat paroxymal nocturanal hemoglobinuria
|
Novel drug approval for 2015
|
|
1/15. Endoxan tablets- (SAVAYSA)- (April 2015)- to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
|
Novel drug approvals for 2015
|
|
2/15. Secukinumab- (COSENTYX)-(Jan 2015)- indicated for the treatment of moderate to severe plaque psoriasis
|
3/15. Parathyroid Hormone- (NATPATRA)- (Jan 2015)- to control hypocalcemia in patients with hypoparathyroidism.
|
|
Itopride- Antiflatulants
|
4/15.Palbocictib-(IBRANE)- (Feb 2015)- for treatment of postmenopausal women with estrogen receptor
|
|
5.Lenvatinib- (LENVIMA)- (Feb 2015)-
|
5/15.Lenvatinib-( LENVIMA)- (Feb 2015)- to treat Renal Failure and Impairment
|
|
6/15.Panobinast-(FARYDAK)- (Feb 2015)-
|
6/(FARYDAK)- (Feb 2015)-
|
|
7/15. Ceftazidime- (AVYCAZ)- (Feb 2015)-
|
8/15. Erdafitinib-(BALVERSA)- (Apr-2015)- Anti-cancer drug
|
|
9/15.Dinutuximab- (UNITUXIM)- (Mar 2015)- to treat pediatric patients with high risk Nevoblastoma
|
10/15. Choli Acid- (CHOLBAM)- ((Mar 2015)- to treat pediatric adult patients with bile synthesis disorders due to single enzyme decfects
|
|
10/15.Choic Acid- (CHOLBAM)- (Mar 2015)- to treat pediatric patients
|
10/15. Cho
|
|
11/15.
|
11/
|
|
11/15. CORLANOR-(Ivacadine)-(Mar 2015)-
|
13/15. VIBERZI- (Eluxadoline)- (May 2015)- to treat irritable bowel syndrome with diarrgea in adults men and women
|
|
13/15.VIBERZI- (Eluxaduline)- (May 2015)- to trrat iritable bowel syndrome
|
13/15. Viberzi-Eluxaduline
|
|
13/15. CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Eluxadoline is a mu-opioid receptor agonist; eluxadoline is also a delta opioid receptor antagonist and a kappa opioid receptor agonist. The binding affinities (Ki) of eluxadoline for the human mu and delta opioid receptors are 1.8 nM and 430 nM, respectively. The binding affinity (Ki) of eluxadoline for the human kappa opioid receptor has not been determined; however, the Ki for guinea pig cerebellum kappa opioid receptor is 55 nM. In animals, eluxadoline interacts with opioid receptors in the gut. 12.2 Pharmacodynamics Cardiac Electrophysiology At a dose 10 times the maximum recommended dose (100 mg), VIBERZI does not prolong the QT interval to any clinically relevant extent. 12.3 Pharmacokinetics Following oral administration of 100 mg VIBERZI in healthy subjects, the Cmax of eluxadoline was approximately 2 to 4 ng/mL and AUC was 12 to 22 ng.h/mL. Eluxadoline has approximately linear pharmacokinetics with no accumulation upon repeated twice daily dosing. The variability of eluxadoline pharmacokinetic parameters ranges from 51% to 98%. Absorption Absolute bioavailability of eluxadoline has not been determined. The median Tmax value was 1.5 hours (range: 1 to 8 hours) under fed conditions and 2 hours (range: 0.5 to 6 hours) under fasting conditions. The administration of VIBERZI with a high fat meal that contained approximately 800 to 1000 total calories, with 50% of calories being derived from fat content decreased the Cmax of eluxadoline by 50% and AUC by 60%. Distribution Plasma protein binding of eluxadoline was 81%. Page 12 of 18 Reference ID: 3766744 Elimination The mean plasma elimination half-life of eluxadoline ranged from 3.7 hours to 6 hours. Metabolism Metabolism of eluxadoline is not clearly established [see Drug Interactions (7)]. There is evidence that glucuronidation can occur to form an acyl glucuronide metabolite. Excretion Following a single oral dose of 300 mg [14C] eluxadoline in healthy male subjects, 82.2% of the total radioactivity was recovered in feces within 336 hours and less than 1% was recovered in urine within 192 hours. Specific Populations Hepatic Impairment Following a single oral 100–mg dose in subjects with varying degrees of liver impairment and healthy subjects, mean eluxadoline plasma exposure was 6-fold, 4-fold, and 16-fold higher in mild, moderate, and severe hepatically impaired subjects (Child Pugh Class A, B, C), respectively, compared to the subjects with normal liver function [see Dosage and Administration (2), Contraindications (4), Use in Specific Populations (8.6)]. Drug Interactions In Vitro Assessment of Drug Interactions In vitro studies indicate that eluxadoline is neither an inducer of CYP1A2, CYP2C9, CYP2C19, and CYP3A4, nor an inhibitor of CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP3A4 and CYP2D6 at clinically relevant systemic concentrations. Alth1
|
13/15.
|
|
13/15. Vibella- (Deoxycholic acid)- (Apr 2015)- to treat irritable bowel syndrome with diarrhoea (IBS-D)- in adult men and women
|
14/15.
|
|
14/15.
|
14/15. Cangrelor-(KENGREAL)- (June 2015)- to pevent the formation of harmful blood clots in the coronary arterties for adult patients undergoing percutaneous cororonary interventions
|
|
15/15- Lumacaftor 200mg/ Ivacaftor125mg( ORKAMBI)- (July 2015)- To treat cystic fibrosis
|
16/15. Sacubitril/ Valsartan- (ENTRESTO)- (July 2015)- to treat heart failure
|
|
17/15. Brepiprazole- (REXULTI)- (Jul 2015)- to treat schizophrenia as as add on antidepressant to treat mjor depressive disorder
|
18/15. Airocumab- (PRALUENT)- (July 2015)- to treat certain patients wihg cholestrol
|
|
19/15. Sonidegib- (ODOMZO)- (July 2015)- to treat patient to treat patients that has recurred following surgery or radiation therapy
|
20/15. Dacatasvir- (DAKLINZA)- (July- 2015)- to treat hepatitis virus (HCV)- genotype infections
|
|
21/15. Flibanserin- (ADDYI)- (Aug 2015)- to treat generalized hypoactive sexual desire disorder (HSDD)- in premonopausal women
|
21/15. Flibanserin- (ADDYI)- (Aug 2015)- to treat generalized hypoactive sexual desire disorder (HSDD)- in premonopausal wom
|
|
21/15. Flibanserin- (ADDYI)- (Aug 2015)- to treat generalized hypoactive sexual desire disorder (HSDD)- in premonopausaln
|
22/15. Evolocumab- ((REPATHA)- (Aug 2015)- to treat certain patients with high cholesterol
|
|
23/15. Rolapitant- (VARUBI)- (Sept 2015)- to prevent phase chemotherapy-induced nausea and vomiting (emesis)
|
24/15. Uridine triacetate -(XURIDEN)- (Sep 2015)- to treat patients with hereditary orotic aciduria
|
|
24/15. Uridine triacetate -(XURIDEN)- (Sep 2015)- to treat patients with hereditary orotic id
|
25/15. Cariprazine- (VRAYLAR)- (Sept 2015)- to treat schizophrenia and bipolar disorder in adults
|
|
26/15. Trifluridine and Tipiracil-(LONSURF)- (Sept 2015)- to treat patients with an advanced form of coorectal cancer who are no longer responsing to other therapies
|
26/15. Trifluridine and Tipiracil-(LONSURF)- (Sept 2015)- to treat patients with an advcd form of coorectal cancer who are no longer responsing to other therapies
|
|
27/15. Insulin degludec Inj-(TRESIBA)- (Sep 2015)- to improve blood sugar (glucose) in adults with diabetes control in adults with diabetic mellitusme
|
28/15. Aripiprazole- (ARISTADA)- (Oct 2015)- to treat adults with schizophrenia
|
|
29/15. Idarucizumab- (PRAXBIND)- (Oct 2015) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa's blood thinning effects
|
30/15. Patiromer for Oral Suspn. (VELTASSA)- (Oct 2015)- to treat hyperkalemia in which the amount of potassium in the blood is too high
|
|
31/15. Trabectedin- (YONDELIS)- (Oct 2015)- to treat specific soft tissue sarcomas(STS)- liposarcoma and leiomyosarcoma -that cannot be removed by surgery (unresectable) or is advanced (metastatic)
|
32/15. Asfotase alfa- (STRENSIQ)- (Oct 2015)- to treat perinatal, infertile and juvinile-onset
|
|
33/15. Mepolizumab- (NUCALA)- (Nov 2015)- for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older
|
34/15. Fixed dose combinatin tablet contg Elvetegravir,Cobicistatavir- (GENVOYA)- (Nov 2015)- (Nov 2015)- for use as a complete treatment of HIV -1 infection in adults and pediatric patients 12 years of age and older
|
|
35/15. Cobimetinib- (COTELLIC)- (Nov 2015)- to be used with combn of Vemrafenib to treat svanced melanoma that has spread tp other parts of the body that cannot be removed
|
36/15. Osimertinib- (TAGRISSO)- (Nov 2015)- to be used in combination with vemurafenib to treat advanced melonoma that has spread to other parts of the body or cant be removed by surgergy and that has a certain type of abnormal gene BRAF V600E or V600k mutation
|
|
37/15. Daratumumab- (DARZALEX)- (Nov 2015)- to treat patients with multiple myeloma who have received at least three prior treatments
|
38/15. Ixazomib- (NINLARO)- (Nov 2015)- to treat people with multiple myeloma who have received at least one prior therapy
|
|
39/15. Necitumumab- (PORTRAZZA)- (Nov 2015)- to treat patients with advanced (metastatic)- squamous non-small cell lung cancer (NSCLC)- who have not previouslymedication specially for treating their advanced lung cancer received
|
40/15. Elotuzmab- (EMPLICITI)- (Nov 2015)- to treat people with multiple myeloma who have received on or three prior medications
|
|
41/15. Sebelipase alfa- (KANUMA)- (Dec 2015)- to treat patients with a rare disease known as lysosomal acid lipase (LAL)- deficiency
|
42/15- Alectinib- (ALECENSA)- (Dec 2015)- to treat ALK- positive lung cancer
|
|
43/15. Sugammadex-( BRIDION)- (Dec 2015)- to reverse effects of neuromuscular blocking drugs used during surgery
|
44/15. Selexipag- (UPTRAVI)- (Dec 2015)- to reverse effects of neuromuscular blocking drugs during surgery
|
|
45/15. Lesinurad- (ZURAMPIC)- (Dec 2015)- to treat high blood uric acid levels associated with gout
|
42/15. Alectinib- (Alecensa) (Dec 2015)- to treat ALK positive lung cancerug
|
|
44/15. Selexipag- (UPTRAVI)- (Dec 2015)- to treat pulonary hypertension
|
44/15. Selexipag- (UPTRAVI)- (Dec 201 to treat artterial hyperstension
|
|
44/15. Selexipag- (UPTRAVI)- (Dec 2015)- to reverse effects of neuromuscular
|
44/15. Selexipag(
|
|
44/15. Selexipag-(UPTRAVI)- (Dec 2015)- to treat pulmonary arterial hypertension
|
44/15. Selexipag (UPTRAVI)- (Dec 2015)- to treat pulmonary artetial hypertension
|
|
45/15. Lesinurad- (zurampic )- (Dec 2015)- to treat high blood uric acid levels associated with gout
|
BRITISH NATIONAL FORMULARY- 68-(BNF 68)@@@
|
|
47/15. Pegaptanib Sodium- (BNF)- (MACUGEN -Pfizer)- Ocular diagnostic agent
|
46/15. Aflibercept- (BNF)- (EYELEA) -Bayer) -Ocular diagnostic agent ==
|
|
47/15. BRITISH NATIONAL FORMULARY (BNF 1968) DRUGS
|
1/25. Berdazimen- (ZELSUVMI)- (Jan 2024) to treat
|
|
1/25. Berdazimen- (Zelsuvmi)-
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat mollusconm contra glos
|
|
1/24
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat musculat contrtation
|
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to tre at contration of muscles
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024) to treat muscular contration
|
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat contration of muscles
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat mollusconm
|
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat molluscon
|
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to
|
|
novel drug approval for 2024
|
About Us